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1. Introduction 
This is a thesis about breast cancer screening. Screening is searching for disease in a 
population free of symptoms (Forsmo, 2003). Breast cancer is the most common 
cancer among women in the western world. In Norway, the most recently published 
statistics on cancer showed an age adjusted incidence rate for breast cancer of 72,4 
per 100.000 (Cancer Registry of Norway, 2007). There were 2735 new cases of 
female breast cancer in average every year between 2002 and 2006, while 694 women 
died of breast cancer in 2004. The wish to reduce mortality from breast cancer 
resulted during the 1990’s in a political will to initiate a screening program for breast 
cancer in Norway (NOU, 1987), even though experts were sceptical to its benefit 
(Westin, 1989; Mørland, Lund Håheim, & Linnestad, 2002; Holst et al., 1989). The 
initial breast cancer screening project started in four counties in 1996, and became 
nationwide in 2004 (Hofvind, 2005). In the Norwegian Breast Cancer Screening 
Programme all women aged 50-69 are invited to mammography every second year. 
Nearly 80% of the target population participated during its first round. Later there has 
been a decline in participation rates (Feiring, 2004). 
Mammography is an x-ray examination of the breast. The result of the examination is 
black-and-white images that are interpreted by radiologists in search for abnormalities 
that may be indications of cancer. Research on mammography screening has primarily 
been randomized controlled trials to establish the effect of screening upon mortality. 
Women’s experiences as participants have not been much studied, with only three 
studies in Norway – of which all are survey studies (Ekeberg, Skjauff, & Kåresen, 
2001; Gram, Lund, & Slenker, 1990; Hofvind, Wang, & Thoresen, 2003). Yet, not all 
aspects of the experience of mammography screening can be explored through 
surveys and quantitative studies.  
Lay women who receive an invitation to participate in a screening programme are 
likely to have experiences of mammography that are somewhat different than those of 
medical professionals working with breast cancer or of policy-makers discussing 
effects from randomized controlled studies. It is worth noting here that screening is 
primarily an examination of the non-symptomatic. The implication of this is that 
participants in a screening programme may have an experience of going from well to 
unwell – not due to symptoms experienced in their bodies, but through technological 
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detection of non-symptomatic abnormalities. This raises questions about experiences 
of screening, health and breast cancer, as well as questions about these experiences’ 
relation to other aspects in our society. I will attempt to answer some of these 
questions in this thesis.  
My Ph.D project has been part of the umbrella project “Screening and health 
examinations – the path to improved health?”. When starting the research project 
there were few articles to be found on Norwegian women’s experiences and 
knowledge about mammography. Therefore, our research group wanted to explore 
how women experienced being participants in a national screening program for a 
potentially lethal disease. We wanted to gain knowledge about women’s experiences 
of mammography screening, as well as study their knowledge of breast cancer and 
attitudes towards screening programmes, medical technology and examinations for a 
disease of which they were non-symptomatic.  
The focus of my part of the project has been on how women experience their 
participation in a public screening programme and what it is that makes them 
experience mammography screening as they do. Furthermore I wanted to look into 
how women experienced meeting the consequences of screening participation, that is, 
how they experienced being recalled for further examinations due to an abnormal 
mammogram.  
The field of mammography screening has many agendas and different statements. As 
a member of a Canadian provincial government committee planning the 
implementation of a breast cancer screening programme, Patricia Kaufert discovered 
that there were two discourses at the field. One discourse was about whether 
mammography satisfies the formal rules of screening, while the other was about faith, 
emotions, responsibility, morality, compliance and guilt (Kaufert, 2000). Kaufert 
found that she had to read medical rather than social science literature since the 
discourses of screening were much neglected by social scientists. This has also been 
the case when exploring the field surrounding women’s experiences of mammography 
screening in Norway. It has been necessary to define the field while looking at it. I 
will discuss this at greater length in the final article of this dissertation, a 
methodological article on focus group research. Meanwhile, it is necessary to present 
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the field quite thoroughly in this introduction to give the reader an impression of how 
I perceive the context of mammography screening.  
The two discourses Kaufert (2000) identified in the field of mammography screening 
will be mentioned in the different parts of this thesis. Continuing the introduction, I 
will present themes from the “first” discourse: the discourse about the formal rules of 
screening. I will present medical debates about mammography screening and look 
into its implications. Furthermore, I will present prior research about participation and 
experiences of mammography screening, issues related more to Kaufert’s “second 
discourse of screening”. In the following chapters I will discuss more issues about 
both these discourses on mammography screening; issues that show the relations 
between them and how they are present in women’s experiences.  
First in this chapter I will give a presentation of the term screening, and questions 
rising from its definition that concerns screening in general and mammography 
screening in specific.  
What is screening? 
Screening for preclinical disease has a short history. Defining screening through 
questions of validity of the screening test, prognostic benefit from early treatment and 
the existence of a screening service, screening has existed no longer than the 20th 
century (Morabia & Zhang, 2004). The term “screening” was originally meant to 
describe the process in which particles of different sizes were separated by filtering 
them through a screen, for instance in coal mines (Brodersen, 2006). The mesh width 
through which particles were screened, determined which particles were let through 
the net, and which were left behind. This is also the case with medical screening: the 
mesh width, or rather the precision of the test, decides who are classified as well and 
who are in need of further examination.  
Using screening to describe a medical practise has generated many definitions of the 
term, with the search for non-symptomatic disease as its main aim (Holland, Stewart, 
& Masseria, 2006). Summarizing them, one can say that screening is searching for a 
defined disease, using a specific tool, in a whole population free of symptoms 
(Forsmo, 2003). It is based on the assumption that diagnosing a disease in an early 
stage improves its prognosis, and its main aim is to reduce morbidity and mortality 
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among those who are screened (Hofvind, 2005). Mass screening is the large-scale 
screening of whole population groups (Holland et al., 2006). The National Screening 
Committee in the United Kingdom defined screening to be:  
“a public health service in which members of a defined population, who do not necessarily perceive 
that they are at risk of, or already affected by, a disease or its complications are asked a question, or 
offered a test to identify those individuals who are more likely to be helped than harmed by further 
tests or treatment to reduce the risk of disease or its complications” (Holland et al., 2006).  
Different definitions of screening can thus, as we see from these examples, include 
different values and insinuate a variety of consequences from screening practice. An 
implication of this last definition is that the public health service defines people to be 
at risk or even diseased when perceiving themselves as well and healthy.  
In 1968, the World Health Organisation (WHO) established ten principles of early 
disease detection (Hofvind, 2005; Wilson & Jungner, 1968; Holland et al., 2006). 
These principles can be seen in all debates on mammography screening, but with 
emphasis on different elements in different discussions, and also depending on the 
position of the discussant.  
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Figure 1: The World Health Organization’s ten principles for screening for 
disease (Wilson & Jungner (1968), used in Hofvind (2005)). 
1. The condition sought should be an important health problem 
2. There should be an accepted treatment for patients with recognized disease 
3. Facilities for diagnosis and treatment should be available 
4. There should be a recognizable latent or early symptomatic stage 
5. There should be a suitable test or examination 
6. The test should be acceptable in the population 
7. The natural history of the condition, including development from latent to 
declared disease, should be adequately understood 
8. There should be an agreed policy on whom to treat as patients 
9. The cost of case-findings (including diagnosis and treatment of patients 
diagnosed) should be economically balanced in relation to possible 
expenditure on medical care as a whole 
10. Case finding should be a continuing process and not a “once and for all” 
project 
 
Whether mammography screening fulfils all these principles has been, and still is, 
subject to debate. Here I will only give a short outlining of difficulties of some of the 
principles; that is the ones I perceive as most important for women’s experiences as 
screening participants. As for the first three principles, breast cancer can be stated as 
an important health problem as it is the most common cancer among western women 
today. Incidents are still rising (Hofvind, 2005), although there are claims that the 
rising incident can be blamed on over-diagnosis due to screening (Zahl, Strand, & 
Maehlen, 2004; Zackrisson et al., 2006). Furthermore, accepted treatments for breast 
cancer exist, and in Norway there are facilities for diagnosis and treatment – facilities 
that have been further developed due to the implementation of the breast cancer 
screening programme. Also the tenth principle about a continuing process of 
screening is attended to by having an ongoing screening programme. The ninth 
principle of an economically balanced cost of case-findings is a large and major 
question, but is outside of the problems to be addressed here and will not be further 
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discussed in this thesis. This leaves five principles (4-8) to which I will give some 
more attention.  
Principle 4 of “The WHO’s ten principles of early disease detection” is that there 
should be a recognizable latent or early symptomatic stage. Cancer has for a long time 
been seen as a disease where patients might benefit from early detection, even before 
symptoms occur. This has made cancer screening attractive for health service 
providers. Cancer screening has for many years been viewed as a public health task 
aimed at disease prevention through early discovery and cure (Jepson et al., 2005). 
Breast cancer, as well as cancer of the cervix, has been seen as especially suitable for 
early detection as they occur near the surface of the body rather than “deep below” as 
in other organs (Kaufert, 2000).  
The question of whether cancer has a recognizable early symptomatic stage is also 
closely connected to the seventh principle about how the natural history of the 
condition should be adequately understood. The natural history of breast cancer 
includes for instance development from latent to manifest disease, its lead time bias 
and its potential to spread to other organs. Viewing cancer test results as a trajectory 
with normal at one end and cancer at the other is a theoretical construct (Kaufert, 
2000). One dilemma concerning breast cancer is the issue of ductal carcinoma in situ 
(DSIS). This is a precancerous stadium that is relevant for breast cancer examinations. 
DSIS may, or may not, progress to invasive cancer (Hofvind, 2005; Evans et al., 
2001; Kaufert, 2000). This is not necessarily common knowledge among screening 
participants. Women in an American study were found to know little of DCIS, even 
after being diagnosed with it (Schwartz et al., 2000). Another claim that has been 
raised about the nature of cancer is a theory of cancer as potentially regressive (Zahl 
& Maehlen, 2005). Even though this claim has met resistance in medical journals, it 
points to uncertainties in knowledge of the nature of breast cancer. Both the question 
of regressive cancer and issues of DSIS are indications of a certain amount of over-
diagnosis of breast cancer from having a screening programme (Zahl et al., 2004; 
Zackrisson et al., 2006). These are important questions when discussing the eighth 
principle of early disease detection from the WHO about an agreed policy on whom to 
treat as patients.  
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The problems with not knowing the natural history of breast cancer with complete 
certainty is that medical personnel have a moral obligation to act upon symptoms or 
signs of disease. Once a potential cancer is discovered, it becomes unethical to 
maintain a “wait and see”-approach (Kaufert, 2000). This implies that when searching 
for pre-symptomatic disease, interventions will be made on more individuals than 
would have been necessary if symptoms were discovered at a later stage. 
Interventions may save lives, but they do also alter women’s lives and identities 
(Kaufert, 2000).  
A question of particular importance is the issue of whether you have a suitable test or 
examination (WHO’s fifth principle for early detection of disease). A criterion for the 
suitability of a test is its accuracy: its sensitivity and specificity. A test’s sensitivity 
depends on its ability to find those who have the disease, so that no one with a disease 
is left undiagnosed. Its specificity concerns the test’s ability to avoid diagnosing those 
who are healthy. There are thus four outcomes of medical screening (Figure 2). Either 
the test is positive, or it is negative. And the person tested can either be healthy or 
have the disease. 
Figure 2: The outcomes of medical screening 
 Person with disease Healthy person 
Positive screening test True positive False positive 
Negative screening test False negative True negative 
 
In a screening with low sensitivity, many persons with disease are missed, while in 
screening with low specificity many healthy persons will test positive and either be 
diagnosed or have to go through further unnecessary testing. This can be seen in 
medical screening as well as for crime surveillance technologies (Sætnan, 2007). 
Debates about mammography screening have most recently been concerned with the 
question of false positives, and the amount of wrong diagnoses acceptable while 
maintaining a screening programme (Brodersen, 2006; Zahl et al., 2004). The 
percentages of false negative and false positive results are difficult to estimate. What 
can give an impression of the accuracy of the test is the positive predictive value. This 
is the number of true positives from all those who test positive in the screening test. 
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During the initial mammography project in four counties in Norway, the positive 
predictive value were 16,2 per cent (Wang, Hofvind, & Thoresen, 2000). This means 
that out of 100 women with an abnormal screening mammogram about 16 women 
were subsequently diagnosed with breast cancer. However, false positives and false 
negatives will always be an issue when using probabilistic reasoning to determine the 
treatment of individuals (Rose, 2001).  
The sixth WHO-principle on early detection of disease, and the last to be discussed 
here, is the principle that the screening test should be acceptable in the population. 
This means that the negative consequences should not outnumber the positive, and 
should not be more severe than the positive consequences. The disadvantages of 
screening are harms that would not appear without participating in screening 
(Hofvind, 2005). Hofvind (2005) points to the 76 per cent attendance rate in the 
Norwegian breast cancer screening programme as indicating that mammography is an 
acceptable screening test in the population. Nevertheless, little is known about what 
lay participants know about the problematical aspects of screening as discussed 
above. The question is thus not only about the acceptability of the test in it self, but 
also what kind of implications that are acceptable for lay participants when there is an 
ongoing debate among experts about the benefit from mammography screening. An 
implication of screening is that it might provide large gains for those few whose lives 
are saved, while disadvantages from screening influences many women but are 
probably smaller for each woman going through recalls and potential false positive 
diagnosis. It is thus a simple task to name benefits from screening, but discussing its 
disadvantages is a more complex question (Holland et al., 2006). I will therefore ask 
how benefits and disadvantages from screening are interpreted among lay users of a 
screening programme, and whether false-negatives and false-positives are seen as 
comparable positions. A disease is only appropriate for screening if its benefits 
exceed the disadvantages (Hofvind, 2005). But who are the ones who should decide 
when the benefits exceed the negative consequences? And what information is seen as 
needed as a basis for that decision?  
Screening for pre-symptomatic disease is an attempt to reduce mortality and 
morbidity. The discussions for and against a screening programme for breast cancer 
can be seen as a discussion about “good intentions”: all parties want the population 
provided with the best means for securing its health. The purpose of detecting the 
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abnormal within a normal population is well intended (Kaufert, 2000). But, a 
screening programme initiated by a national health authority by targeting healthy 
individuals nevertheless raises questions. A national public screening programme can 
be understood as a technology for governing the health of the population (Hydle, 
2003). Meland (2007) says that these are not about the paternalistic nature of the 
programme, but also about how the programme is a means for the authorities to 
shepherd the population. I will return to this question in the second chapter of the 
thesis, but first I will go more into the specific debates about mammography 
screening.  
Mammography screening – the debate continues 
Breast cancer is seen as appropriate for screening because its lethality is related to 
clinical stages of diagnosis (Hofvind, 2005). The need for detecting lumps early to 
give better prognoses for survival from breast cancer made mammography screening 
a good alternative to other interventions, that had been primarily radical mastectomy1 
(Lerner, 2001). Mammography screening was initiated in the United States during the 
1960’s (Lerner, 2001). A randomized controlled trial (RCT), the HIP-study, was 
launched in 1963, becoming the only RCT carried out in the United States (Shapiro, 
1977). Other studies would follow in other countries, such as the Canada trials (Miller 
et al., 2000; Miller et al., 2002), the Edinburgh trial (Alexander et al., 1999), and 
studies in several counties in Sweden – Malmö (Andersson et al., 1988); Kopparberg 
and Östergotland (WE-study) (Tabar et al., 1995); Stockholm (Frisell et al., 1997); 
and Göteborg (Bjurstam et al., 1997).  
Most of the studies have reported some reduction in breast cancer mortality among 
women participating in mammography screening compared to control groups, with 
reductions up to 30 per cent in the WE-study (Tabar et al., 1995). The WE-study has 
later been criticised for bias (Gøtzsche & Olsen, 2000), and the Kopparberg part of 
the study was not available for the meta-study of the Swedish randomized controlled 
trials up to 1996 (Nystrom et al., 2002). The Canada trials and the Malmö trial found 
                                                 
1 Mastectomy is the surgical removal of the breast. For a description of the historical variance in the 
degree of “radical mastectomy” as breast cancer treatment and prophylactic mastectomy as prevention 
of breast cancer, see Lerner (2001).  
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smaller benefit from mammography screening – respectively 20 % from Malmö 
(Andersson et al., 1988), and no effect from mammography in the Canada trials 
(Miller et al., 2000; Miller et al., 2002). The Norwegian breast cancer screening 
programme has not been conducted as a randomized controlled trial. Nevertheless, an 
evaluation of the mammography project in four counties estimated an expected 
mortality reduction of 30 per cent compared to breast cancer mortality in the 
population without mammography screening (Wang et al., 2001). 
RCT’s have become the “gold standard” for medical decision making in the western 
world since the 1960’s, even though they cannot always solve controversies (Weisz, 
2005). This has not least been the case with RCT’s on mammography screening. 
Claims for evidence can be somewhat different between clinicians and 
epidemiologists, with epidemiologists favouring specific forms of quantified data 
(Johansson, Risberg, & Hamberg, 2003). But, in a data material of published papers 
on mammography screening, Sætnan (1992) found no significant difference in 
conclusions about the benefit of mammography between epidemiologists and 
clinicians. Both clinicians and epidemiologists seemed to be in favour of 
mammography screening (Sætnan, 1992).  
Without having made a similar study on recently published papers, there are 
indications that the tide may have turned. Lately, critics of mammography screening 
have made their voices heard, especially questioning the validity of hitherto published 
RCT’s (Gotzsche & Olsen, 2000; Zahl et al., 2004; Welch, 2004). Debating the 
evidence of mammography’s effects also implies debating whether or not 
mammography screening is worthwhile (Nystrom et al., 1993; Gotzsche & Olsen, 
2000; Nystrom et al., 2002). Critical voices on mammography screening were heard 
in the United States already in 1976 (Lerner, 2001), and have later had an impact on 
debates, but obviously not enough impact to prevent screening programs. Screening 
programmes have been initiated in several countries, including most countries in the 
EU, but with some difference in target group and organization (Holland et al., 2006). 
Evaluations from screening programmes indicates reduction in breast cancer 
mortality, even though effects varies in groups of women with different characteristics 
(Gabe & Duffy, 2005; Banks et al., 2004).  
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The research focus on randomised controlled trials for evaluating mammography 
screening can be claimed as a feature of medical research per se, but it is not always 
the medical, quantitative research based evidence that wins ground. May (2006) found 
that argumentation for implementing new technologies in health care systems in UK 
has become more a matter of practice-based evidence than evidence-based practice. 
Evidence-based studies were seen as too distant to practical problems, as well as 
taking too long to provide for practitioners and politicians on the field of local health 
care (May, 2006). Similarly, politicians in Norway did not take the time to await 
evaluations from the initial project of mammography screening in the four counties 
before deciding upon a nationwide screening programme. The 1989 Norwegian 
consensus conference on mammography screening would not recommend a 
mammography screening programme at that time (Holst et al., 1989; Ertzaas, 
Hofvind, & Thoresen, 2001). Nevertheless, the focus on early cancer detection, 
combined with the increasing status of randomized controlled trials, seems to have 
made mammography screening a possibility for the public health authorities and 
policy makers. If politicians are evaluated by their ability to act, technologies that 
allow interventions that pursue better health may be welcomed with or without 
scientific evidence. That at least some of the RCT evidence in this instance supported 
their decision to implement a screening programme must have been a welcome factor 
even though not a necessary condition.  
I will now turn to how the medical perspective may influence participation in 
mammography screening, and further down I will look into what is known about lay 
women’s experiences of mammography screening. 
Participation – more than medical logics 
A question of importance for mammography screening is the question of participation 
in the screening programme. How many and who it is that participates is of interest to 
both screening providers, policy makers and researchers as it can tell us about the 
screening programme’s acceptance in the population, or about the distribution of 
health service use in the population. It can also tell us something about women’s 
choices about participation, but the rates of participation cannot tell how women make 
their decisions. I will go more into this later in this chapter.  
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Participation rates have indeed been much studied, both by service providers and by 
others. A number of characteristics relevant for participation rates among invited 
women have been found, such as education and high income as positive predictive 
values, while increasing age and poor health are negative predictive values (Lairson, 
Chan, & Newmark, 2005). Even though these predictive factors may have different 
impact in different countries, one can expect the main variables to have an effect in 
most of the western countries. Place of residence seems to have an effect on screening 
uptake, both as an urban-rural gradient (von Euler-Chelpin et al., 2006) that may be 
explained by distance to the screening unit as well as an outcome of the connotation 
between place of residence and socioeconomic factors (Pelfrene, Bleyen, & De 
Backer, 1998). Uptake is also connected to ethnicity and cultural beliefs about breast 
cancer (Yi & Reyes-Gibby, 2002; Pfeffer, 2004b; Garbers & Chiasson, 2004).  
A number of studies have been directed towards the issue of screening uptake. Some 
have explored reasons why some groups have particularly low participation rates, for 
instance immigrants in the UK (Ahmad, Cameron, & Stewart, 2005). Others have 
proposed organizational models that make it easier for underserved women to 
overcome barriers towards using health services (Lillquist, 2004). Knowledge of 
breast cancer risks and effects of mammography are concerns for ensuring equal 
uptake in screening programmes among different socioeconomic-, geographical- or 
age groups. Knowledge of breast cancer and prior acquaintance with mammography 
can be connected to questions of family history of cancer (Unic et al., 1997).  
Both lay and professional knowledge has been a concern for those attempting to 
increase uptake. Johnson et al (1998) found for instance that physicians in Seattle had 
relatively low knowledge about breast cancer screening, even though most of them 
saw themselves as competent to answer patient’s questions on the subject. This ought 
to be of importance to screening providers, since another American study (from 
Wisconsin) found recommendations by a physician about annual mammography to 
have an effect on patient’s use of mammography (Brown et al., 1996). Physician’s 
advices might be of greater importance for mammography uptake in countries where 
breast cancer screening is organized through the primary health care service than in 
Norway and other countries where screening is provided by a separate health 
authority. Nevertheless, it could be an indication of the health service’s ability to 
influence people’s choices about mammography screening.  
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Information from interest groups or from screening service providers is thought to 
influence participation and women’s ability to make an informed choice. A question 
raised by critics is whether the information provided is biased, for instance in 
invitation letters (Jørgensen & Gotzsche, 2006) or on websites (Jørgensen & 
Gøtzsche, 2004). Biased information may increase participation rates, but does not 
enable people to make an informed and autonomous choice. Making an informed 
choice is not only about having access to relevant and unbiased information, but also 
about autonomy enabling decisions that reflect personal preferences (Jepson, 
Hewison, Thompson, & Weller, 2005). There might still be practical obstacles or 
value-determined barriers towards carrying out the preferred choice, and indeed there 
is also the question about whether it is possible, or even desirable, to make an 
individual informed choice. This is also discussed in the first article of this thesis.  
Nevertheless, lay women’s knowledge about breast cancer, mammography and 
screening have been put forward as important factors in questions about informed 
choice, as well as about reasons for participation. For instance, beliefs about breast 
cancer and screening among lay women can be seen as a hindrance for making an 
informed consent (Denberg, Wong, & Beattie, 2005). The knowledge and beliefs of 
breast cancer and screening that Denberg, Wong and Beattie found in their study did 
not fit with biomedical knowledge and well-known risks of screening, such as false-
positives or false-negatives, psychological harms or going through diagnostic 
procedures, were hardly mentioned by the interviewed women.  
So, the factors that influence participation are not always given. An Israeli study 
(Hagoel et al., 1999) found that groups of Israeli women participating in 
mammography when invited were more similar to those not participating than to those 
who initiate mammography by themselves, based on a set of structural, behavioural 
and perceptual variables. This may indicate that participating in mammography is 
connected to a lifestyle marker (Hagoel et al., 1999). A question arising here is how 
participation is connected to the organization of a public screening programme as 
opposed to private health service screening. In this research project the focus is on a 
public screening programme, even though it is known that Norwegian women also 
attend private mammography screening (Hofvind, 2006). Statistics for attendance at 
private mammography screening is not available. We can thus only assume that many 
of those who decline the public screening programme attend a private clinic to have 
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non-symptomatic mammography. Private screening will not be discussed in this 
thesis.  
Other important factors for participation in a mammography screening programme 
seems to be whether one has prior experience with mammography (von Euler-Chelpin 
et al., 2006), and how the prior mammography examination was experienced 
(Hofvind et al., 2003; Peipins et al., 2006). There are conflicting views on whether 
fear of cancer acts as a facilitator or inhibitor of breast cancer screening participation. 
Worries about breast cancer have been found to influence screening behaviour (Hay, 
McCaul, & Magnan, 2006). In their meta-analysis, Hay et al (2006) found that there 
was a positive relationship between breast cancer worries and participation in 
mammography screening. However, one of the studies in the meta-analysis found a 
negative effect of breast cancer worries on screening participation.  
Studies on the effect of false-positive mammograms on screening attendance also 
varies in their results (Brewer, Salz, & Lillie, 2007). While some studies conclude that 
false-positive breast cancer screening participants are more likely to participate in the 
following screening rounds compared with those experiencing a normal mammogram 
(Ganott et al., 2006; Lampic, Thurfjell, & Sjødén, 2003; Schwartz et al., 2000; Gram 
et al., 1990), other studies found women with a false-positive mammogram to be less 
inclined to participate in routine screening (Brett & Austoker, 2001; Hofvind et al., 
2003). Brewer et al’s review (2007) found unexpectedly that re-attendance was higher 
among women with a false-positive mammogram in the United States than in Europe 
and Canada – where a false-positive mammogram gave less re-attendance in routine 
screening. The reasons for this can be ascribed to structural factors of screening in 
Europe and the United States respectively, with screening interval, accuracy of 
mammography readings, national screening programs and “opt out” versus “opt in” 
systems (Brewer et al., 2007). 
Even though Brewer et al (2007) found that the studies in their review showed 
variance in the effects of having a false-positive mammogram, having a false-positive 
screening result can give other long-term consequences, such as a higher degree of 
breast cancer worries, higher degree of performance of self-examinations and anxiety 
when facing the next mammography screening (Brett & Austoker, 2001; Aro et al., 
2000; Lampic et al., 2003). Nevertheless, measurements of anxiety levels have been 
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criticized for being inadequate. One response to this has been the development of a 
specific questionnaire (PCQ) to measure breast cancer screening anxiety in particular 
(Cockburn et al., 1992; Brodersen, Thorsen, & Cockburn, 2004). A Swedish study 
using the PCQ found anxiety levels among recalled women to be significantly higher 
than among women with a negative screening result (Olsson et al., 1999).  
Yet, women’s perspectives on (their own) health are not only based on their 
knowledge and this knowledge’s connections with biomedicine. On the contrary, life 
experiences, everyday life and cultural interpretations may influence how biomedical 
knowledge is perceived. Lay women do not necessarily see cancer as connected to an 
organ or cell as biomedicine does, but rather categorize its causes as a mixture of 
cultural and normative claims (Pfeffer, 2004b). These culturally conditioned 
understandings of cancer can also influence participation in, and experiences of 
screening for cancer. For instance, if cancer is seen as a curable disease when detected 
early, screening can be worthwhile, but if cancer is seen as always fatal, early 
diagnosis might be seen as a waste of time (Pfeffer, 2004b; Straughan & Seow, 2000). 
Thus, even though knowledge of biomedical facts might be necessary for enabling an 
informed choice as defined by medical ethics, it is not necessarily enough. As 
presented in article I in this thesis, there remain questions about whether women want 
to make an autonomous choice about participation in medical screening, or if 
autonomy is secondary for women’s concerns of their own health.  
Lay experiences of screening  
Lay women who are invited to and who participate in mammography screening not 
only have to make choices about participation, but are also facing experiences of a 
mammography examination, as well as a period of waiting for the results, receiving a 
recall or being diagnosed with breast cancer. Women’s experiences from screening 
can be seen from different perspectives and levels. Experiences of mammography 
screening can be understood as experiences of the mammography examination in 
terms of waiting time, pain or care, as well as experiences of anxiety and relief from a 
“good” result (Hofvind et al., 2003).  
But, there are also other elements to women’s experiences of screening. Participating 
in screening can be seen as a moral obligation (Howson, 1999). Howson found 
women participating in cervical screening to see the screening as a routine, as well as 
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a possibility to fill one’s responsibility to oneself, and an obligation to participate 
when called. Responsibility for health can be seen as both as a matter of individual’s 
responsibility for their own body and health, as well as a question of good citizenship 
(Willis, 2004). Women’s experiences of screening are thus closely connected to the 
attribution of meaning. If we perceive screening as a moral obligation towards 
ourselves, others and the state, choices about participation are no longer solely an 
issue of rational choice based on statistical health effects. Rather, the meanings 
attributed to screening are part of a social process, dependent on relations to others.  
The interaction between women’s responsibility for both good health and good 
citizenship can be seen as made possible by the government providing a screening 
service. Women in rural Australia saw the government as “reaching out to them” 
when communities were provided with a mobile screening unit for breast cancer 
(Willis, 2004). Governmental “reaching out” can also be seen when talking about the 
letter of invitation for a screening programme. A Swedish study of cervical screening 
found that the letter of invitation gave incentives for two types of reasoning about 
participation in the screening (Forss et al., 2001). On the one hand, the letter of 
invitation catalysed thoughts about the beneficial aspects of attendance, and on the 
other hand it became a means to overcome hindrances to attendance. Also, 
participating in the cervical cancer screening programme was described by some as 
part of their own contact with the health care system that made it possible to maintain 
their active role in personal health promotion (Forss et al., 2001).  
Women’s responsibility for their bodies and health is not a new issue in medical 
thought. The American Journal of Nursing wrote as early as 1923 that “only neglected 
cancer is incurable” (Jasen, 2002). In 1977 this utterance seems to have maintained its 
validity, when one of the “fathers” of the HIP-study2, radiologist Philip Strax, claimed 
that women declining to be screened were “playing Russian roulette with their lives” 
(Lerner, 2001). One can ask whether or not the idea of women’s responsibility for 
breast cancer is different now.   
In a Danish study, women participating in screening believed that “early detection of 
cancer will save lives” (Lunde, 1997). A qualitative study from the United States 
                                                 
2 The HIP-study is the randomized controlled study of mammography screening in New York. 
 22
found women’s beliefs about early detection of breast cancer as so essential for saving 
lives that it overshadowed any doubts the women might have about mammography 
screening (Silverman et al., 2001). Women who have recently had a mammography 
have also been found to overestimate the benefits of  mammography (Domenighetti et 
al., 2003; Ganott et al., 2006). Whether this would apply to Norwegian women were 
unknown when we started this research project. 
Different groups of women may have different experiences from being the target of a 
screening programme for breast cancer. Some are “just” participants in the 
mammography examination while some women feel the consequences of 
participation in mammography screening through being among those recalled. A few 
of these women are even diagnosed with breast cancer. About 20 per cent of those 
recalled eventually have a breast cancer diagnosis.3  
Recalled and diagnosed women may have a more complex experience than those who 
receive an “all well”-notice after the mammography examination. Recalled women in 
Montreal seemed to overestimate their own risk of having a malign tumour when 
having a breast biopsy following an abnormal mammogram (Lebel et al., 2003). 
Anxiety rising from the recall letter as well as other aspects of being recalled may 
influence these women’s experiences. Relief over having a good result in the end can 
be mixed with doubts about whether it was worth the trouble (Padgett et al., 2001).  
There are also some women who decline the invitation to mammography screening. It 
is possible that many of these non-attenders are women who choose private 
mammography clinics instead of participating in public screening, leaving only a 
small group of women as actual non-attenders. Little is known about these non-
attenders. A Swedish telephone-interview study of non-attenders found that barriers, 
benefits and worry represented the major determinants of participation in 
mammography, and that knowledge could overcome barriers to screening 
participation (Lagerlund et al., 2000). In a pilot interview to a third part of this 
research project that was never carried through, I found that there can be small 
differences between attendance and non-attendance in terms of arguments for or 
against participation. But, the interview showed that there are other kinds of aspects 
                                                 
3 Information given in the recall letter sent to screened women in Central Norway. 
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of women’s everyday lives and life experiences that are perceived as more important 
than mammography screening or other medical tests. However, even though 
knowledge of non-attending women and their reasons for declining an invitation to a 
health examination is interesting for many parties, there are also ethical questions 
about whether or not they ought to be explored. Giving non-attenders a voice in the 
public debate is one side of the coin; the other side is whether non-attenders rather 
should be allowed to maintain a space of non-regulation without counter-arguments 
from screening providers.  
The exploration of how women interpret their participation, mammography and breast 
cancer is indeed important for the discussion of cancer screening. Cultural aspects of 
how women understand breast cancer and the fact that mammography screening had 
just been initiated in Norway were some of the research group’s reasons to be curious 
about Norwegian women’s perceptions and interpretations of being participators in a 
screening programme for breast cancer.  
Aim and approach of the study 
As I have shown in this introduction, mammography screening is a multifaceted 
research field, and a field where both policy and research base their credibility on 
several discourses. Prior research has had its main focus on the effect of cancer 
screening on mortality and participation. But, as shown above, there has also been 
some research on individual choice and autonomy in screening programmes, as well 
as some research on how women experience participating in screening programmes. 
Of the three studies conducted on women’s experiences of mammography screening 
in Norway (Gram et al., 1990; Hofvind et al., 2003; Ekeberg et al., 2001) none are 
qualitative studies.  
The kind of problems that has been addressed in research on mammography screening 
has primarily been from the “first discourse on mammography screening” pointed to 
by Kaufert (2000). But, one might ask what other answers one would produce if the 
questions were posed from a different position than the dominant one (Bacchi, 1999). 
Researching mammography screening, I will ask what is left unproblematized when 
mammography screening is represented as a medical, statistical or “rational choice” 
problem. It will be relevant to ask whether these representations of screening 
influence women’s experiences of being the target population for a mammography 
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screening programme. Furthermore, there might exist a “second discourse on 
mammography screening” (Kaufert, 2000); a discourse that is about faith, emotions, 
responsibility, morality, compliance and guilt. In the midst of these discourses we find 
the lay women who are invited to, and who participate in the mammography 
screening programme. The aim of this study is to explore how women experience 
participating in a public mammography screening programme. Different groups of 
women have different experiences of mammography screening, and I have chosen to 
study women who go through the mammography screening and receive an “all well”-
answer, as well as those women who have to go through further examinations due to 
an abnormality at their first mammogram. The research question is thus:  
What are the experiences of women who are invited to join the screening 
programme when making their decision to participate, when participating, and 
when facing a recall letter?  
Structure of the thesis 
This thesis consists of four articles plus a “framing section”. The four articles that are 
the result of the analyses from my PhD-project are presented in the end of the thesis. 
The first article is an exploration of how women experience being invited to a public 
breast cancer screening programme and what it is that has the greatest influence on 
their decision to participate. The second article examines if and why women have 
trust in mammography to save them from cancer. Article three is about participants in 
mammography screening who receive a recall letter due to an abnormal mammogram. 
It asks how they interpret the recall letter and how information influences their 
experience of facing a potential cancer diagnosis. The fourth article is about the use of 
a qualitative methodology on a research field primarily dominated by medical 
research with its focus on statistical generalization and evidence-based research.  
The framing section in turn provides four cornerstones: 1) This chapter, in which I 
present features of the field that form a background for my study, 2) A discussion of 
the theories undergirding my approach, 3) Methodological reflections, going 
somewhat deeper into these issues than the article format allows, and 4) an 
overarching discussion and conclusions tying the four articles closer together than 
when each stand alone in separate publication contexts.  
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In the next chapter I will thus give a theoretical framework to the analyses that are 
given in the four articles. The theories are used more implicit than explicit in the 
articles, except for discussions of trust in article II. The article format has not given 
room for explicit theoretical discussions, and the perspective of governmentality that 
is the main point in both the theoretical framework and discussion is used more 
implicitly in the articles. Nevertheless, the theoretical framework will present a 
perspective on how we can understand women’s experiences of mammography 
screening in a wider social context. The theoretical framework will also explore 
themes concerning the “second discourse of mammography screening” (Kaufert, 
2000).  
The third chapter of the thesis presents the methods used to sample and analyse the 
data material for the study. As the thesis is built upon two studies where one is a focus 
group study with women invited to a breast cancer screening programme, and the 
other contains data from individual interviews with women recalled after participating 
in mammography screening, I will present both these methods respectively.  
In the final chapter I will draw the lines between the articles and the introductory 
chapters of the thesis. I will discuss how women’s experiences of mammography 
screening draw on both the first and the second discourses of mammography 
screening that have been presented by Kaufert (2000). I will also lean on the fourth 
article in the thesis to see how these discourses influence how we study women’s 
experiences of mammography screening.  
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2. Theoretical framework 
As mentioned in the introductory chapter, Kaufert (2000) has identified two 
discourses about mammography screening. The first discourse is about whether 
mammography satisfies the formal rules of screening, whilst the other was about faith, 
emotions, responsibility, morality, compliance and guilt (Kaufert, 2000). In the first 
chapter of this thesis I looked into aspects of the “first” discourse of mammography 
screening. In this chapter I present a theoretical approach for understanding the latter 
and how these two discourses are connected and work together. However, I do not use 
one single theory from sociology or other fields. Rather, I have taken a pragmatic 
stand and will use elements from different theoretical perspectives to give a 
framework for interpreting how women experience mammography screening.   
When analysing the data material, the women’s ways of talking about their up-coming 
participation in the mammography screening programme and their following 
experiences with worries and relief came out of the material as complex relations. 
These were the relations between concrete experiences, obligations in everyday life, 
perceptions of health and risk, and women’s trust in the health authorities, expert 
advice and the mammography technology. This led me and the rest of the research 
group to look more into explanations of women’s experiences of mammography 
screening. In the previous chapter I presented a background for understanding 
problematic aspects of individual choice in screening. Difficulties of individual choice 
can be explained through the concept of governmentality (Foucault, 1991). The 
concept builds on an alliance between the individual and the collective which gives a 
sense of individuality and choice. This is a reason for why I have chosen this 
approach. Governmentality gives a framework to analyse how individual women 
choose and experience participation in mammography screening. However, it also 
provides us with explanations of the limits of autonomy.  
A main point when using the concept of governmentality is to explore and understand 
how technologies of governance work together with individual’s self-governance. In 
order to study how we govern and are governed within different regimes one must 
study the characteristic ways of seeing and perceiving, knowledge, techniques, 
practices and identities within a regime of government, since all these parts 
presupposes the others, but are not reducible to them (Dean, 1999). In this chapter I 
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will describe the elements that appeared as most relevant for understanding women’s 
experiences of mammography screening. I will explore how, in the case of 
mammography screening, the axes of visibility, knowledge, techniques, expertise and 
identities (Dean, 1999:23) are expressed through expert knowledge, statistics, 
technology and medicalisation. Furthermore I will go into how trust can be a part of 
how women’s health is governed. In the last sequence of this chapter I will discuss the 
gendered aspect to the experiences women have when enrolled in a mammography 
screening programme. But first I will develop how society is governed and present 
how government in our society follows a logic that can be called liberal. 
Governmentality 
The concept of government provides a way of analysing the concerns of social 
authorities in administering the lives of individuals (Miller & Rose, 1990). 
Government is a general term for calculated direction of human conduct while the 
concept governmentality seeks to distinguish mentalities and regimes of government 
and administration that have emerged since “the early modern period” in Western 
Europe (Dean, 1999). More than the direct regulation or inference by the state, 
governmentality refers to the government of populations through agencies and 
techniques, for instance when experts identify healthy practices (Brownlie & Howson, 
2006) that the public then follows on their own accord. Thus, it is not possible to 
reduce government to the intentions of one actor. Rather, regimes of practices have a 
logic that is irreducible to the intentions of any one actor but the logic still has an 
orientation toward particular ends and purposes (Dean, 1999).  
A problem with an analysis that looks into government is what kind of power one can 
attribute to the state (Neumann, 2003). More than understanding the state as giving 
rise to government, one can say that the state is a particular form that government has 
taken (Miller & Rose, 1990). A central part of the formation of the state was the 
recognition by the state that the health and welfare of its population were among the 
key objectives of its rule (Dean, 1999). Governmentality is thus a kind of power 
which is in a productive relation to the population’s well-being (Hammer, 2008). The 
question is not how much power the state inherits but what governmental techniques 
the state mobilizes to maintain a specific governmental regime (Neumann, 2003). 
Government is accomplished through multiple actors and agencies rather than a 
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centralized set of state apparatuses, without any a priori distribution of power and 
authority (Dean, 1999). We can rather see a number of techniques that have a 
common goal; namely to hold the population within the boundaries of normality 
(Hammer, 2008). These techniques make it possible to lead the population to do what 
is considered best for the state and the population, but nevertheless leaving the 
individuals with a sense of making their own choices. So governmentality is a mobile 
and changeable set of technologies and rationalities that is different from both law and 
individual discipline and works in a complex manner as a productive relation to 
secure the population in the best way (Hammer, 2008). The state is the “good 
shepherd” with its responsibilities to guide each individual in the population to its best 
possible level (Rose, 2001; Neumann, 2003).  
Governmentality is about the processes through which the body and populations are 
managed and governed (Brownlie & Howson 2006). The discipline of bodies as a 
technique at a micro level has transformed into a continuous self-controlling 
technique in our modern society (Hammer, 2008). The concept of governmentality 
can thus be understood as a point where technologies of the self and technologies of 
domination meet (Petersen, 1997). Government presupposes the activity and freedom 
of the governed, and to govern individuals is thus to get them to act on their particular 
wills with ends imposed upon them through facilitating models of possible action 
(Burchell, 1991). Government is thus not only how we exercise authority over others 
but about how we govern ourselves through practices of the self (Dean, 1999).  
This view of governance involves seeing power and autonomy not as opposites, but as 
intertwined facets of one another. Power is only effective if the subjects are able to 
react in certain ways which do not suppose that individuals are passive (Nettleton, 
1997). One can for instance see individuals as reflexive agents who are active when 
facing modern medicine and technological developments (Williams & Calnan, 1996). 
Nevertheless, this does not mean that subjects are free as outside discourse, but rather 
that they are free to act within the discourses that constitute the subject (Neumann, 
2003). The mentality of government is the way in which thought involved in practices 
of government is collective and taken for granted, but not necessarily open to 
questioning by its practitioners (Dean, 1999).  
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Individuals are recruited to take care of themselves with techniques deployed by 
experts, techniques that inevitably shape how individuals think about themselves 
(Nettleton, 1997). The liberal art of governance explained through the concept of 
governmentality is thus about disciplining and regulating the population without 
direct intervention but rather steering discourse through setting agendas, legitimating 
statements and authorizing technologies, etc, so that actors perceive problems in 
similar ways and accept responsibility to transforming their position themselves 
(Flynn, 2002). Given the power of discipline and surveillance it is difficult to see how 
one can explain opposition (Williams & Calnan, 1996). But, the concept of 
governmentality is also an answer to a critique that Foucault’s theories of discourse 
deprived individuals of their status as acting subjects (Foucault, 1991; Neumann, 
2003). The practices of the self are only possible through the freedom of the 
individual, and can also be means of resistance to other forms of government (Dean, 
1999). Governing at a distance is moreover dependent on individuals’ internalisation 
of governmental perspectives and self-governance.  
Foucault implied that our society is characterized by particular ways of thinking about 
which problems can and should be addressed by the authorities, rendering fields open 
to intervention (Miller & Rose, 1990). It might thus be in its place to ask why breast 
cancer has become one of the problems that health authorities should address and 
what it is that makes screening a solution to the problem. A frame to this question is 
that in the liberal society, health has formed a zone between political concerns for the 
fitness of the nation and personal techniques for the care of self (Rose, 2001). There is 
however, a danger of exaggerating the control modern medicine has over people’s 
experiences in contemporary society (Williams & Calnan, 1996). Medicine and 
medicalisation is rather one among several instances by which liberal societies are 
governed, but may still be a rather important one.  
The liberal society  
Self-governance and autonomy are values of liberalism. In the welfare state however, 
the main focus has been on solidarity and equality (Christensen, 2005). Although 
Norway is a welfare state, its government structures have been influenced by liberal 
ideas on how to govern by governing as little as possible. This implies that a central 
power in our society is indirect power, that is, a power that works through its 
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definitions of normality, rather that by forcing individuals to do what they initially did 
not intend to do (Neumann, 2003).  
The liberal character of our society is exemplified by an analysis of the white paper 
on public health from 2003. Norwegian health policy was characterized as “social 
liberal” in comparison with Danish and Swedish white papers that were characterized 
as “liberal” and “social democratic” respectively (Vallgårda, 2007). There has been a 
change from the white paper on public health in 1993 where focus was on institutions 
and structures, to the white paper in 2003 with its focus on individual responsibility 
(Stenvoll, Elvbakken, & Malterud, 2005). During the 1980s and 1990s Norwegian 
politics, where a rationality of the welfare state had been dominant, was supplemented 
with a liberal rationality (Neumann 2003:238). Rather than substituting other forms of 
power, liberal rationalities supplemented ways of ruling, so that one can identify a 
trilateral ruling power in society; strategic power, discipline and governmentality. 
Traditional relations of power such as strategies and dominance are developed with 
technologies that allow governing at a distance (Neumann, 2003). The development 
of government as a central logic of power has to be understood as part of an 
established framework where the state is the carrier of sovereignty, but with the 
presupposition that there exist freedom and social spaces independent of the state 
because otherwise it would not be possible to govern in the direction of less state 
dominance (Neumann, 2003). Liberal modes of government attempt to work through 
the freedom of the governed (Dean, 1999).  
The discussion of whether there should be spaces in society free of state power can 
hardly be settled in the area of health care. Studying issues of health rather raises 
questions about the complexities of self-government and individual choice than give 
solutions to it (Burchell, 1991). Health is thus an example of an area which consists of 
strategies from the welfare state and at the same time has a space free of state 
government. Moreover, Rose (2001) sees health politics today as strategies following 
arguments such as economic cost-benefit of ill-health, or moral terms such as 
reducing inequalities in health. Health indicators are seen as nations’ rates of success 
but it is nevertheless citizens who must take active response ability for their own 
health, with the state governing at a distance (Rose, 2001).  
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A question here is how the liberal society with its governing at a distance affects 
mammography screening and women’s experiences of it. Mammography screening in 
Norway is – as in most western countries (see Holland et al (2006) for a description of 
the organization of European mammography screening programmes) – managed by 
the health authorities in order to reduce mortality from breast cancer (Cancer Registry 
of Norway, 2007). Even though the national mammography screening programme can 
be seen as a strategic initiative from the welfare state, it is voluntarily to join. Breast 
cancer screening is not imposed on the population as screening for tuberculosis was. It 
has nevertheless been claimed that mammography screening emphasizes individual 
choice, but that there exists a framework around this choice such that those choosing 
non-attendance come to be seen as irresponsible (Hydle, 2003).  
It is exactly the voluntary aspect of mammography screening that makes it interesting 
to look at it from the perspective of governmentality. In a recent editorial in the 
British Medical Journal, opposition towards direct government and expert advice 
about mammography screening were put this way: ”Women should be encouraged to 
decide what is right for them, rather than being told what to do” (Schwartz & 
Woloshin, 2007). I will thus ask how it is possible to choose what is right for oneself 
if we are all surrounded by a multitude of expert advice and governmental discourses 
and techniques – discourses that point to ones obligation to secure ones health.   
It is important to investigate empirically how members of the lay population respond 
to and even seek out the medical gaze rather than seeing them as passive bodies 
(Lupton, 1997). Women attending mammography screening are in my opinion a good 
example of a lay population submitting themselves to health surveillance, yet at the 
same time they constitute an example of individual choice and resistance. In order to 
analyse the mobile, changing and contingent assemblages of regimes it is necessary to 
give attention to what is put into these assemblages: i.e. the routines of bureaucracy, 
the technologies of recording and transporting of information, the programmes, 
knowledge and expertise that compose a field to be governed, the ways of seeing and 
representing embedded in practises and the different agencies with various capacities 
that practices of government require and form (Dean, 1999:27). I will therefore now 
go further into which techniques and technologies it is that make the process of 
governing the population’s health work so “smoothly”.  
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Elements in the government of health 
In this part of this chapter I will provide a framework for the analysis of women’s 
experiences as participants in a mammography screening programme. This sketch is 
not meant to be a complete representation of influences on women’s experiences of 
mammography screening. Even though other elements could be mentioned, such as 
the division of labour and the care obligations women have in our society, I have 
chosen to focus on expert systems, technology, statistics, medicalisation and risk, and 
trust.   
Expert systems are relevant as providers of knowledge. When we exercise self-
government, we draw upon certain forms of knowledge and expertise provided by for 
instance health professionals (Dean, 1999). It is also an arena for professional power. 
Experts have knowledge that is valued by society, and this knowledge can give them 
monopoly of truth and intervention. For instance can experts have monopoly over 
technology, and technology is an important asset for power and knowledge in our 
society. Statistics is relevant as part of the expert system for mammography screening, 
as shown in chapter one. And statistics forms a basis for making risk estimates, which 
in turn are one of the undergirdings of medicalisation. In other words, these elements 
are tightly intertwined with one another.  
The medicalisation of society is closely connected to risk because medical expertise is 
called upon to solve questions of risk. When facing uncertainty individuals and 
society turn to the experts for solutions, and medicine has provided or promised 
solutions. One consequence is thus that the medical profession and medical 
knowledge has become “the” solution to questions about human life that previously 
was seen as the purview of other institutions. However, the liberal society with its 
focus on individual autonomy could not function without individuals trusting the 
expert’s solutions to be the best for them. In order to “lead” individuals to participate 
in self-governance - applying expert advice - it is necessary for individuals to trust the 
practices which they are presented. I will now present the elements mentioned above. 
Keeping the intertwined whole in mind as a backdrop, I will examine the elements 
one by one. 
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Expert systems 
Expert systems are systems of a technical and professional expertise that organize 
larger areas of our material and social environment (Giddens, 1990). The language of 
expertise plays a key role in governmental networks as expertise provides norms and 
values with claims of disinterested truth (Miller & Rose, 1990:10). The complex 
mechanisms which make it possible to link calculations at one place with action at 
another makes expert systems relevant for governance.  
Expert systems are abstract systems which functions on the basis of exclusive 
knowledge of which lay people are likely to understand very little (Giddens, 1990; 
Brown, 2008). Those who are in position to provide and interpret a given area of this 
knowledge are deemed experts, or professionals. One definition of a profession is an 
occupational group characterized by sharing skills based on theoretical knowledge, 
provision of training and education, testing of competence, organisation and 
adherence to a professional code of conduct (Witz, 1992). However, a profession 
could also be seen as an occupation which has successfully struggled for a right to 
control its own work (Freidson, 1988). Also, professionalism can be seen as a strategy 
of exclusionary closure to limit and control the entrance to an occupation (Witz, 
1992), thereby also controlling knowledge possessed by that profession and having 
jurisdiction over the field in question (Abbott, 1988).  
However, in this thesis I will not go into issues of professionalism per se. Rather, my 
perspective is how the medical profession and professionals are part of a larger 
system of experts and expertise that are providers of knowledge that induce practises 
and technologies of government. Thus, the first point here is how experts and expert 
systems take part in the government of individuals. However, medical (and other 
professions) expert systems are also part of the liberal society and its governance 
technologies. I will therefore also briefly look into how surveillance technologies, 
such as audits and clinical governance, enrol the medical expert system into practices 
of self-governance.  
Expertise can play a vital translating role between general politico-ethical principles 
and the self-regulatory activities of individuals (Miller & Rose, 1990:26). This links 
rationalities of personal autonomy to technologies of regulation. Within these 
rationalities new relations can be formed between the health of the nation and the 
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private choices of individuals, and the power of expertise has shaped and normalized 
the self-regulation of subjects (Miller & Rose, 1990). Expertise has thus become a 
resource for liberal democratic governing at a distance. 
But, in order for lay individuals to follow expert advice, it is required that they have 
trust in the experts to have their best interest at heart. Expert systems embody faceless 
commitments (Giddens, 1990) of professional judgements to which lay users are 
dependent  in order to assess future risks and products available to meet them 
(Stevenson & Scambler, 2005). We need to trust doctors because medical knowledge 
is too complex for each of us to grasp fully, or even adequately, on our own (Greener, 
2003). A key dimension of public trust in health services is, among others, the 
assessment of whether the doctor behaves professionally and gives patients enough 
attention, and the perceived level of professional expertise (Calnan & Sanford, 2004). 
A decline in trust in the health care system can be part of a general lack of certainty in 
a post-modern era, where medical knowledge is highly questioned and de-privileged 
(Brown, 2008; Scambler & Britten, 2001). In current day society, much of our trust in 
the medical profession has come to be in response to risk: Experts tell us what we are 
at risk for, and how we can reduce or avoid those risks. 
However, scientists frequently disagree about the significance of statistical 
correlations on which estimates of risk are based (Petersen, 1997). This makes expert 
advice generate its own uncertainties even though it is meant to create security and 
help avoid risks. An increased sensitivity of risks has been accompanied by an 
awareness of the limitations of medical expertise (Alaszewski & Brown, 2007). 
Control of the access and application of medical knowledge has been one means of 
ensuring a perception of expertise (Brown, 2008; Abbott, 1988). Thus, the medical 
profession’s status has depended on its management of privileged knowledge, even 
though a growing focus on risk has contributed to the yielding of power away from 
the experts (Brown, 2008; Castel, 1991). However, medical knowledge remain 
privileged but the focus on risk in health-care has led policy makers to necessitate 
regulation of professional practice and a systematisation of knowledge (Flynn, 2002). 
Audit of has become a large-scale activity for governing the activities of experts at a 
distance (Flynn, 2002; Rose, 1999).  
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The concept of governmentality (Foucault, 1991) enables us to understand the 
institutionalisation of expertise as part of the operation of systems of power (Flynn, 
2002). But, it can also show how expertise and expert systems are governed. What 
can be named “clinical governance” imply the monitoring and auditing of medical 
experts. Clinical governance is a tool by which the risks of negative consequences in 
healthcare are minimised (Brown, 2008). It marks a transition in knowledge from 
“embodied knowledge” held by the individual to “encoded knowledge” by which 
knowledge is spread across a community of doctors in the form of guidelines, 
directives and standards (Brown, 2008). It is thus not the individual autonomy of the 
medical doctor that is in focus but rather a strong organisational control. It is the 
system itself that will play the main part in identifying failings (Flynn, 2002). In the 
rationality of clinical governance, little emphasize is put on access points (Giddens, 
1990) as influencing public trust in the health care system. Rather, the communicative 
trust where patients believe that professionals place their best interest above all others 
is seen as secondary to the instrumental trust provided by the instrumental systems of 
clinical governance (Brown, 2008). It thus becomes necessary for the system to imply 
self-governance. Through clinical governance regulations are monitored by the 
system itself.  
The question is how knowledge provided by expert systems – systems being governed 
themselves – influence and become part of how individuals govern their health. The 
monopoly experts have on providing knowledge on their field of expertise, as well as 
on the use and interpretation of that knowledge, give experts a unique position as 
translators on knowledge to the lay population and policy makers. Experts can 
communicate through mobile inscriptions (Latour, 1990) which can be numbers and 
images – also meaning number or images. For mammography screening, statistics 
provide numbers and the technology provides images that need interpretation by 
experts.  
Technology  
Mammography screening is not only about experts debating statistical evidence or 
political decisions. It also involves a machine that must be handled by experts and that 
provides the medical expertise with images to interpret. Mammography’s visualising 
aspects can have a persuading power (Willis & Baxter, 2003). The visual aspect of 
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mammography is developed further in article II of this thesis (“You Have to Have 
Trust in Those Pictures”. A Perspective on Women’s Experiences of Mammography 
Screening), but it is important to highlight how women feel visual proof more 
trustworthy than perceptions from other senses. The imperative of objectivity and 
visual modes of representation link together as instruments of “truth” in medical 
knowledge (Reventlow, Hvas, & Malterud, 2006).  
However, it is not only the mammographic machine that can be explored through the 
term technology. It is also tempting to see even the screening programme as a 
technology. The workings of the screening programme has similarities to Bruno 
Latour’s fable of the metal key holder (Latour, 1991). Latour tells a story of how a 
hotel manager makes more and more people surrender to his wish that they should 
leave the hotel key at the reception when leaving the hotel. First the hotel manager 
asks his guests to leave the key. A few polite guests follow his request. Next he puts a 
notice at the reception, urging people to leave the key. Now also the polite but 
forgetful guests leave the key. Finally he attaches a heavy and bulky metal keyholder 
to each key. Suddenly most people leave the key at the reception, eager to get rid of 
the heavy weight in their pocket or purse. In my opinion it is possible to interpret 
mammography screening in similar terms. Mammography equipment has been around 
for a long time, and some women have made use of it. Expert advice about its use has 
added some more women as users of mammography. But, it seems to be some aspect 
of the screening programme that leads nearly 80 per cent of women in the target 
group to become users of mammography.  
What separates the public screening programme from other kinds of mammography 
screening is the personal letter with a preset appointment that is sent to all women in 
the target group. This can be described as an “opt-out” strategy (Junghans et al., 
2005). “Opt-out” is a term primarily used in recruitment of research participants. It 
refers to practices whereby research participants are included unless they choose to 
withdraw from the study. This is opposed to the recruitment strategy of “opt-in” 
where research participants must take a more active part in joining the study to be 
included. A randomised trial on “opt-in” versus “opt-out” strategies for recruiting 
participants to a research project on angina found that there was a significantly higher 
recruitment rate with the “opt-out” strategy, and that the “opt-in” strategy provided a 
more biased sample (Junghans et al., 2005). Nevertheless, “opt-in” strategies are 
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considered more ethical when recruiting participants to research. The question when 
choosing between these strategies is whether it is most important and ethical to put 
individual choice first, or whether the perceived requirements for valid research hold 
a morally higher ground since research results presumably serve the common good 
(Hewison & Haines, 2006).  
A similar comparison can be used when considering screening participation as well. 
Screening programmes are dependent on high participation rates in order to reduce 
mortality from cancer, and this will presumably serve not only society as a whole but 
also individuals who participate. Also, the opting-out strategy in a screening 
programme can overcome the participation bias that an opting-in strategy may 
provide, for instance through minimizing a socio-economic gradient and thereby 
securing an equal distribution of health care services in the population. Nevertheless, 
an “opt out” structure of the screening programme is likely to influence the choices of 
those invited into the programme, thereby inflicting on their autonomy and thus the 
individualistic values of the liberalistic government. 
Statistics  
One of the manners in which expert systems can influence practices is through the use 
of statistics. The function of statistics is to generalize, to move from the individual 
towards the larger picture. At the same time there is a more hidden effect. Statistics 
provide us with a position along a scale, a personal connection to certain categories 
(Hammer, 2008). This double edge has made it possible for the welfare state to 
combine long-term planning with direct intervention towards those outside the 
statistically defined normal range (ibid). Drawing the limits of normality narrowly can 
open for the inclusion of large groups of individuals into programmes of intervention.  
Calculations of risk as deviance from statistical normality can thus contribute to 
medicalisation (Skolbekken, 2007). Statistics make persons and actions governable 
through turning them into numerical sizes that makes uncertainties predictable 
(Hammer, 2008; O'Malley, 2004). Numbers can be understood as mobile inscriptions 
that make it possible to transfer knowledge into symbols and signs that are 
(presumably) interpreted similarly by all their readers (Latour, 1990). Statistics are 
thus not only about formal methods or techniques; they are also a co-producer of 
knowledge and technologies for the governing of society (Hammer, 2008). 
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This is not least evident in medical knowledge. Quantification of medicine is indeed 
part of the growing trust in numbers that has affected all aspects of social life during 
the past centuries; it is part of a process of objectification in clinical medicine that has 
been going on since the eighteenth century, even though counting had a rather low 
epistemological status in the latter half of the nineteenth century (Weisz, 2005). But, 
the objectification of medicine is indeed not only visible through the focus on 
numbers, but also as images in living patients through visualizing technologies 
(Weisz, 2005). Visualization and quantification may both be seen as part of the 
objectifying of medicine. For instance did Keating and Cambrosio (2005) find that 
cancer pathology has gone through a process of objectivation through which the more 
subjective visual elements has been eliminated in exchange for quantitative 
dimensions in the analysis of pathological lesions. One example of this is the 
quantification of cancer pathology of cervical cancer through the Pap-test (developed 
in the 1920’s by George Papanicolaou). The quantification of the cervical cancer test 
made it possible for those promoting the early detection of cancer to provide not only 
diagnostics but also a pre-diagnostic test (Keating & Cambrosio, 2005). The history of 
the Pap-smear has been a long and winding road (Bryder, 2008). Its success has been 
attributed to a number of assets, for instance its ability to be standardized (Casper & 
Clarke, 1998). I will not look further into the example of cervical screening. 
Nevertheless, it provides a good example on how the merging of biological aspects 
and quantitative techniques can pave the way for pre-diagnostic screening (Keating & 
Cambrosio, 2005). The objectivation of medical practice through use of numbers and 
visualizing techniques has thus been a basis for the development of medical 
screening, and may also have had an impact on the acceptability of screening in the 
population.  
In medicine quantification is especially evident in randomized controlled studies 
which has become the gold standard for evidence based medicine (Weisz, 2005; 
Makela, 2004). This has not least been the case with mammography screening 
(Lerner, 2001). Even though mammography screening is visual rather than numerical, 
the evidence of the usefulness of mammography screening has been randomized 
controlled trials. Numbers and statistics, as well as recorded images, can be 
understood as mobile inscriptions. Mobile inscriptions give a unique advantage when 
it comes to proving that ones science is right or true (Latour, 1990). Statistics and 
images can thus be used to prove the truth of science and medical practise such as 
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screening. When experts are arguing that mammography screening is saving lives 
through providing the most truthful statistical evidence, discussions can centre on 
whether the numbers are obtained correctly rather than on whether statistics are the 
best proof for mammography screening’s superiority. Studying women’s experiences 
of mammography screening, it is exciting to see whether the focus on statistics that 
exists in expert debates is also present in lay perceptions of mammography screening 
or whether it is rather taken for granted as truth. 
A part from giving a scientific knowledge base statistics are also used in information 
and invitation letters that are presented to the population which are in target of 
participation. For instance women in the Norwegian breast cancer screening 
programme are presented with numbers and statistics for their risk of having breast 
cancer and their risk of being recalled. This is an example of how statistics provides 
us with a personal connection to certain categories (Hammer, 2008). The accumulated 
numbers of those saved from breast cancer if participating in mammography 
screening are returned to the women and thereby inflicting upon them a choice of 
which statistical group they want to belong to – those following statistical expert 
advice or those taking the risk to do otherwise. Again, we can see how utterances 
based on expert advice have a potential for governing individual choice. Moreover, 
statistics used for the development of risk estimates for potential disease can 
contribute to medicalisation.  
Medicalisation and risk 
One supporting beam of medical activity in our society is preventive medicine, 
attempting to avoid morbidity and mortality. To achieve the goal of “a long healthy 
life”, there has been a rise of surveillance medicine (Armstrong, 1995).  
Mammography screening can be seen as surveillance of un-symptomatic individuals 
through its periodic mammography examinations. A screening programme does not 
only provide one examination for the potential disease but rather monitor individual’s 
health at specific times during a period of time. Frequent periodic examinations are at 
the core of screening. In order to optimize the advantage of screening the interval 
between two consecutive examinations is based on a statistical estimate on a 
minimum lead-time of the disease (Forsmo, 1997). For mammography screening, the 
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recommendations for screening interval range from one to three years.4 A screening 
programme is thus a thoroughly calculated way of surveillance of the health of 
population and individuals.  
Surveillance medicine as a dominant form of medicine in the twentieth century is 
connected to the medicalisation of life (Armstrong, 1995). A characteristic of the 
medicalisation process5 is the widening of who is in need of medical attention. This 
also implies enrolling individuals free of symptoms into medical attention 
(Skolbekken, 2007). Even when accepting breast cancer as a medical problem, 
enrolling a whole population free of symptoms into a system of medical examinations 
can be interpreted as medicalisation.  
Surveillance of healthy populations can be seen as the problematisation of the normal 
and pointing to potential future disease as pieces in a chain of risks (Armstrong, 
1995). A risk is thus not only the presence of danger. It is also the probable 
occurrence of an effect of a combination of abstract factors (Castel, 1991; Petersen, 
1997). Health risks are estimated by the use of epidemiological data. Nevertheless, 
there are challenges to communicating what may look like causality at the 
epidemiological group level as uncertainty at the individual level (Skolbekken, 2007; 
Hollnagel, 1999). Communication of risk is also a question of how lay people 
understand risk and concepts related to risk. Interpretation of risk can even vary 
among socio-economic groups (Woloshin, Schwartz, & Welch, 2007). I will not go 
into how women in this study perceive of their risk for breast cancer, but it is studied 
in another part of the research project (Østerlie, 2008).    
Nevertheless, when enrolled into a screening programme for a disease of which the 
women have no symptoms, it might influence how women perceive their own bodies 
and health. Risk is not perceived through bodily experiences but through 
                                                 
4 Recommendations varies in different mammography screening programmes: every year is 
recommended in the United States, biannually mammography is recommended in Norway, while the 
mammography screening programme in the UK invites women every third year.  
5 The causes of medicalisation has been attributed to professional dominance; industrialization and 
bureaucratization; as a means of social control – both from the ruling class and to serve a 
heterogeneous array of interests; and as a patriarchal means to control women’s bodies (Williams & 
Calnan, 1996). Medicalisation can thus be seen to happen through the actions of a multitude of actors, 
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measurements and calculations which makes individuals dependent on medical 
knowledge and technology to have knowledge of their own body and health 
(Skolbekken, 2007). Pre-symptomatic diagnostics can thus become part of the 
practices women must do in order to control risk. The urge to control mortality and 
morbidity are part of a need to make the future predictable and manageable (Rose, 
2001).  Thus, risk becomes an existential parameter for structuring life both for 
experts and lay people (Williams & Calnan, 1996).  
A characteristic of governance is that it consists of a variety of strategies to identify, 
treat or administer those individuals where risk is seen to be high (Rose, 2001). For 
risk to be a tool of governance it must not only communicate uncertainty but promise 
a solution to control that uncertainty (Skolbekken, 2007). Estimating risks may be one 
way to govern ourselves in the moment and towards the future. Thus, medical expert 
systems provide technology and statistics as solutions to problems of life and death. 
But, these are not only solutions to medical problems felt on citizen’s bodies. Rather 
they are also solutions to questions that come out of the problematizations of 
normality that arise from liberal discourses. More than seeing experts and health 
authorities as agents for medicalisation, I see them as providers of utterances and 
mobile inscriptions that are both creators of and created by discourse. Thus, expert 
systems with their technology and statistics are among what makes government of a 
population possible. A mammography screening programme can thus be interpreted 
as a medical and governmental solution to a health risk estimated by experts.  
But, since individuals are not forced to participate in mammography screening, there 
must be something making governance possible. What is it that makes it possible for 
women to do self-governance in the manner suggested by the health authorities? One 
answer to this may be trust. I will now discuss whether and how trust can be the 
cement holding elements of governance and self-governance together. 
Trust 
The previous parts of this chapter have presented elements that are relevant for the 
techniques of government in a liberal society. What these elements have in common is 
                                                                                                                                            
such as the medical profession, the pharmaceutical industry, the mass media, politicians, lay people and 
patient organizations, as well as the health authorities (Skolbekken, 2007).  
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that they are about knowledge and how knowledge is closely connected to power. 
Nevertheless, looking into knowledge is not enough when studying women’s 
experiences of mammography screening. In our modern society we cannot know all 
aspects of relations, authorities or systems. Our modern society is complex and 
personal knowledge is more difficult to attain than in a traditional society (Giddens, 
1990; Möllering, 2001). In order to make sense of abstract knowledge it is necessary 
to trust. One can claim that the complexity of modern society results in active trust 
(Giddens, 1990). It is not possible for lay women to test all aspects of expert claims 
about the usefulness of mammography screening, and accepting expert knowledge 
must therefore involve trust.  
The aim of screening is to precede symptomatic diagnostics of breast cancer, and 
anticipation about what the future might bring middle aged women is a reason for the 
initiation of mammography screening. Anticipation of the future is the nature of trust 
(Brownlie & Howson, 2008). Trust about the future must be based on some form of 
knowledge which may be personal (as when we trust in a person based on our 
previous experiences with him or her), or abstract (as when we trust in institutions, 
rules, science) (Hardin, 2001; Tyler, 2001).  
If we accept that we live in a complex society, we need simplifying processes, and 
risk estimates have been mentioned above as one way to predict an unknown future. 
Risk estimates are attempts at rational prediction, which is one strategy for reducing 
complexity. But, even if one assumes a determinant universe we do not have the time 
and resources to predict all actions (Lewis & Weigert, 1985). Trust is an alternative to 
reduce complexity since trust enables us to live as if certain possible options will not 
happen (Lewis & Weigert, 1985). This certainty can be grounded in security about 
one’s social position, for instance arising from a context of group identity (Tyler, 
2001).  
Furthermore, relations and acknowledgement can create trust between the trusted and 
the trustee. How people are treated gives them information of their own status in the 
social group they belong to, and of the status of their social group in society (Tyler, 
2001). When people are treated well they get the feeling of having a valuable identity 
and being acknowledged as an important part of society. Thus, in Tyler’s account, 
acknowledgment of social status can make people trust authorities. People receiving 
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good treatment from the authorities are more likely to defer to group authorities and 
group rules. This interpretation of trust might explain women’s trust in 
mammography. The invitation to participate in mammography screening and the 
mammography examination itself can both be seen as communication between 
women and the authorities, acknowledging the importance of these women’s health.  
Trust can be seen as something we do every day, as a routine we do since it would be 
unthinkable to act otherwise (Möllering, 2006). The routine aspect of trusting can 
indicate that individuals are passive, but also that individuals do not see the need to 
make a fresh choice to trust on a regular basis. A new decision may only be made if 
and when some unusual event disturbs the routine. Moreover, routines may enable 
action when facing uncertainties and are moreover an element of social life - in which 
agency and identity should not be overlooked with regard to routines (Möllering, 
2006).  
Trust enters the picture when something remains unknown (Möllering, 2001). That is 
when knowledge and rational action based on that knowledge is insufficient. If all 
options and their contingent outcomes were known there would be nothing left to 
trust. It is thus not knowledge and security that are essentials for trust, but rather 
uncertainties that has to be overcome in order to trust (Giddens 1990). Yet trust does 
not eclipse rational action; rather, it is a cognitive process that combines “good 
reasons” with an emotional dimension (Lewis & Weigert, 1985). Knowledge can give 
good reasons for trusting, but good reasons are more a rationalisation of one’s trust 
than what actually constitutes trust since good reasons do not produce trust by 
themselves as there are mostly good reasons for the opposite as well (Lewis & 
Weigert, 1985). 
Trust is thus something more than reasoning, and can be seen as a process of the three 
elements of expectation, interpretation and suspension (Möllering 2001). Expectation 
is the presumed future outcome; interpretation is how one makes knowledge one’s 
own; and suspension mediates between interpretative bases (good reasons) and certain 
expectations. Möllering (2001) describes suspension as a mental “leap” from 
interpretation into expectation, that is, the point where we accept our interpretations 
and suspend our awareness of the unknowable. Suspension overcomes uncertainties 
and makes it possible to make the “leap of faith” into trusting (Brownlie and Howson 
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2005; Lewis and Weigert 1985; Möllering 2001). Indeed, the leap into trust can not 
happen from nowhere, it needs to be made from a place where interpretation leads us 
even though we cannot be entirely certain (Möllering, 2001) . 
A question when researching trust is of course who it is that trusts and what it is they 
trust. Health issues are marked by uncertainties which make it a special analytical 
opportunity to researching trust (Brownlie & Howson, 2008). A relevant question 
here is whether or not women trust mammography screening, and what it is that they 
trust if they trust it. Their trust or distrust in a screening programme or medical 
technology with its interpretations and its surrounding expert systems is likely to be 
connected to how they experience their participation in the breast cancer screening 
programme. And here is where all the strands meet and intertwine. Expert systems 
provide knowledge and interpretations of technological outcomes and statistics. These 
statistics are also the basis for risk estimates which again can be a vehicle for 
medicalisation. Through these elements it becomes possible for women to imply self-
governance, choosing practises that minimizes risks and thereby securing their future 
health. Government of women’s health through self-governance is thus made possible 
when women have trust in experts and health authorities to have the expertise and 
their best interest at heart when offering medical screening for a disease of which they 
have no symptoms.  
One last aspect is worth mentioning when theorizing about women’s experiences of 
mammography screening. This is the aspect of gender. Mammography screening is an 
initiative directed at women only. Even though this thesis does not have a particular 
gendered perspective, I understand gender as an implicit element in how women 
experience their screening participation. The last sequence of this chapter will 
therefore focus on the gendered elements of women’s experiences of breast cancer 
screening.  
Women’s experiences 
An assumption when studying women’s experiences of mammography screening is 
that participation in a screening programme will influence and be influenced by 
aspects in people’s lives. Another assumption is that women’s experiences might be 
gendered, especially when concerning a “women’s disease”. The place of women in 
society is likely to influence experiences of screening, as well as women’s decisions 
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for participation in screening. Statements about beneficial medical surveillance 
technologies such as cervical or mammography screening seem to place women as 
care-givers for others, and thereby making their participation in self-surveillance and 
preventive health programmes an obligation towards both themselves and others 
(Howson, 1998; Lerner, 2001). Wanting medical screening is, however, not solely a 
feature of women’s relations to medicine. The prostate specific antigen test is widely 
used to screen men for prostate cancer even though its value is controversial (Chapple 
et al., 2008).  
Theories about women, womanhood and femininity have changed over time. I will 
not go into these theories and scientific debates here, neither will I explore or explain 
how women’s positions in society and women’s rights have developed. Nevertheless 
there are aspects about women’s experiences of breast cancer screening that need to 
be discussed with a gendered focus. Breast cancer screening is one of only two 
screening programmes for cancer in Norway, with cervix screening as the other. 
Indeed, both screening programmes have women’s health and bodies as their target. 
Thus, not all bodies receive the same inscriptions. Rather, different inscriptions target 
different kinds of bodies (Sandell, 2001).  
Women’s bodies as a target for medical practice are not a new invention. Biological 
perspectives to the feminine body have resulted in different kinds of interventions - 
for instance the extensive use of hysterectomy, or other surgical interventions. What 
part of biology that has been seen as determinant for femininity, has varied in 
different epochs. Apart from the breast, also bone structure, the uterus and hormones 
have been seen as signifying the feminine at different times (Forsmo, 1998).   
Feminist writers have described the ways in which women’s health is controlled by a 
male technology-dominated medical system, but to analyze women’s roles as passive 
is to perpetuate the kind of assumptions about women that feminists have been 
challenging (Riessman, 1983). In Riessman’s view, women collaborate in the 
medicalisation process due to their own needs and motives. She exemplifies the co-
constructive position of women through the medicalisation of childbirth which was 
part of a struggle for professional dominance, but at the same time the demand for 
anaesthesia can be seen as part of a social process where pregnancy no longer was 
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seen as a condition that women should endure with fatalism and passivity (Riessman, 
1983).  
Indeed, there has tended to be a fit between women’s interests in having their 
experiences acknowledged and medicine’s interests in expanding its jurisdiction, and 
medicalisation is thus part of the problem and at the same time part of the solution for 
women (Riessman, 1983). Also breast cancer screening can be seen as part of this 
complex relation between women’s health and experiences on the one hand and 
medicalisation and governance on the other hand. Furthermore, one can not see 
women’s experiences of screening solely as the internalisation of disciplinary 
techniques but should maybe rather focus on these complex relations. For instance did  
Howson (1998), in her study on cervical screening, find that even when women 
expected to subject themselves to medical surveillance, they also developed a critical 
response to their experiences. 
Breast cancer 
Of course, one gendered aspect of the mammography screening experience may stem 
from larger discourses on the breast, discourses which render breasts central to 
women’s gender identities (Broom, 2001; Davis, 2008; Wilkinson & Kitzinger, 1993). 
The breast has been an issue for politics and commercial interests, and a sign for 
femininity in a multitude of ways, as well as a site for medical intervention (Yalom, 
1999). Yet despite medical “eagerness” to intervene on women’s bodies, the breast 
was initially characterized by radiologists as too soft, too irregular and too changeable 
to image clearly with x-ray technology (Cartwright, 1995). According to Cartwright, 
such characteristics were classified as feminine, showing how the feminine breast was 
unsuitable for standardized screening. Instead of adapting the technique some 
radiologists tried to adapt the breast to the technique (ibid). This may explain the 
technical solution of squeezing the breast between two glass plates while performing 
the x-ray examination. This technical choice was critiqued dramatically by Schei 
(1989) in her parody where she modified defence of mammography by exchanging 
references to women’s breasts with a reference to men’s testicles.  
Breast cancer, with its treatments and detection strategies influencing women and 
their bodies, has been subject to feminist critique. The medical gaze with its male 
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dominance is credited for focusing on the breast as an object for male desire more 
than the woman’s sensation of loss or anxiety for a severe disease (Wilkinson & 
Kitzinger, 1993). Characterizing the female body after mastectomy as mutilated, 
defective and not normal is for Wilkinson & Kitzinger (1993) a construction of 
femininity connected to women as medical and sexual objects. They show how 
women are represented in both mainstream medical and alternative health discourses, 
with medicine as male dominated and alternative health care as a blame-the-victim 
mentality accusing women of failing.  
One can claim that breast cancer is at the centre of at least four discourses: those 
relevant to life-threatening illness, those surrounding cancers, those of female-specific 
conditions and discourses on the breast specifically (Broom, 2001). These discourses 
will presumably also influence the experiences of women invited to a breast cancer 
screening programme. In addition, one can talk about the discourses of “the 
imperative of concealment” and “personal blame and responsibility for illness” 
(Wilkinson, 2001).  
To lose a breast due to breast cancer influences a woman’s image of her self, her 
bodily experience and her sexuality, while a reconstruction of the breast may reset her 
experience of her body as a whole (Sandell, 2001). Losing a breast can thus, 
according to Sandell, symbolize the loss of a body part, but also an abnormality and 
lost femininity and health. In Sandell’s study women’s experiences of losing a breast 
influenced their decision about breast reconstruction but Sandell also found the term 
“the male gaze” important when analysing her data. “The male gaze” saw the missing 
breast as deviance and a sign of a lack of femininity and influenced the ideals for size 
and appearance of a breast after breast surgery (Sandell, 2001). These discourses on 
the breast and femininity are also part of what women participating in breast cancer 
screening relate to, and that may influence their experiences of mammography 
screening. Knowing that early detection of breast cancer can influence the degree of 
surgical intervention on the breast might also be a reason for women’s decisions about 
participating in mammography screening.  Breast cancer experiences have been 
studied by many (see for instance (Sandaunet, 2008) or (Davis, 2008)). I have chosen 
to not go more into the subject. Nevertheless, survival stories from breast cancer 
patients can influence how women experience breast cancer screening.  
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I will pursue the question of a particular female experience – whether social or bodily 
- with some caution in the analysis. Working inductively from my respondents’ own 
words, I will keep an open mind as to whether they present their experiences of the 
mammography screening programme as somehow specific for women. Also, the 
gendered experience may be both implicit and explicit in women’s stories of their 
participation in the mammography screening programme.  
Conclusion 
Women’s experiences of mammography screening can be interpreted in a framework 
of governmentality and liberal ways of governing. When approaching this research 
project, we knew little about how women experienced being enrolled in a 
mammography screening programme. The elements of expert knowledge and 
statistics, technology and medicine appeared as important for women’s interpretations 
of their experiences when analysing the data. Each article does not focus on all the 
theoretical aspects of mammography screening that has been discussed here. Writing 
articles do not always allow extended theoretical explorations, and each of the articles 
is a result of an analytical process with focus on only one or few of the elements 
discussed in this chapter. The analyses of the data had different steps and levels of 
theoretical interpretation. Nevertheless, each article can be seen as within the 
theoretical framework of governmentality – showing a piece of the whole picture of 
how women’s health is governed and how women govern themselves.  
Theoretical approach to the research question 
In the introductory chapter I asked “what are the experiences of women who are 
invited to join the screening programme when making their decision to participate; 
when participating; and when facing a recall letter?”. In this chapter I have provided a 
theoretical framework for the analyses of women’s experiences of mammography 
screening. Putting the research question into the theoretical context, I will outline a 
theoretically based research question that I attempt to answer in the concluding 
chapter of this thesis:  
How do technologies of government influence women’s experiences of 
mammography screening? 
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The theoretical framework’s relevance for the articles 
In the first article in this thesis the discussion is whether or not women’s decisions to 
participate are made following the rational ideals that are inherent in discourses on 
medical interventions. In the article we can see how women’s knowledge about breast 
cancer and the health authorities’ techniques for information and enrolment into the 
screening programme give practises of government and self-government that at the 
same time use and oppose the liberal ideals of individual freedom that are pursued in 
discussions about screening. 
The second article is an analysis of how women’s knowledge about the 
mammography technology makes them question the screening programme’s ability to 
work in a trustworthy manner. Both the technology and the expertise involved in 
practising it are questioned as too uncertain. Nevertheless, the visualising aspect of 
mammography persuades women into trusting it to find breast cancer. I interpret how 
“ways of seeing and perceiving, knowledge, techniques and practices” (Dean, 1999) 
are woven together into knowledge that can be interpreted and accepted by the 
women in order to suspend of doubts and make the “leap of faith” (Möllering, 2001) 
into trusting mammography screening to save them from breast cancer.  
In the third article I explore women’s experiences of a recall after mammography 
screening. This article analyses how information and efforts made to comfort the 
recalled women are interpreted in several manners by the women who find themselves 
in a somewhat unexpected situation. It shows how the routinization of mammography 
screening that makes the government and self-governance of women’s health possible 
influences how women experience a recall. Trusting the expertise and the technology, 
and seeing screening participation as the “normal” thing to do render the recall all the 
more surprising and frightening. In this light the “rationality” of numbers and a short 
waiting period becomes irrelevant or even distorted into something frightening. 
Nevertheless, the recalled women were glad to be part of the screening programme, 
and only one of the women in the study was in opposition to the screening 
programme.   
The fourth article is an article about how qualitative research can be done and how it 
can contribute in the research field of mammography screening that has been 
primarily quantitative and dominated by medical perspectives. The medical 
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perspective that has been identified as “the first discourse on mammography 
screening” by Kaufert (2000), influenced how our research group did our research 
even as we studied “the second discourse on mammography screening”. This raises 
questions about how one can study the field in question, and I will explore this more 
in the next chapter of the thesis; that is the methods chapter.  
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3. Methods 
Research on women’s experiences of mammography screening has been dominated 
by survey studies, as shown in the introductory chapter. In spite of the number of such 
studies, many aspects from experiences of screening are overlooked when using 
surveys. In this study, our research group chose to do a qualitative, prospective 
interview study. We wanted to use research methods that would let women tell about 
their experiences in their own words and about their own perspectives on the subject. 
Using qualitative methods such as open-ended interviews give women an opportunity 
to tell the stories they consider most important rather than telling about their views on 
issues considered important by the researchers.  
Moreover, qualitative interviewing was the best option in order to know more about 
how women’s decisions and experiences turned out as they did. Listening to how 
women talk about their experiences and feelings can show which discourses women 
draw upon when making their decisions, and which discourses that influence their 
experiences. In this chapter I will give a short presentation of why qualitative 
interviewing was seen as the most relevant method for studying women’s experiences 
of mammography screening. I will give a presentation of the studies that provided the 
data material for this thesis and discuss aspects of focus group interviews and 
individual interviews. Furthermore, I will present the process of analysis and discuss 
whether and how these analyses can be generalised to a larger population, as well as 
reflect upon how I might have influenced the data material and the analysis. Finally I 
will discuss the ethics of the research project.  
Qualitative research on mammography screening 
The main strength of qualitative research is that it allows those who are studied to 
give their perspectives and interpretations of the phenomenon in question. This is an 
advantage when studying people’s experiences and ideas, as well as when studying 
issues that concern personal matters (Edwards & Ribbens, 1998). Health is an 
example of a personal matter in our culture. Personal aspects of health are people’s 
bodies and psyche, as well as individual and social experiences related to having a 
body. At the same time health and citizen’s bodies are a matter of public concern in 
the welfare state, thereby presumably drawing on public discourses on what it implies 
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to be a citizen with a body that require health services. Researching experiences of 
mammography screening mean dealing with women and their bodies in both private 
and public spheres. Considerations of mammography screening’s double-sided 
position ought to be important before, during and after deciding how to do research on 
the field.  
Since mammography screening is a screening programme that invites all women at a 
certain age, and of whom nearly 80 per cent participate (Feiring, 2004), experiences 
of being invited and participating could be expected to be relevant for most women. 
Furthermore, this relevance can be seen as constructed through public discourses. 
Data are bound to context and a person is likely to answer differently when set in a 
focus group than in an individual interview (Kitzinger & Barbour, 1999). It was 
therefore both possible and desirable to study women’s experiences of screening in a 
group setting. Focus groups are better than individual interviews for examining how 
knowledge, stories and self-presentation operate in a given cultural context, while 
individual interviews are more effective for getting information about individual 
biographies (Kitzinger & Barbour, 1999). 
The research group thus chose to see the experience of being invited to a population 
based screening programme as a “public” event, suitable for being studied by group 
interviews. Being recalled, on the other hand, is something extraordinary, and 
something that might be experienced as more private, and thus more suitable for being 
explored in individual interviews. Even though group interviews can give participants 
a chance to discuss personal experiences, individual interviews are probably more 
appealing for conversation about personal thoughts, anxieties and life experiences. 
Nevertheless, women talking in a group might experience solidarity with each other 
and thereby give room for another kind of intimacy. In the following I will present the 
parts of this study and the data material, as well as discuss aspects of focus groups and 
individual interviews.  
The study 
This thesis consists of data from two data sampling processes. The first part of the 
study is a focus group study with women participating in the national breast cancer 
screening programme. I will call this part of the research project “the focus group 
study”. In this part of the study we conducted a series of focus group interviews with 
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women invited to the Norwegian Breast Cancer Screening Programme for the first 
time. Even though more than half the women had prior experience with 
mammography, this was the first time they had received an invitation letter with a set 
appointment in the public screening programme. The second part of the study consist 
of individual interviews with women recalled for further examinations due to an 
abnormal mammogram after participation in the breast cancer screening programme. I 
will call this study “the recall study”.  
The focus group study 
The focus group study had its first round of interviews during the spring of 2003.  As 
the national screening programme expanded, the spring of 2003 was the last chance to 
talk to women over enrolment age in Central Norway the first time they were invited. 
The thought behind this haste to talk with the screened women was that their 
experiences would be somewhat different when they participate in mammography 
screening for the second time than for the first. We wanted to know about their 
experiences as first time participants. This was a somewhat optimistic expectation 
since most of these women had already had one or even several experiences with 
mammography. Some women had been to a private clinic on their own initiative, 
others had joined “health tours” organized by The Norwegian Women's Public Health 
Association6. Nevertheless, participating in a public screening programme for breast 
cancer was a new experience for all the women. Seeking to explore women’s personal 
experiences in a relatively unexamined area, we opted for a semi-structured focus 
group study.  
Design 
The design of the study was prospective. Eight groups from four different 
municipalities were gathered three times. The first round was held about a week 
before the women were going to their mammography examination. The second round 
of meetings was held between two and four weeks after the mammography. Half of 
the groups had received their answers before the second focus group meeting, while 
                                                 
6 In Norwegian: Norske kvinners sanitetsforening (NKS); known among the women in our study as 
“Sanitetsforeningen” – an organization with 1324 local branches across the country, with over 52.000 
members doing voluntary work.  
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the other half had not yet received the result of the examination. This dissertation is 
primarily based on analyses of data from the first round of focus groups. Only article 
IV draw on data from the second round of groups. The third round of focus groups 
has been analysed in another part of the project, see Østerlie, W et al (2008, 
forthcoming).  
The point with choosing a prospective design was to see whether women felt 
differently about mammography before and after they had participated in the 
screening program. The experience of joining a screening program for a potential 
lethal disease can make women change perspective on their own health and on 
screening per se. It was also important for us to talk with the participating women 
before they went for the mammography examination to hear how they interpreted the 
experience at that moment, not how they saw the experience in retrospect. 69 women 
participated in the focus group study, unequally distributed in the eight groups, as 
shown in table 1. 
Table 1: Distribution of participants in focus groups  
Group Age Number 
of invited 
women 
Participants 
1. focus 
group (pre-
screening) 
Participants 
2. focus 
group (2 
weeks after 
screening) 
Participants 
3. focus 
group (6 
months after 
screening) 
Women with no 
previous 
mammography 
experience 
1 50-59 35 8 7 4 0 
2 60-69 35 8 7 6 3 
3 50-59 36 8 8 7 3 
4 60-69 30 10 10 10 3 
5 50-59 40 10 8 7 5 
6 60-69 38 6 6 5 4 
7 50-59 36 9 8 7 2 
8 60-69 36 10 8 7 2 
Total  286 69 62 53 22 
 
Sampling  
To be able to have a prospective design in the focus group study, we cooperated with 
the Cancer Registry of Norway - the agency in charge of setting up the screening 
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invitation lists. This made us dependent on their procedures concerning time and 
place for the focus group meetings, selecting communities according to the Cancer 
Registry’s screening calendar. Since the screening programme is based on inviting 
women municipality by municipality, we chose to do the same. From a list of 
municipalities scheduled for mammography screening during the upcoming months 
we chose four communities. Since parts of Central Norway have large areas of low 
population density, we chose municipalities that had a population density that made it 
probable that we could gather enough women for group interviews without them 
having to drive for hours to meet. Four municipalities were chosen on a rural-urban 
scale, with groups in one city, one small industry town, and in two rural communities; 
one near the fjord and one in the mountains. The rural municipalities we chose had 
populations from about 6.000 inhabitants, while the city in the area had a population 
of about 150.000.  
We divided the women in each municipality in two groups, aged 50-59 and 60-69 
since discussions of health issues may have variations in connection to age and 
generation. We assumed that women would feel that more subjects would concern 
them when talking to other women in the same age group. Researchers using focus 
group methods seem to agree that homogeneity in each group is the best environment 
for group discussion, while heterogeneity between groups can generate variation in 
responses and get a broader representation of existing meanings on the topic in 
question (Kitzinger, 1994; Morgan, 1996; Barbour, 2005). In this study we knew only 
the women’s age and place of residence unless they revealed more about themselves 
it during the interview.  
Based on the mammography screening calendar and the project’s selection criteria we 
received randomly selected lists of women who were going to be invited to the public 
mammography screening program. From each of the four chosen municipalities we 
invited 30-40 women in each age group (Table 1). Which women that should be 
invited were thus selected strategically at the group level (communities and age 
groups), while individuals within the groups were selected randomly.  
Women who were invited to the research project received a letter of invitation to the 
focus group in their community. The letter consisted of information about the project 
and how the group interview would proceed as well as time and place for the 
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interview, a form of consent and a reply note with pre paid postage. This stage of the 
sampling process was thus dependent on self-recruitment by the women. For each 
group between 6 and 18 women replied. One can only theorize about the reasons for 
the variety in the number of answers, but we had a hint of one reason when one of the 
women in the less-participating parish was delayed due to a sheep in labour. The 
research group consisting of city dwellers had not thought about May as a busy month 
for farmers. Another reason for not answering the research invitation might be a lesser 
degree of interest in research of this kind in the rural district than in municipalities 
closer to the university and colleges, but this will always remain as qualified guessing.  
The variance of response in different communities gave different challenges. Even 
though the number of participants in each focus group may vary, we had to gather 
enough participants to carry out each group. The preferred number of participants is 
between three and twelve (Kitzinger & Barbour, 1999). For the most eager population 
we had to withdraw a few of the invitations to participate so that the focus group 
would have no more than twelve participants. The selection of who should not 
participate even after accepting the invitation was based on their addresses, 
withdrawing the invitation to those being the closest neighbours. In the end no group 
ended up with more than ten participants since some women were prevented from 
participating. Despite our assumption that twelve would be a suitable number of 
group participants, even ten turned out to be a bit too many for one group.  
Recruiting participants from sparsely populated areas or small towns gave us 
neighbours, friends or relatives in each group. This can be viewed as positive or 
negative for the data collection and analysis. Some researchers, especially in market 
research, see a group of already well known participants as polluting. The positive 
interpretation is that this makes the group more similar to an ordinary situation and 
can give the researcher a better glimpse of how this question is handled in a real 
social context, but at the same time group participants may avoid sharing sensitive 
information (Kitzinger & Barbour, 1999). It is impossible to know overall in what 
way our data were “biased” by the composition of each group, but  “bias” is not a 
central issue here. We were not searching for “the truth” per se. Rather we wanted to 
hear different voices with somewhat different characteristics. But, in one instance the 
influence was positive since it made it easier to recruit participants to the focus 
groups. Some of the women told they would not have come without a neighbour to 
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drive them to the group meeting room, and also to make them feel safe about 
participating. We thus experienced one of the advantages of focus groups when the 
research method allowed the inclusion of voices that would otherwise have been left 
out (Kitzinger, 1995).  
When putting a group or a series of groups together, it is important to consider the 
number of groups and the number of people that will be necessary to find both 
patterns and diversity in the material. Focus group studies can contain from 3 or 4 
groups to more than 50 groups (Kitzinger & Barbour, 1999). When deciding on the 
number of focus groups we drew on the research group’s experiences from an earlier 
study on osteoporosis (Skolbekken, Østerlie, & Forsmo, 2008). In order to find 
common features of the participant’s experiences and illuminate the ways in which 
participants identify discourses (Starks & Trinidad, 2007), our previous experience 
suggested that eight groups would be sufficient for this kind of study. 
Our experience turned out to be that even six groups might have been enough as the 
last two groups added little new to the analyses, but rather supported what was found 
in the previous groups. Still, if the order of the municipalities represented in the 
material had been different we might have missed important information with only six 
groups since the two groups from the most rural municipality gave a different 
perspective than the other groups (Saracevic, 2003). 
Procedure and conduct of focus groups 
The focus groups were held at a meeting place near where the women lived. Groups 1 
and 2 met at the University, groups 3 and 4 at a research centre, while groups 5-8 met 
at community centres. The place for the group sessions were primarily determined by 
the access of localities. Since some of the municipalities were low-density areas there 
were not many places to choose from when we wanted to be undisturbed from others 
outside the group and at the same time at a place the women would easily find. Each 
group meeting lasted for approximately two hours.  
The focus group interview is a qualitative group interview that focuses on a specific 
topic, selected by the researchers (Sim, 1998). The focus group can be more or less 
structured with preset questions. The group sessions in this study were structured by 
an interview guide. Each interview guide consisted of five questions (Appendix 2). 
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They were copied and given to the participants, one at the time. Some were repeated 
across the focus group meeting rounds, others were specific to each of the three 
sessions with each group. A facilitator read the questions and kept control of the 
discussion so that it stayed within the research themes. Apart from this, the women 
were encouraged to speak freely about the subject in question (Kitzinger & Barbour, 
1999; Bender & Ewbank, 1994; Sim, 1998).  
The women in the focus groups were also encouraged to ask one another questions 
rather than asking the researchers, and to share their opinions, stories and comment on 
each others point of view (Kitzinger & Barbour, 1999). This means that we could 
study the interaction between the participants while discussing their expectations and 
experiences of mammography screening, drawing on discourses that they saw as 
relevant for the topic (Hyde et al., 2005; Kitzinger, 1994).  
It has been argued that participants in group interviews give their answers according 
to what they believe to be the most common attitude in the group (Brandth, 1996). 
This might be a problem if one attempts to use focus groups to measure attitudes, but 
not if one uses group interviews to talk about experiences, since most people like to 
talk about their experiences with others (Brandth, 1996). Even though the research 
group setting was unfamiliar to the women, most of them exceeded their shyness 
during the first session. Moreover, there were of course also some women who talked 
about their opinions and experiences from the very beginning of the focus group. 
Some of these extrovert women even dominated their group to some extent and the 
facilitator had to make sure other women could have their turn talking.  
As we experienced, the group interview setting might give an advantage to 
participants familiar with the dominant culture and to talking in groups of a certain 
size (Pfeffer, 2004a). Differences in participation during the group discussion can 
influence the results. Whereas differences between participants can create hierarchical 
structures that make participants avoid expressing their opinions, we chose age as a 
means for creating internally homogenous groups. Nevertheless, there were 
differences between participants. In the small communities the other women knew 
who was the nurse, the school teacher or in the local council. This influenced some of 
the interviews, especially when one of the women came out as a nurse with 
knowledge to answer the other women’s questions. 
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When making focus group interview guides about mammography screening, we could 
not know whether the topic would be an issue for conflict or for consensus between 
the group participants. Nevertheless, the group discussions turned out to focus on 
consensus between participants. Even though experiences varied between the women 
on issues such as pain and fear, the women agreed on the usefulness of 
mammography screening. Disagreements between the women were also solved by 
themselves by attempting for consensus.  
One example of the group seeking consensus was a discussion about risk factors for 
breast cancer where some women emphasized the importance of having children, as 
seen below. One of the women told that she had never given birth, and this led the 
other women to reconsider their statements:  
A: I have read something about… […] it has been said that those of us that have 
children early and breastfeed are less at risk [for breast cancer]. Or am I 
confusing things here? 
B: I have read exactly the same, yes I have. 
C: It is more natural to have children at 20 than at 40. 
D: What about the ones who have never given birth then? 
A: Yeah... what about them, I wonder.... 
D: Yes? 
E: That is a question too.... 
D: I have never given birth. But I do have a son.... 
A: No... But we are not all the same... So we can’t say that, if it was like that… 
well, it doesn’t apply to all women.... 
B: One reads all kinds of stuff you know.... 
 
(Group 4,1,25) 
 
Consensus oriented group interviews can thus tell us about participant’s mutual 
attitudes to a theme, and maybe show discourses that all group participants can agree 
on. A second example was from another group where one woman who had never been 
to mammography earlier was sceptical and asked critical questions to the researchers 
and the other group participants. She was met with both laughter and discussion, but 
the group seemed to reach consensus as this woman also wanted to participate in 
mammography screening and admitted that one reason for not being to 
mammography earlier were her fear of breast cancer.  
It is not only the utterances of each participant that produces relevant data in focus 
group interviews, but also interaction between the participants. Discussions, 
negotiations of meaning and presentations of selves is what makes focus group 
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methodology special (Wilkinson, 1999). One can say that it is a process of collective 
sense-making that happens in the interaction between focus group participants (ibid; 
67). The group interview brings about processes where meaning is created between 
the participants in the group (Crossley, 2002). Different understandings of the subject 
can come forward, as well as argumentation that seeks to legitimate views from 
different angles (Søndergaard, 1996). Focus group interviews are in this manner a tool 
for constructing data, as these data would not have been created without setting up the 
focus group study. Still one can claim that these data-creating processes are similar to 
how people talk about such topics amongst themselves in other contexts.  
The researchers present during the focus groups made a choice to avoid answering 
questions from the group participants. The facilitator rather turned questions back to 
the group to facilitate more discussion. Putting the researchers outside the group 
process probably influenced the group discussions. The idea of researchers staying out 
of the discussion can be seen as an argument from the position of a focus group as a 
construction site for data. The choices made about researcher participation during 
focus groups interviews are discussed more thoroughly in article IV. 
The presence of the facilitator might influence how participants talk and what they 
talk about. For instance it might be an advantage if the researcher has some similar 
features to the group participants, such as gender, ethnicity or manner of using the 
language (Kitzinger & Barbour, 1999). This was the reason why we chose to have one 
of the female researchers as facilitator even though she was not the most experienced 
focus group facilitator in the research team. Having a man as facilitator might have 
influenced which subjects the women would have talked about. In addition to the 
facilitator, we were several women from the research group present. I was in charge 
of the technical equipment and assisted the facilitator in asking follow-up questions to 
the group participants. We also brought a secretary who took notes while the women 
talked. In some groups a researcher from the Cancer Registry of Norway was present. 
The presence of a group of researchers may have influenced how the women felt 
about participating in the discussions, but after the initial awkwardness we could not 
spot any direct influence of our presence. Nevertheless, in one manner my appearance 
influenced the relation to some of the women. During most of the focus group 
sessions I was visibly pregnant, and this seemed to influence how the women talked 
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to me. For instance one woman talked about the pain of having mammography, but 
then told me (and the rest of the group) that it wasn’t as bad as giving birth.  
Similarities between researchers and informants can give two kinds of knowledge. 
The informants may tell a woman what they would not say to a man. But, being part 
of a collective can on the other hand imply that knowledge is implicit in what is said, 
instead of being said out loud. Expecting the others to already know about certain 
experiences can have made it unnecessary to express all thoughts that the women had 
when participating in mammography screening. It is important that the facilitator 
knows when to let group participants talk freely and letting them introduce themes 
important to them that the researcher(s) had not imagined beforehand (Kitzinger & 
Barbour, 1999). During the focus groups the facilitator attempted to make women 
develop their statements when conscious about implicit knowledge. But, the data is 
still left with both utterances and silences open for interpretation.  
All interviews were recorded by cassette or minidisk. They were transcribed by an 
assistant that had also been resident during the interviews, taking notes. The 
interviews were transcribed in dialect, but were later standardized. Translating the 
dialect into standard Norwegian was done to make them more accessible to the reader. 
For the English articles and this thesis the excerpts have been translated into English.  
The recall study 
“The recall study” was conducted during the winter of 2004/2005. Women who had a 
recall letter were invited to participate in individual interviews, assuming they would 
prefer to talk about their experiences privately. Also, it would be difficult to sample 
groups of women in the short time span between women receiving the recall letter and 
their follow-up examination. None of the women in the recall study had participated 
in the focus group study.  
Design 
The recall study was also a prospective study, with interviews both before and short 
time after the follow-up examination. Women who are recalled after mammography 
screening in Central Norway receive a recall letter four or five days prior to their 
follow-up examination. Performing individual interviews in the short time gap 
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between the recall letter and the follow-up examination, I have studied the women’s 
“real time” experiences of being recalled. Women’s experiences of recall while 
awaiting the follow-up examination are underexplored. Only few studies have looked 
into this part of the screening experience. So far, I know only of three studies on the 
subject. Two of these were conducted through a self-report questionnaire or 
questionnaire interviews (Pineault, 2007; Austoker & Ong, 1994). The last study 
consists of qualitative interviews for a pilot trial of a questionnaire (Cockburn et al., 
1992).  
I wanted to study recalled women’s experiences told in their own words. The purpose 
of interviewing women in the waiting period was to see what had the greatest 
relevance for women waiting for a follow-up, rather than interpreting the experience 
retrospectively. Qualitative interview method has been advocated as particularly well 
suited to collecting data on sensitive topics (Hewitt, 2007). 
Sampling 
Informants for the recall study were sampled among women who were recalled for 
further examinations after participating in the national breast cancer screening 
programme. Criteria for being invited to the research interview were to be free of self-
detected symptoms of breast cancer and live within 45 minutes drive from the 
hospital. A total of 35 women met the inclusion criteria during four months of 
sampling. They received a recall letter four to five days prior to the scheduled 
examination. An invitation to join the research project was presented in the same 
envelope. Women joined the project by calling the interviewer and making an 
appointment for an interview. Eight women actively agreed to participate in the first 
interview while waiting for the follow-up examination. Six of these women took part 
in a second interview after having the follow-up and result. Three of the eight women 
were diagnosed with cancer, while four women were “false-positives”. The diagnostic 
status of the last woman remains unknown as she never got in touch for the second 
interview.  
The low response rate for participating in the research project can have several 
explanations. First, the information provided may have been too vague. Some women 
had come to the outpatient breast cancer clinic with the intention to join the project on 
the day of their appointment for the follow-up examination. This can be due to 
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insufficient information in the invitation letter, or because the invitation to participate 
in a research project was presented in the same envelope as a letter about an abnormal 
mammogram. In order to avoid recalled women to feel pressured into participation in 
the research project, an important point was to let them recruit themselves when 
receiving the invitation. Thus, this was the only way to get in touch with recalled 
women.  
Another reason for the low response rate can be that receiving a letter about an 
abnormal result of an examination for a potentially fatal disease can be scary. For 
some women it may not be the best time to make a decision about participation in a 
research project. Being anxious from the recall letter can prevent women from 
participating in the research project. The period between receiving the recall letter and 
the follow-up appointment may be the time of greatest anxiety during the screening 
process (Austoker & Ong, 1994). And yet, this is exactly why the experience of 
awaiting a follow-up examination is important to study. I have looked more into this 
in the third article of this thesis.  
Procedure of individual interviews  
The eight women who responded to the interview invitation were presented with 
options to where they could be interviewed. All eight women preferred to be 
interviewed in the researcher’s office at the university campus. Each interview took 
between 10 minutes and an hour. Most of the second interviews were shorter than the 
first interview with the same woman. All interviews were audio taped and transcribed 
verbatim by research assistants or researcher.  
The interviews followed an interview guide (Appendix 4). After offering each woman 
coffee and biscuits, I told about the purpose of the project and then asked questions 
from the interview guide. Sometimes the questions were rearranged due to the 
interviewee’s storyline. Some of the women talked about the subject almost without 
me asking the questions. Other women were quiet and provided short answers for my 
questions. A goal of the qualitative interview is to explore the meanings of topics 
central to the interviewee (Kvale, 1997). During the interview I was opting for 
nuanced descriptions of different aspects of the interviewee’s life world and 
experiences. An open or semi-structured interview might bring out unexpected 
perspectives to the topic, or other topics related to the primary research question. 
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Since the interview will create new insights through the interaction between the 
interviewer and the interviewee, different interviewers can co-produce different 
discussions on the same topic (Kvale, 1997). 
I was considerably younger than the women who were interviewed. Conducting 
individual interviews with the women, my personal characteristics may have 
influenced what the women told about. In which direction my person may have 
influenced the data I can for the most part only guess. Some of the recalled women 
used the fact that I was at their children’s age to talk about mutual experiences in life; 
but it is not unlikely that some women chose to keep quiet about experiences or 
feelings that they thought I could not understand. Several of the women told me 
stories from their lives that were very personal; but some women seemed to feel 
uneasy in the interview setting and were not very talkative. 
Interviewing women who were awaiting their follow-up examination after 
mammography screening can be, as in all qualitative research, intrusive on the 
interviewees. In order to know more I used follow-up questions during the interview. 
It was however important for me to highlight how I wanted to know about their 
experiences as recalled, without intruding on the women’s lives and feelings. Even 
though a qualitative individual interview is a conversation between a researcher and 
an informant, the research interview is not a conversation between equal parts as the 
researcher is defining and controlling the situation (Kvale, 1997). Nevertheless, it is 
the interviewee who decides what information she will give to the researcher.  
Also, when doing individual interviews about issues of health it can be difficult to 
draw the line between therapy and research (Hewitt, 2007; Kvale, 1997). I had invited 
women to the research interview by using the hospital channel for communication. 
This could have given the interviewees the impression of the research interview as 
part of the therapeutic procedure of being recalled. Even though some of the women 
said that they appreciated to have a chance to talk about their experiences, none of 
them seemed to perceive the interview as therapy.  
Analyses 
Analysing qualitative interview material can be done in different manners. Qualitative 
approaches can be classified as phenomenology, discourse analysis and grounded 
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theory (Starks & Trinidad, 2007).7 These approaches have in common the analytical 
methods and processes of coding, sorting, identifying themes and drawing 
conclusions, but their methodology differs in that they have different focuses when 
formulating a research question (Starks & Trinidad, 2007). In this project we have not 
situated ourselves exclusively in grounded theory, discourse analysis or 
phenomenology. Rather, we have drawn upon all these approaches. Even though the 
goals and epistemologies of the approaches are different, they have been used at 
different stages of the project. Asking about women’s experiences of a screening 
programme can be a phenomenological project in the way that its goal is to describe 
meanings and the lived experiences of a phenomenon. At the same time, I have opted 
to describe how discourses on the field of mammography screening shape and are 
shaped by women’s experiences.  
In this study with two different interview materials, I had to treat the two materials 
differently, but nevertheless, most of the analytical tools and analytical methods were 
the same. Both the focus group material and the individual interviews from the recall 
study were analysed as written text. The interviews were read by all authors to the 
articles in which the analysis were to be presented. After reading one of the 
interviews, analytical categories were discussed by the research group. The categories 
were found on the basis of what the interviewed women said in the texts. Categories 
were thus found inductively from the data, rather than pre-determined. But at the 
same time, we had of course some thoughts of potential findings from theory and 
research made by others (Forss et al., 2001; Willis & Baxter, 2003; Lagerlund et al., 
2000). Nevertheless, analytical topics arose that we had not expected in advance. This 
happened for instance with the topic of trust that appeared as an analytical category 
after analysing the whole focus group material.  
After discussing the categories, the two PhD-candidates in the research project (me 
and Wenche Østerlie) categorised the transcripts from the focus group interviews. 
During this process, we discussed and re-defined categories and their connection to 
each other. For the material with individual interviews, I did the sorting of data after 
                                                 
7 Other classifications of analytical approaches add narrative methodologies, ethnographies, 
participatory action research and different case study approaches (Carter & Little, 2007). It is a 
question whether these should be called methods or analytical approaches. I will only mention this, not 
discuss it further.  
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discussing categories with the co-authors for the article on recalled women’s 
experiences. When analysing, we used both categorizing, condensation and 
interpretation (Kvale, 1997). First the data were categorized. Then we looked more 
into the most relevant quotations and condensed their meaning. Lastly we interpreted 
the quotes from theoretical perspectives, looking for patterns, paradoxes and 
discourses.  
Analysing the focus group material 
A question arising when using group interviews as data material is whether it is the 
group or the individual that is the analytic unit. In this study both groups and 
individuals have been treated as subjects in the analysis. Each statement by a woman 
has been seen as an utterance with its own meaning. But, each of the women has not 
been followed during the three focus group sessions in which she participated. Rather, 
each utterance has been seen as part of the group discussion and discourse. In this way 
the groups stand out as analytic units. Each woman in the group and the interaction 
within the group has thus become part of the presentation of the group in the material.  
As the facilitator of each group opted to make the women discuss with each other 
rather than with us, there was interaction between the participants. The degree of 
interaction varied between the groups; nevertheless, all the groups had some degree of 
discussion between participants. These discussions gave insight into different 
perspectives that the women had towards mammography screening. When analysing 
the material the discussions provided important information on which discourses the 
women draw upon when making their decisions for mammography screening. Both 
disagreement and consensus has become focus points during the analyses as they both 
provide strong hints about what is most important for the participating women.  
Another issue concerning the analysis of these data is that the groups differed in the 
way they discussed the subject. These were eight different groups with dissimilar 
characteristics. Even though their attitudes to mammography screening pointed in the 
same direction, their interpretations of breast cancer and mammography nevertheless 
differed. This especially became visible when analysing the issue of trust as presented 
in article II. While doing the data collection, trust was not an explicit issue for the 
research. Rather, it was during the process of analysing the data that it became clear 
that many of the focus groups discussed questions of mammography and trust. 
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Researching trust explicitly is difficult. The concept is complicated to discuss as trust 
is implicit in our daily lives and doings (Brownlie & Howson, 2008). It would thus 
have been difficult to ask the women directly about whether or not they had trust in 
mammography, and what it was they had trust in. When the women themselves 
started to discuss their trust in mammography as a technology and as an expert 
system, I considered this a unique opportunity to study trust.  
Not all the focus groups discussed their trust in mammography. The two groups from 
the most rural district in our sample differed from the other groups in this regard. In 
these two groups trust and the potential “untrustworthiness” of mammography were 
not mentioned at all. This does not mean that these women have less trust in 
mammography than the women in the other groups. Rather, their approach to the 
discussion insinuated that they may have more trust in mammography than the other 
women, or that problematizing the subject was irrelevant. Since fewer of these women 
had previously had mammography than in the other groups, it may also be that these 
women were less familiar with mammography than the other groups. If women are 
unfamiliar with mammography, they may not have any expectation of what it is, or 
know of its critical points. With no expectations, there are also no doubts. If these 
women had no doubts to suspend, then their unproblematic relation to mammography 
may be better explained as acceptance rather than trust. Or rather, they trust, but their 
point of suspension is for instance that the invitation to mammography is issued by 
the national health authorities. I still chose to interpret the remaining six focus group 
interviews from the perspective of visualization and trust. It gave a good explanation 
to why these groups of women had trust in the mammography screening program. 
This is developed further in the second article.  
A weakness of my analysis is that I have not used the data material to its full extent. 
Even though there is evidence of differences between the focus groups, I have chosen 
to focus on the similarities between them. This can give an air of a unity in the data 
material that is not real. But, the ways in which the groups differed were vague, and 
difficult to spot. One impression is that there was more of a “wait and see”-attitude in 
the two most rural groups than in the other groups, with the city groups as most 
proactive (Saracevic, 2003). So, there is some indication of an urban-rural dimension 
in this material.  
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Furthermore, neither analysis on the prospective design, nor of the age specific groups 
has been developed in this analysis. These paths of analysis are left unexplored for 
now. This is a consequence of the article-based dissertation format, but I hope to be 
able to pursue these paths later on.  
Analysing the individual interviews 
When doing the interviews of the recalled women I did not know what I would find 
about their experiences. Since there was little knowledge about women’s experiences 
of a recall, particularly during the time span of waiting for the follow-up examination, 
I had asked the women open questions to allow them to give their perspectives. When 
analysing the data I therefore chose an open inductive approach.  
Reading the interviews after the transcript, it was the ambivalence in each woman and 
between the women that struck me. That the women were worried about the result of 
the test while at the same time hoping for the best was not a surprise. Rather, it was 
what could be expected for persons awaiting a follow-up examination. Thus, I looked 
for other aspects of the data material. Categorizing what the women had talked about, 
the issues of numbers and time struck me as important for the women’s experiences of 
being recalled. This was not expected in advance; neither did I have a theoretical 
perspective to lift these issues out of the material. Rather, it was an inductive analysis 
with themes rising out of the interview material. Then, when these themes had 
emerged in the analysis I looked for theoretical explanations.  
Other subjects from the data could also have been developed in the analysis. For 
instance many of the women talked about their relation to family members and who 
they told about the recall while others were spared from knowing about it. Also, some 
women talked about earlier disease and how other experiences in life influenced their 
perception of the recall. Even though these subjects could have been developed in an 
analysis, I chose to focus on the aspects of surprise, numbers and time. Even though 
the data material of the recalled consisted of only eight interviews, I opted for issues 
that could be generalized as important topics for other women than the eight women 
in the material. In this study I chose to focus on patterns in the material. Focusing on 
individual stories and family relations could have given another perspective, but 
would also have given a story of unique histories rather than focusing on what the 
women had in common.   
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Generalizability  
Statistical generalization is not a goal of qualitative research (Kvale, 1997). More 
important is giving new perspectives to a subject, and letting the persons who are 
studied give their stories in their own words. The claim in qualitative research is to 
represent a version of reality, not the “truth per se” (Hewitt, 2007). Nevertheless, a 
scientific study must provide information interesting for more people than the 
researcher and the informant. Generalization can thus be different processes, even 
opposed to statistical generalisation.  
When starting this study the goal was to gain data that could tell us how women 
experiences to be part of a mammography screening programme. The sampling 
procedures for the study were thus made in order to provide a material that would 
both give homogeneity and heterogeneity. The procedure has been discussed further 
in article IV. One question is, however, how the age- and municipality-specific 
sampling has influenced the generalizability.  
The material for both parts of this study is sampled from the same two-county area of 
Norway. Whether women from Nord- and Sør-Trøndelag are different from women in 
other parts of the country is impossible to say. The Norwegian culture is 
homogeneous, but there may still be differences between groups of women based on 
class, education, or regional differences. For instance, we found some differences in 
women’s attitudes toward the importance of mammography screening between the 
urban and the rural groups. This can probably be applicable as an indication of 
differences across the country as well. Age was another classification in our sampling 
in the focus group study. The data consists of women from the whole age range in the 
target group for mammography screening, and the analyses are thus probably liable to 
be generalized to the mammography screening population.  
In the recall study the age span was narrower. Only women aged 50-59 volunteered to 
join the study. This is a weakness when stretching the results to the whole population. 
Rather, I will claim that the recall study is only valid for the age group that was 
interviewed. We cannot know if older women have different perspectives to being 
recalled than those in the youngest group. Also, the small material with only eight 
informants makes it difficult to generalize. Nevertheless, Patton (2002) argues that 
sample size depends on what you want to find and how it is to be used when you have 
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found it. The recall study has provided important knowledge about how women 
interpret information in a difficult situation – or rather how they find information with 
numbers as out of place when worrying about having a diagnosis for a potentially 
lethal disease. This perspective can provide researchers, health personnel and policy 
makers with a different perspective than a “rational decision-making”-perspective.  
Studying women’s experiences of mammography screening with qualitative interview 
methods gave a large and multifaceted data material. When analyzing the data I found 
both patterns and special cases. A question I had to relate to was whether I should 
focus on universals or particularities, whether the focus was to find patterns or to 
exploit complexity (McPherson & Thorne, 2006). Whether the results of the study can 
be generalized is dependent on how the analyses deal with the variance and paradoxes 
in the data material. When doing the focus group interviews the women seemed to 
search for consensus but the interaction between the women also showed diversity. 
We were conscious of the diversity between groups and between women in the groups 
when analysing. Despite our wish to provide analyses that gave insight into both 
commonalities and diversity, I see our analyses of the focus group material as 
primarily seeking patterns in how women experience mammography screening.  
When analysing the recall study interviews I also focused on both commonalities and 
diversities, but with individual interviews the diversities became more salient. Even 
though there were many aspects of the women’s experiences of a recall that were 
similar to most of the women, such as having ambivalent thoughts about the recall 
and its result, there were also apparent diversities between their experiences. 
Especially one woman stood out as an exceptional case when compared to the others. 
She was the only one who had a negative attitude towards the recall and who was 
more irritated about joining the screening programme than glad to have an extra 
check-up as the other women were. In order to give a new perspective from the data 
on recalled women it is important to give the woman with a different voice a place in 
the analyses.    
No matter how valid or reliable the data from a research study is, when its results are 
made public, social researchers who are concerned with intimate issues are also 
involved in the social construction of knowledge within public and academic 
discourses (Edwards & Ribbens, 1998). When researching women’s experiences of 
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mammography screening I experienced the problem of translating personal 
experiences into academic and public knowledge. How can I as a researcher standing 
outside the experience say that the women’s experiences represent governmentality? 
This is probably an interpretation none of these women would offer on their own. It is 
my own theory-based interpretation. Its credibility stands or falls on my ability to 
argue for it through deploying the data as supportive or critical evidence.  
Ethics 
The project was acknowledged by the Regional Committee for Medical Research 
Ethics (REK IV). Information about the project was sent to all participants before 
interviews were conducted, and they signed an act of consent before joining the group 
or participating in the individual interview. We also emphasized the importance of a 
non-disclosure agreement between participants in the focus groups. Women joined the 
project by their own initiative after receiving a letter of invitation. Those invited to the 
recall study were anonymous to the researchers until they chose to participate and 
those participating remained anonymous to the staff at the hospital unit. Women were 
informed that whether or not they joined the research project would have no impact 
on their follow-up examination or on further treatment. Interviews were conducted 
outside the hospital area to obtain a neutral environment. Nevertheless, some ethical 
challenges arose.  
A question when interviewing women who are about to have an examination for a 
potentially lethal disease is if it is a burden to participate in a research interview. This 
became visible at some of our focus group sessions. During the first focus group the 
women discussed hormone replacement therapy.  At the second group session some 
of the women told that they had begun to worry about what impact their hormone 
medication might have on breast cancer risk. One of the focus group women stopped 
taking her hormone replacement therapy following the discussion at the first group 
session.  
That anxiety may increase because of reflections during a research interview was to 
some extent also visible in the recall study. One of the women going for a follow-up 
examination expressed that she got more nervous after being interviewed than she had 
been before she came to the interview. Nevertheless, most of the interviewed women 
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expressed that it was good to talk to someone during the waiting period and few 
participants dropped out of the study.  
These observations represent ethical challenges with the chosen research design. At 
least it says something critical about the decision to remain passive in the discussions. 
In the women’s own discussions they sought to soothe fears as these arose. When 
choosing the passive role for the facilitator we blocked us off from the consoling role. 
But, a few times during the focus groups the facilitator neglected the passive role and 
offered explanations to women who were worried. The role of the passive facilitator 
in the focus group interviews is discussed more in article four. In the individual 
interviews I did not attempt to maintain a passive role and I attempted to comfort 
those who expressed anxiety in many of the interviews. However, not all of the 
recalled women expressed the need for consolation.  
  
 73
4. Discussion and conclusion 
When initiating this research project, I asked “What are the experiences of women 
who are invited to join the screening programme when making their decision to 
participate; when participating; and when facing a recall letter?”. The four articles 
have offered some answers to how women make their decisions to participate, and 
how they experience to participate – also when receiving a recall letter. Furthermore, 
the second article explores women’s trust in mammography screening – a trust that is 
closely connected to issues of knowledge and technology, as well as to expert 
practices. Even though the study is not completed, nor have all paths of the data been 
explored or mapped, it is time to wind up this thesis.  
During the previous chapters of this thesis I have painted a picture of the field of 
mammography screening. The field has been described as filled with at least two 
discourses (Kaufert, 2000), of which a medical and statistical discourse is the 
dominant in discussions about mammography screening. Based on the medical 
discourse and its statistical proofs it is rational for the health authorities to initiate a 
screening programme. Not surprisingly, women’s own perspectives were, at least to 
some extent, reflections and interpretations of the dominant medical discourse. 
However, the other discourse described by Kaufert (2000) – the discourse about faith, 
emotions, responsibility, morality, compliance and guilt - was also influencing 
women’s experiences of mammography screening. My own conclusions wrap their 
way around the medical perspective and women’s acceptance of it, seeing both as 
instances of “governmentality”. This interpretation does not invalidate the medical 
perspective or women’s acceptance of it. I remain agnostic as to the medial value of 
mammography screening. My perspective merely adds a layer of interpretation to the 
medical and popular discourse, in terms of the role of that discourse in society. Also, 
my interpretation allows me to explore the experiences of the recalled that are among 
those taking the consequences of participation in a routinised mammography 
screening programme. In this chapter I will show the details of this argument. I will 
furthermore give a short discussion about how the research design may have given 
priority to one of the discourses on mammography screening. In the last part of the 
chapter I will conclude this thesis and presents some thoughts about further research.   
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Mammography screening: government or self-governance? 
When invited to the public mammography screening programme, women receive a 
letter of invitation with a preset appointment. This invitation seems to be an important 
contribution to how women choose participation in the screening programme. For 
many of the women the invitation became a means to overcome the “threshold mile” 
(dørstokkmila). In their busy lives, women delay mammography even when they say 
they ought to have it done, but when receiving an invitation with a preset 
appointment, they make it their priority to attend.  
Women who participated in the focus groups were unsure about the nature of breast 
cancer. They described cancer as a frightening disease, with breast cancer as one of 
the most lethal types of cancer, as well as a disease with a high incidence rate among 
Norwegian women. Their perceptions of breast cancer influenced how they 
interpreted the screening invitation letter and how they made their choices about 
participation in the screening programme. Although a bit worried about their own risk 
for breast cancer, these women saw mammography screening as a chance to have 
certainty about not having breast cancer. The possibility of receiving an “all well”-
notice seemed to be just as much in focus as actually receiving a diagnosis of breast 
cancer. The women in this study saw it as their own responsibility to take care of their 
health. Having regular mammograms was part of what they thought they ought to do 
in order to safeguard their health, but at the same time many of them expressed a lack 
of ability to make mammography a high priority on their own initiative. 
Even though the letter is highlighted as an invitation from the screening providers, it 
was seen as a call-in by the participating women. The letter of invitation to 
mammography with the preset appointment was understood as advice from medical 
experts about what women should do to maintain their health. Seeing the invitation as 
a result of expert advice made the choice of participation easy. Moreover, they were 
glad that the health authorities and the welfare state (as they expressed it) had taken 
the decision about their participation. Women in our sample were grateful that 
someone had made the choice for them, rather than having to initiate breast cancer 
screening by themselves. Receiving a letter with a preset appointment seems to 
overcome obstacles women see for their participation, even though some women have 
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to change their appointment, which can take somewhat more effort than just showing 
up at the preset time. 
The women expressed that participating in screening was a responsibility towards 
themselves, but also as a responsibility towards others. Their responsibility towards 
others was related to taking care of their own health so they could take care of their 
families, but also related to showing solidarity with other women who could have 
breast cancer. Similar aspects of women’s compliance to screening was also found in 
a study of cervical screening where the invitation made the screening a routine aspect 
of female embodiment (Howson, 1999). In Howson’s study, compliance was 
associated with responsibility to oneself and emerged with a sense that one was 
obliged to participate. Compliance towards a screening programme expresses thus 
complex obligations that women see as relevant for their participation.  
Nevertheless, the invitation influences women’s participation in and experiences of 
mammography screening. The invitation letter is part of the communication between 
the health authorities and the women, and part of the technology surrounding the 
screening programme. This technology brings more women into compliance with the 
screening programme as it helps women overcome the obstacles they have for having 
mammography when they have no symptoms for breast cancer. Some women would 
nevertheless use mammography as a means to detect pre-symptomatic breast cancer 
without a screening programme. Others have been to mammography since their 
women’s health promotion organization8 has arranged trips to a private 
mammography clinic. Some continued to attend when the private clinic sent them a 
letter reminding them how long it has been since their last mammography 
examination. For others these factors are not enough to make them participate, and 
one can see the preset appointment in the invitation letter as a technology that glues 
more and more women into compliance with the programme, like “Latour’s key” 
(Latour, 1991). The letter of invitation with its preset appointment thus leads 
Norwegian women between 50 and 69 years of age to participate in the public 
mammography screening programme.  
                                                 
8 Norske kvinners sanitetsforening, see page 54.  
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There is of course reason to ask whether the invitation actually has such a big 
influence on women’s participation and experiences of mammography screening. The 
belief women have about breast cancer as curable if detected early is essential for 
their choice to participate. But, this knowledge has not been enough to make all 
women have mammography as often as recommended by the expertise. The fear of 
cancer that some women say leads them to go to mammography, may lead others to 
postpone mammography. Furthermore, in their busy lives and without symptoms to 
make it seem urgent, many women don’t make mammography their priority, but the 
invitation with the preset appointment overcomes their lingering.  
Even though the women are glad to have mammography in order to detect breast 
cancer early, most women do not expect to be diagnosed with breast cancer. The 
women interpret mammography as a way of reassuring good health as much as they 
see it as a technology to detect disease. This does not mean that women believe that 
mammography will prevent breast cancer. Rather, it seems to give them an 
opportunity to let their feeling of being without breast cancer dominate and get rid of 
their fears of breast cancer. Indeed, I cannot know whether they already had a fear of 
breast cancer or whether it was initiated or increased by receiving the invitation to 
mammography screening.  
In one aspect women experienced the screening programme as less positive than 
going to private screening. That aspect was the social bit of going to mammography. 
Before enrolled into a programme, many of the women who lived far from the city 
had as mentioned above been on mammography screening tours organized by a 
women’s organization. There were other attractive aspects to participation in that 
setting than in the more individualized screening invitation. When going on an 
organized screening trip with a busload of women to the nearest city, there was a 
social aspect and a women’s health solidarity-aspect that partly made women 
participate. The social aspect is gone in the national screening programme, but the 
solidarity-aspect was found in the data in this study as well. Some of the women told 
during the focus groups that they were sure they were well themselves, but they still 
saw it as important to participate to maintain the programme, and to have solidarity 
with those women who actually have breast cancer. Indeed, there are several reasons 
for women to participate in the breast cancer screening programme. The choices they 
make are not only influenced by the wish to confirm that they themselves are free 
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from breast cancer or at least found early if diagnosed. Their experiences of being 
participants are also coloured by their relations to other women who have breast 
cancer.  
One question here is whether the screening programme manages to obtain screening 
participation as an informed choice. According to Miller and Rose (1990), 
programmes of government are evaluated in terms of the extent to which they 
enhance personal choice. Individual choice is in focus in the liberal society. We asked 
women about their individual choices and they presented themselves as choosing. 
Nevertheless, the results of this study show that there are other factors that influence 
women’s participation in and experiences of mammography screening.  
The Norwegian breast cancer screening programme provides information to its target 
population along with the invitation to participate, and have designed their quality 
manual in order to follow the WHO’s ten principles for screening. I will not go into 
the discussion of whether information provided to the targeted group is biased or not, 
as others have done (Jørgensen & Gøtzsche, 2004). Rather, questions about bias in 
information may come second when women make their choices about participation. 
Despite receiving information about pros and cons for mammography screening, 
women in this study seems to make their choice about screening participation based 
on other aspects of screening than what was meant to enable their personal choice. 
Their screening participation was perceived as decided by someone else due to the 
preset appointment in the invitation letter, and the fact that the invitation came from 
the public health authorities and the welfare state which they trust. The process of 
choosing to have mammography without having breast cancer symptoms is thus made 
easy. The opting-out structure of a population based mammography screening 
programme were not seen as threatening the women’s autonomy, rather it was 
perceived with gratitude from the invited women. Participation in mammography 
screening can be seen as less of a choice women make and more as an obliging act 
where women submit themselves to compliance into a technique of governance. 
In the liberal society being a good citizen through doing self-governance, implies 
taking care of one’s own health (Brownlie & Howson, 2006). The women in this 
study felt as if the health authorities’ agenda and their own wishes coincided. Seeing a 
screening programme as a technology of governance, we can see how the values 
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which influence how we are governed overlap with those which shape how we govern 
ourselves (Nettleton, 1997). There is a connection between what is wanted by the 
state and what the individuals want for themselves. Women’s wishes about finding 
cancer early to avoid death from breast cancer encourage them to embrace the 
screening programme, even though they are un-symptomatic. The connection between 
women’s wishes and the solutions put forward by the health authorities and the 
medical expertise are thus not characterized by opposition but rather by consensus 
(Riessman, 1983). The consensus is made possible by ethical, epistemological and 
ontological appeals of political discourse about what is possible or desirable – and the 
plans, schemes and objectives that seek to address specific problematizations within 
social, economic or personal existence (Miller & Rose, 1990). This does not mean 
that all parties have the same agenda. Rather, the consensus can be different 
perspectives that coincide but that nevertheless brings about similar practices.  
The consensus between the health authorities and the women can be explained as 
governmentality. Through the perspective of governmentality we can see how 
individuals are taking care of themselves through choosing to follow expert advice or 
not. Thus, expert advice shape how individuals think about themselves (Nettleton, 
1997). Individuals are not forced into specific practises but rather guided through 
expert advice to ensure their health. This does not mean that all women are lead 
headless into mammography screening. Although processes of government leave 
problems with explaining individual choice, the concept of governmentality is also a 
way of making room for the individual in the process (Neumann, 2003). Even though 
this study has highlighted the compliance of Norwegian women in the mammography 
screening programme, there is also room for resistance. Some women decline the 
invitation to mammography, and others drop out of the programme after one or 
several mammography examinations. Nevertheless, the way a screening programme 
defines normality makes little room for those resisting it (Hydle, 2003). If the normal 
and sound thing to do is to participate in mammography screening, resistance can be 
difficult. By initiating a population-based screening programme the health authorities 
have pointed out breast cancer as a health problem for both symptomatic and non-
symptomatic women. Screening is thus an example of governance embedded in 
preventive initiatives and discourses where women are enrolled through practices of 
the self (Howson, 1999).  
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To compare the benefit of those receiving a diagnosis with the benefit of those who 
are well is complicated. When women perceive their risk for breast cancer as being so 
high that they need to have mammography every second year, there may be 
something to gain for all women who participate in screening. The assumptions that 
prevention and early detection are of a common good for all individuals imply that 
even non-symptomatic women are better off under surveillance of a medical expert 
system. This can be seen as part of the medicalisation of society that teaches us to 
think about risks and acting in a way that helps avoid risks. Risk estimates for breast 
cancer are, however, based on estimates from experts who have a specific base of 
knowledge: a medical knowledge based on natural science and statistics. The 
screening programme thus offers women expert advice and a medical examination at 
the same time. Seeing this union as simplifying their own health care, the women in 
this study experienced it as a good thing. In my interpretation, the screening 
programme providing medical advice simplifies the process of self-governance that 
the women feel they ought to do. 
Trusting mammography: between expert advice and 
uncertainty 
Mammography is understood by women as a means to detect cancer early, thereby 
presumably saving (their) lives. Feeling that self-examination of their breasts is 
inadequate for detecting small lumps and not trusting the doctor to examine them 
either, mammography is left as the best way to detect breast cancer lumps early. 
Nevertheless, women know about some weaknesses in mammography technology. 
Without prompting from us, they mentioned that even mammography can miss 
finding some lesions – what medical text refer to as false negative results. They 
acknowledge that mammography cannot be trusted 100 per cent. However, while 
expert discussions mostly concern questions of false positives, the women primarily 
worry about false negatives and to a lesser degree about false positive results. These 
women worry about whether mammography screening might give them a false safety 
when they receive an “all-well”-notice. Still, women trust mammography screening to 
save them from cancer. This gave reason to ask what it is that leads women to trust in 
mammography screening.  
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For the women who were mammography screening participants, two things were seen 
as necessary for detecting lumps with mammography. The first concern was how the 
technology works. The construction of the mammography technology raises questions 
for the women since they perceive it as impossible to get the whole breast into the 
machine, thereby leaving parts of the breast unexamined even when having a 
mammography examination. Secondly, a question of doubt is related to how medical 
personnel interpret the pictures from the mammography. The number of 
mammograms examined by each radiologist is assuring for the women but at the same 
time screening participation gives them a sense of being one of many at a busy 
production line. They ask if lesions are missed due to inattention or rushed and 
routinised work. Detecting pre-symptomatic breast cancer is thus perceived as a 
complex task, but mammography’s visualizing technology seems to tip the scales, 
persuading women to trust mammography to save them from cancer.  
Familiarity with X-ray images from other parts of the body is an indication for lay 
women of how mammography works. Knowledge of the technology gives women an 
expectation about what will come out of having mammography, an expectation of 
how mammography may influence their future. The technology and the expertise 
interpreting the images are good reasons to trust mammography screening to find 
lumps; but knowledge of errors and an understanding of how such faults are possible 
make some women sceptical towards trusting mammography. Nevertheless, the 
visualizing mammogram is seen as a proof of the breast beneath the skin, allowing 
women take the “leap of faith” (Möllering, 2001) into trusting mammography even 
while acknowledging its weaknesses.  
Also, interpretation of complex knowledge is difficult. Having trust is a way to 
simplify complex systems (Lewis & Weigert, 1985). When trusting mammography 
screening to detect pre-symptomatic breast cancer, women do not have to estimate its 
pros and cons. Rather, they can use mammography as a way of doing their own self-
governance; taking care of their health in a way that is perceived as simple by the 
women. Thus, the visualizing technology is part of how screening programmes 
simplifies women’s lives and their self-governance. When choosing to trust 
mammography participation in the screening programme to which they are invited 
becomes the right choice for the women.  
 81
When talking of trust in mammography as a “leap of faith” that is made possible 
through the visualizing technology, I am treating the women in this study as a 
homogenous group. Nevertheless, I cannot assume that the trust women seem to have 
in mammography screening is experienced in the same way by all women, neither that 
the process of trusting is the same for all the women. Some of the other explanations 
of trust are more accurate for some women, for instance that trusting the health 
authorities is more a routine than an actual act (Möllering, 2006). Due to the vital 
nature of health care, people need to trust health care providers (Taylor-Gooby, 2006). 
But, most women who are enrolled in a screening programme do not perceive that 
they have symptoms in need of treatment. Nevertheless, the women see it as so 
important to detect un-symptomatic breast cancer that they choose to have 
mammography screening. Even for those women who discuss reasons not to have 
trust in mammography to save them from breast cancer, there is some issue that 
makes them trust, and that seems to be the visualizing technology that makes it 
possible to look at the breast beneath the skin.  
A striking point in women’s discussions about the trustworthiness of mammography 
is that they never raise questions about the specificity of the examination, that is, the 
possibility of having false positive diagnoses. Women did not raise doubts about the 
content of what an expert might claim to see, that is whether or not signs on the 
mammogram actually are cancers. It seems that women trust the expert’s findings of 
cancer to be correct, precisely because of mammography’s visualizing ability. The 
picture of a potential lump becomes a proof of the state of the breast. This 
interpretation was also found in another study where a woman who was shown a 
potential lump in her first mammogram could not believe that it could disappear on 
the second mammogram (Willis & Baxter, 2003). It is interesting to ask how such 
faith in mammography’s visualising ability influences Norwegian women’s 
experiences when recalled due to an abnormal finding at the mammogram. Having 
trust in the mammography image can make such an experience even more frightening.  
Mammography screening as routine 
Modern society is characterised by surveillance which is institutionalised and 
routinised in every aspect of economic and social life (Flynn, 2002). The screening 
programme becomes a technique through which the health authorities may shepherd 
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the population for its own good, guiding the individuals to do what is considered best 
for the “herd” (Neumann, 2003). The women in this study talk about mammography 
as something they ought to do in order to take care of their own health. The normality 
of having mammography even when non-symptomatic is clearly present in their 
discussions at the focus group sessions. Through receiving the letter of invitation with 
a preset appointment to mammography, women can take part in early detection of 
breast cancer without too much effort. The mammography programme makes 
mammography a routine for invited women. It becomes something to be done 
regularly, like going to the dentist. Women’s experiences of mammography screening 
are strongly influenced by their perception of it as a routine. The routinization of the 
mammography examinations makes participating seem normal, and the adequate 
thing to do for the women who are invited. It becomes just another examination that 
women at a certain age are due to do.  
Mammography screening is not unique in building on routinization of a medical test. 
It can be compared to how the prostate specific antigen (PSA) test – when performed 
without discussion or alongside other routine health tests – is seen by men as “just 
another blood test” (Chapple et al., 2008; Pfeffer & Laws, 2006). The study of the 
PSA-test found that it was perceived as a routine since taken alongside with other 
tests, and this blurred its potential for giving a consequential result. Moreover, when 
men are informed about uncertainties of treatment and side-effects, fewer are willing 
to partake in cancer screening than when solely informed about prostate cancer risk 
(Gattellari & Ward, 2004). This can also yield to mammography screening. When 
mammography screening is perceived as routine, the potential for receiving a cancer 
diagnosis is obscured. Most of the women in the focus group study perceived 
themselves as unlikely to be among those actually diagnosed with breast cancer. The 
routinization of mammography contributes to reducing the sense of risk.  
However, routinization of an examination for breast cancer has consequences. Firstly, 
it takes much of the fright out of the experience. Of course anxiety varies but even 
though many women worry about the results letter; this was not a big issue for most 
of the women. The routinization of the examination contributes to a sense of “nothing 
to worry about”. This seems to increase the shock of receiving a recall letter, the sense 
of being “thrown for a loop” experienced by those who are recalled or even 
subsequently diagnosed with breast cancer. Even though women worry and are aware 
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of how mammography is a test for breast cancer, the aspect of routine seems to make 
a recall all the more of a surprise. The experience of mammography as a routine 
becomes a trap for those recalled. They too have wanted to make sure they are as 
healthy as they feel, and suddenly they are one of those potentially ill.  
Recall after mammography screening – a routine “trap”? 
Women who participate in mammography screening run a cumulative risk of 20 per 
cent of being recalled (Hofvind, Thoresen, & Tretli, 2004). The Norwegian Breast 
Cancer Screening Programme has a recall rate of about three per cent per year. 
However, when receiving the recall letter women reacted with surprise. Even though 
they had been informed about the purpose of the initial mammography, only one of 
the women had expected to be among those recalled. Receiving the recall gave the 
women ambivalent thoughts. Some felt anxious, some wanted to take it in stride, and 
most of the women found themselves on an emotional “roller coaster” ride between 
different kinds of thoughts and feelings. Facing the possibility of having breast cancer 
the women thought about the seriousness of the disease and imagined the worst 
outcome.  
The experiences of the women who were recalled were coloured by their earlier 
expectations of each being one small member of the large group of women going 
through the routine of mammography screening with a routine “all clear” message as 
outcome. Thus they expressed surprise from being recalled. The women’s surprise 
might come as a surprise to us. They had just participated in an examination 
developed to find breast cancer lumps at a stadium prior to what they could know 
themselves. But, it seems like healthy women participating in the mammography 
screening programme are joining the programme to have certainty about being free of 
breast cancer as much as they see it as searching for cancer. Even when knowing the 
purpose of the screening program most women assume they are among the healthy 
ones.  
Though the form of the recall letter points back to an intention of consoling those 
recalled, these women found little comfort in the numbers and risk estimates 
presented in their recall letter. The information in the recall letter was rather 
interpreted in several manners by the recalled women. Being among the three per cent 
recalled made the experience frightening. Information that only one fifth of those 
 84
recalled were likely to have breast cancer was comforting to some, while others felt 
this to be a high number. The leap from 3 per cent to 20 per cent felt as a frightening 
large one. For others again the numbers made no sense since the important issue was 
whether one was well or not. The recall is experienced as difficult to interpret in 
“rational” terms when the only answer wanted is to know whether one is well.  
Information on risks and consequences of screening was perceived as important 
among participants in a British study on patient perspectives on information and 
choice in cancer screening (Jepson et al., 2007). But, information was not seen as 
most important when making ones decision to participate. Rather, the main reason for 
wanting information was to reduce anxiety when waiting for a result or if receiving an 
abnormal result. Information can thus serve to help with coping strategies (Jepson et 
al., 2007), but in my study this is contradicted. The recalled women read the received 
information, but when awaiting a follow-up examination for a potential cancer 
diagnosis many of these women saw the information as irrelevant for their situation, 
or even as frightening. 
The notion of time became important for those who were recalled. Since many 
women had waited many weeks for the recall letter, they perceived it as worrying that 
the follow-up examination was scheduled so quickly after receiving the recall letter. 
The short time frame for the recall made some perceive it as highly prioritised and 
thereby an indication of a serious situation. Also, the weeks passed since the initial 
screening mammogram were suddenly cast in a new light. Some had come to see the 
slow response as an indication that nothing urgent had been found. With the arrival of 
the recall letter, those weeks became a source of fear rather than comfort. The 
women’s understanding of the nature of cancer made them think about whether they 
might now have had cancer for too long without being diagnosed. 
Although worried before the follow-up examination, most of the women said they 
were glad to have participated in the screening programme. Those who were 
diagnosed with breast cancer expressed they were glad to have been caught early, 
while those who were false-positives were glad to have been checked out. Only one 
woman said she was annoyed by the recall and that she would not participate in the 
next screening round. This woman had had benign cysts before and expected the same 
again. In her view, this predictable false positive result was an annoyance. For some 
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of the women there remained an uncertainty after the follow-up. One woman did not 
receive the result during the follow-up examination due to a biopsy test that had to be 
double checked. Two other women were told they had benign cysts, and that made 
them worry about whether they could be really certain about their “all well”-answer.  
European women are less inclined to participate in the next routine screening than 
American women after having a false positive result (Brewer et al., 2007). Following 
the results of our study, it is a surprise that women in Europe are less inclined to 
participate in the next screening round. Even though not directly comparable, in this 
small material all but one of the women were certain they would return for screening 
in two years time. One explanation for the fall in participation rates among recalled 
women is that they may find the two-year span too long to wait for a new 
mammography after having a false positive mammogram, and therefore joined a 
private clinic with mammography screening instead of following the national 
programme. However, Brewer et al’s claim is that the "opt out" screening system of 
European countries may explain the difference. While the “opt in” system may 
require a minimum of reflection before joining a screening programme, the “opt out” 
system gives women a chance of overcoming obstacles to screening without relating 
so much to its potential consequences. Rather, it is exactly the “opt out” system that 
gives screening participation the air of routine and natural behaviour that overcomes 
“the threshold mile” that had kept the women from initiating mammography 
themselves. Facing the consequences of screening through a recall can make some 
women revise their thoughts about mammography screening as a mere routine.  
Research design and the priority of discourses 
Academic discourses on mammography screening have primarily been conducted as a 
biomedical discourse, which is also to say a discourse legitimated by quantitative 
methodologies, especially RCTs. Even though there had been done some research on 
lay experience of mammography screening, the research field was underexplored and 
our research group chose to explore the field by conducting qualitative focus group 
interviews. The question is what we obtained by choosing qualitative methods.  
As we wanted to explore women’s experiences of mammography screening both 
before and after participating in the screening programme, the research group chose a 
prospective design. While doing the data collection, we experienced for instance that 
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women’s focus changed from uncertainty about what to expect at the mammography 
examination, to seeing the examination as obvious but still being excited about how 
their result would turn out. A prospective design can be seen as improving validity by 
grasping the women’s experiences as they occur rather than as understood in 
hindsight. Even when not using the prospective design to its full extent in the 
analyses, the focus on women’s experiences “here and now” have probably given 
important information that would not have been found if studying the same 
experiences in retrospect.  
Sampling and recruitment to the study were done using both random and strategic 
sampling. This may have made the data communicable to several parties in the field, 
satisfying both medical and qualitative discourses on recruiting informants. Women 
participating in the research project partially interpreted our project as connected to 
the screening programme, and that might have influenced how they talked in the focus 
groups. Also, this can have influenced which discourses that were drawn upon by the 
women in the group discussions. If accepting, as I have done, Kaufert’s identification 
of two discourses of mammography screening (Kaufert, 2000) it is interesting to ask 
to what extent this research design has given priority to either one of these discourses. 
The interview guide for the focus group sessions might have given priority to one of 
the discourses. When asking about women’s thoughts prior to the mammography 
examination, we might have given priority to the discourse on faith, emotions, 
responsibility, morality, compliance and guilt. However, when asking how women 
perceived their own risk for breast cancer we probably gave priority to the first, 
medical discourse. But, throughout the analyses of the focus groups and the individual 
interviews, the medical discourse has appeared more as a black box in the women’s 
experiences – that is, knowledge that is accepted rather than reflected upon. The 
discourse on obligations, morality, compliance and guilt did, on the other hand, 
become more and more evident as relevant for the reflections the women had on their 
own experiences of mammography screening.  
Conclusion 
In this thesis I have studied women’s experiences of mammography screening. 
Women who participated in this study experienced participation in mammography 
screening as the right choice, rendering non-participation almost impossible. The 
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medical reasoning about how “early detection saves lives” is experienced as the 
rational way to make a decision. Expert systems provide knowledge and technology 
which women value and trust. When mammography is offered as a routine 
examination it helps women to govern their health. But when facing the possibility of 
having a breast cancer diagnosis it is not statistics or technology that is in focus. 
Rather, all women want to know is whether they are well or not. The routinization of 
mammography which takes the fright out of the breast cancer examination when all is 
well makes a recall a disturbing surprise. However, the experience of screening 
participation which gives some women pain and anxiety while waiting for the result 
seems to be outshined by the relief when receiving an all well-notice.  
Further research 
Women’s experiences of mammography screening are complex and multifaceted. 
However, the format of a thesis and four articles does not give room for presenting 
more than parts of the picture. There are of course other aspects of mammography 
screening that could have been studied. I have for instance not focused on how the 
women experience the examination in itself. Neither have I looked much into how 
they experienced meeting with the staff at the mammography clinic. Exploring these 
issues could give a broader picture of women’s relations to the screening programme, 
and also show other aspects of what it is that encourage them trust mammography 
screening to save them from cancer.  
Moreover, mammography screening may have consequences for more women than 
those recalled. Even though some of the women in the recall study in this thesis were 
diagnosed with breast cancer, I chose to focus on the experiences of those women 
who were “false-positives”. The experiences of non-symptomatic women receiving a 
diagnosis after mammography screening, could add interesting perspectives to 
screening. A study on this subject is currently taking place in Denmark, but would 
also be interesting in a Norwegian context.  
Furthermore, there are also other groups of women who face consequences from the 
screening participation. That is women with a “false-negative mammogram” or 
“interval cancer”. The false-negative women are undiagnosed with breast cancer even 
though having a lump at the time of the mammography, while the last group consists 
of women who discover a lump in between screening rounds. It is possible that having 
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trust in mammography screening and being part of a screening program can delay 
diagnosis for women who experience one of these two scenarios. Further research 
questions can thus be whether or not participation in a screening programme gives a 
delayed diagnosis for some women, and not least how these women interpret the 
experience.  
Finally, it would be useful to know how health personnel working in the 
mammography screening programme experiences and interpret their position and 
debates about mammography screening. How do health personnel relate to “the two 
discourses on mammography screening” that Kaufert (2000) identified? Do health 
personnel and decision makers solely relate to a discourse on scientific knowledge, 
statistics and principles for screening? Or, do health personnel and decision makers 
also, as the women themselves, relate to discourses on morality, responsibility, 
compliance and guilt? An interesting question following from the latter is how these 
discourses on health and women’s lives are part of political agendas and decision 
making. Through studies of women’s experiences as participants in a screening 
programme, and of health service providers’ perspectives to the programme and 
technology, we can understand more of the processes of medicalisation that occur in 
our society when our bodies, regardless of symptoms, are subjected to medical 
surveillance. 
An evaluation of the Norwegian breast cancer screening programme is scheduled to 
start in 2008. It will be exciting to see what aspects are included in the evaluation, 
how they are studied, and what conclusions will be drawn. It will also be exciting to 
see what impact these results have on public discourse and public policy. Given what 
we know today, the influence of the evaluation is far from certain. Moreover, it will 
be even more interesting to imagine a scenario where the effect of the mammography 
screening programme is questioned by the evaluation. The consensus conference on 
mammography screening in Norway in 1989 did not recommend a mammography 
screening programme at that time (Holst et al., 1989). Nevertheless, this did not 
influence the initiation of a national mammography screening programme. It will be 
surprising if a potential negative evaluation will make health authorities remove a 
public health service already running. Also, it is interesting to ask how the potential 
scenario of a negative evaluation may influence women’s participation in the 
programme. Maybe women governed by expert advices are letting themselves being 
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governed as long as the advice fit with how they perceive of mammography screening 
themselves?  
 90
5. Reference List 
Abbott, A. (1988). The System of Professions. An Essay on the Division of Expert 
Labor. Chicago: The University of Chigaco Press. 
Ahmad, F., Cameron, J. I., & Stewart, D. E. (2005). A Tailored Intervention to 
Promote Breast Cancer Screening among South Asian Immigrant Women. 
Social Science & Medicine, 60, 575-586. 
Alaszewski, A. & Brown, P. (2007). Risk, uncertainty and knowledge. Health Risk & 
Society, 9, 1-10. 
Alexander, F. E., Anderson, T. J., Brown, H. K., Forrest, A. P., Hepburn, W., 
Kirkpatrick, A. E. et al. (1999). 14 years of follow-up from the Edinburgh 
randomised trial of breast-cancer screening. Lancet, 353, 1903-1908. 
Andersson, I., Aspegren, K., Janzon, L., Landberg, T., Lindholm, K., Linell, F. et al. 
(1988). Mammographic screening and mortality from breast cancer: the 
Malmo mammographic screening trial. British Medical Journal, 297, 943-948. 
Armstrong, D. (1995). The Rise of Surveillance Medicine. Sociology of Health & 
Illness, 17, 393-404. 
Aro, A. R., Absetz, S. P., van Elderen, T. M., van der Ploeg, E., & van der Kamp, L. 
J. T. (2000). False-positive findings in mammography screening induces 
shortterm distress - breast cancer-specific concern prevails longer. European 
Journal of Cancer, 36, 1089-1097. 
Austoker, J. & Ong, G. (1994). Written information needs of women who are recalled 
for further investigation of breast screening: results of a multicentre study. 
Journal of Medical Screening, 1, 238-244. 
Bacchi, C. L. (1999). Women, Policy and Politics. The construction of policy 
problems. Sage Publications. 
Banks, E., Reeves, G., Beral, V., Bull, D., Crossley, B., Simmonds, M. et al. (2004). 
Influence of personal characteristics of individual women on sensitivity and 
specificity of mammography in the Million Women Study: cohort study. 
British Medical Journal, 329, 477. 
Barbour, R. S. (2005). Making sense of focus groups. Medical Education, 39, 742-
750. 
Bender, D. E. & Ewbank, D. (1994). The focus group as a tool for health research: 
issues in design and analysis. Health Transition Review, 4, 63-79. 
 91
Bjurstam, N., Bjorneld, L., Duffy, S. W., Smith, T. C., Cahlin, E., Eriksson, O. et al. 
(1997). The Gothenburg breast screening trial: first results on mortality, 
incidence, and mode of detection for women ages 39-49 years at 
randomization. Cancer, 80, 2091-2099. 
Brandth, B. (1996). Gruppeintervju : perspektiv, relasjoner og kontekst. In H.Holter & 
R. Kalleberg (Eds.), Kvalitative metoder i samfunnsforskning (2 ed., pp. 145-
165). Oslo: Universitetsforlaget. 
Brett, J. & Austoker, J. (2001). Women who are recalled for further investigation for 
breast screening: psychological consequences 3 years after recall and factors 
affecting re-attendance. Journal of Public Health Medicine, 23, 292-300. 
Brewer, N. T., Salz, T., & Lillie, S. E. (2007). Systematic review: the long-term 
effects of false-positive mammograms. Annals of Internal Medicine, 146, 502-
510. 
Brodersen, J., Thorsen, H., & Cockburn, J. (2004). The adequacy of measurement of 
short and long-term consequences of false-positive screening mammography. 
Journal of Medical Screening, 11, 39-44. 
Brodersen, J. (2006). Measuring psychosocial consequences of false-positive 
screening results - breast cancer as an example. Department of General 
Practice, University of Copenhagen, Copenhagen. 
Broom, D. (2001). Reading breast cancer: reflections on a dangerous intersection. 
Health, 5, 249-268. 
Brown, P. (2008). Trusting in the New NHS: instrumental versus communicative 
action. Sociology of Health & Illness, 30, 349-363. 
Brown, R. L., Baumann, L. J., Helberg, C. P., Han, Y., Fontana, S. A., & Love, R. R. 
(1996). The simultaneous analysis of patient, physician and group practice 
influences on annual mammography performance. Social Science & Medicine, 
43, 315-324. 
Brownlie, J. & Howson, A. (2006). 'Between the demands of truth and government': 
Health practitioners, trust and immunisation work. Social Science & Medicine, 
62, 433-443. 
Brownlie, J. & Howson, A. (2008). Introduction. In J.Brownlie, A. Greene, & A. 
Howson (Eds.), Researching Health and Trust (pp. 1-16). New York: 
Routledge. 
Bryder, L. (2008). Debates about cervical screening: an historical overview. Journal 
of Epidemiology and Community Health, 62, 284-287. 
 92
Burchell, G. (1991). Peculiar interests: civil society and governing "the system of 
natural liberty". In G.Burchell, C. Gordon, & P. Miller (Eds.), The Foucault 
Effect. Studies in Governmentality (pp. 119-150). Chicago: The University of 
Chigaco Press. 
Calnan, M. W. & Sanford, E. (2004). Public trust in health care: the system or the 
doctor? Quality and Safety in Health Care, 13, 92-97. 
Cancer Registry of Norway (2007). Cancer in Norway 2006 - Cancer incidence, 
mortality, survival and prevalence in Norway Oslo. 
Carter, S. M. & Little, M. (2007). Justifying knowledge, justifying method, taking 
action: Epistemologies, methodologies, and methods in qualitative research. 
Qualitative Health Research, 17, 1316-1328. 
Cartwright, L. (1995). Screening the body. Tracing medicine's visual culture. 
Minneapolis: University of Minnesota Press. 
Casper, M. J. & Clarke, A. E. (1998). Making the Pap Smear into the "Right Tool" for 
the Job: Cervical Cancer Screening in the USA, circa 1940-95. Social Studies 
of Science, 28, 255-290. 
Castel, R. (1991). From dangerousness to risk. In G.Burchell, C. Gordon, & P. Miller 
(Eds.), The Foucault Effect. Studies in Governmentality. (pp. 281-298). 
Chicago: The University of Chicago Press. 
Chapple, A., Ziebland, S., Hewison, P., & McPherson, A. (2008). Why Men in the 
United Kingdom Still Want the Prostate Specific Antigen Test. Qualitative 
Health Research, 18, 56-64. 
Christensen, T. (2005). The Norwegian state transformed? West European Politics, 
28, 721-739. 
Cockburn, J., De Luise T., Hurley, S., & Clover, K. (1992). Development and 
validation of the PCQ: a questionnaire to measure the psychological 
consequences of screening mammography. Social Science & Medicine, 34, 
1129-1134. 
Crossley, M. L. (2002). 'Could you please pass one of those health leaflets along?': 
exploring health, morality and resistance through focus groups. Social Science 
& Medicine, 55, 1471-1483. 
Davis, E. M. (2008). Risky business: medical discourse, breast cancer, and narrative. 
Qualitative Health Research, 18, 65-76. 
Dean, M. (1999). Governmentality. Power and rule in modern society. London: 
SAGE. 
 93
Denberg, T. D., Wong, S., & Beattie, A. (2005). Women's misconceptions about 
cancer screening: implications for informed decision-making. Patient 
Education and Counseling, 57, 280-285. 
Domenighetti, G., Avanxo, B. D., Egger, M., Berrino, F., Perneger, T., Mosconi, P. et 
al. (2003). Women's perception of the benefits of mammography screening: 
population-based survey in four countries. International Journal of 
Epidemiology, 32, 816-821. 
Edwards, R. & Ribbens, J. (1998). Living on the Edges. Public Knowledge, Private 
Lives, Personal Experiences. In J.Ribbens & R. Edwards (Eds.), Feminist 
Dilemmas in Qualitative Research (pp. 1-23). London: Sage Publications Ltd. 
Ekeberg, Ø., Skjauff, H., & Kåresen, R. (2001). Screening for breast cancer is 
associated with a low degree of psychological distress. The Breast, 10, 20-24. 
Ertzaas, A. K. O., Hofvind, S. S.-H., & Thoresen, S. (2001). Mammografiprogrammet 
i Norge. Evaluering av prøveprosjektet 1996-2000 (Rep. No. 2). Oslo: 
Kreftregisteret, Institute of population-based cancer research. 
Evans, A. J., Pinder, S. E., Ellis, I. O., & Wilson, A. R. (2001). Screen detected ductal 
carcinoma in situ (DCIS): overdiagnosis or an obligate precursor of invasive 
disease? Journal of Medical Screening, 8, 149-151. 
Feiring, E. (2004). Færre kvinner møter til mammografi. Tidsskrift for den norske 
lægeforening. 27.09.04: http://www.tidsskriftet.no/pls/lts/pa_lt.visnyhet?vp_id=6022  
Flynn, R. (2002). Clinical governance and governmentality. Health, Risk & Society, 4, 
155-173. 
Forsmo, S. (1997). Aspects and Consequences of Opportunistic Screening for 
Cervical Cancer. Results Based on Data from Three Norwegian Counties. 
Norwegian University of Science and Technology, Trondheim. 
Forsmo, S. (1998). Jakten på "kvinneligheten". Tidsskrift for den norske 
lægeforening, 118, 4753-4757. 
Forsmo, S. (2003). På jakt etter uoppdaget sykdom. In Ø.Larsen, A. Alvik, K. 
Hagestad, & M. Nylenna (Eds.), Helse for de mange. Samfunnsmedisin i 
Norge. (1 ed.) Oslo: Gyldendal akademisk. 
Forss, A., Tishelman, C., Widmark, C., Lundgren, E.-L., Sachs, L., & Tornberg, S. 
(2001). 'I got a letter...' a qualitative study of women's reasoning about 
attendance in a cervical cancer screening programme in urban Sweden. 
Psychooncology, 10, 76-87. 
 94
Foucault, M. (1991). Governmentality. In G.Burchell, C. Gordon, & P. Miller (Eds.), 
The Foucault Effect. Studies in Governementality (pp. 87-104). Chicago: The 
University of Chicago Press. 
Freidson, E. (1988). Profession of Medicine. A Study of the Sociology of Applied 
Knowledge. (2 ed.) Chicago: The University of Chicago Press. 
Frisell, J., Lidbrink, E., Hellstrom, L., & Rutqvist, L. E. (1997). Followup after 11 
years - update of mortality results in the Stockholm mammographic screening 
trial. Breast Cancer Research and Treatment, 45, 263-270. 
Gabe, R. & Duffy, S. W. (2005). Evaluation of service screening mammography in 
practice: the impact on breast cancer mortality. Annals of Oncology, 16 Suppl 
2, ii153-ii162. 
Ganott, M. A., Sumkin, J. H., King, J. L., Klym, A. H., Catullo, V. J., Cohen, C. S. et 
al. (2006). Screening Mammography: Do Women Prefer a Higher Recall Rate 
Given the Possibility of Earlier Detection of Cancer? Radiology, 238, 793-
800. 
Garbers, S. & Chiasson, M. A. (2004). Patterns of agreement on breast cancer 
screening knowledge and practices among women in Dominican and Mexican 
families in New York City. Medical Science Monitor, 10 (11), CR628-634. 
Gattellari, M. & Ward, J. E. (2004). A community study using specified and 
unspecified scenarios to investigate men's views about PSA screening. Health 
Expectations, 7, 274-289. 
Giddens, A. (1990). The consequences of modernity. Cambridge: Polity. 
Gøtzsche, P. C. & Olsen, O. (2000). Is screening for breast cancer with 
mammography justifiable? The Lancet, 355, 129-134. 
Gøtzsche, P. G. & Olsen, O. (2000). Screening mammography re-evaluated: Authors' 
reply. The Lancet, 355, 752. 
Gram, I. T., Lund, E., & Slenker, S. E. (1990). Quality of life following a false 
positive mammogram. British Journal of Cancer, 62, 1018-1022. 
Greener, I. (2003). Patient choice in the NHS: the view from economic sociology. 
Social Theory and Health, 1, 72-89. 
Hagoel, L., Ore, L., Neter, E., Shifroni, G., & Rennert, G. (1999). The gradient in 
mammography screening behavior: a lifestyle marker. Social Science & 
Medicine, 48, 1281-1290. 
 95
Hammer, S. (2008). Styring, statistikk, subjektivitet. Utledning av et analytisk 
rammeverk. Tidsskrift for Samfunnsforskning, 49, 73-105. 
Hardin, R. (2001). Conceptions and Explanations of Trust. In K.S.Cook (Ed.), Trust 
in Society (pp. 3-39). New York: Russell Sage Foundation. 
Hay, J. L., McCaul, K. D., & Magnan, R. E. (2006). Does worry about breast cancer 
predict screening behaviors? A meta-analysis of the prospective evidence. 
Preventive Medicine, 42, 401-408. 
Hewison, J. & Haines, A. (2006). Overcoming barriers to recruitment in health 
research. British Medical Journal, 333, 300-302. 
Hewitt, J. (2007). Ethical components of researcher-researched relationships in 
qualitative interviewing. Qualitative Health Research, 17, 1149-1159. 
Hofvind, S., Thoresen, S., & Tretli, S. (2004). The Cumulative Risk of a False-
Positive Recall in the Norwegian Breast Cancer Screening Program. Cancer, 
101, 1501-1507. 
Hofvind, S. S., Wang, H., & Thoresen, S. (2003). The Norwegian Breast Cancer 
Screening Program: Re-attendance related to the women's experiences, 
intentions and previous screening result. Cancer Causes Control, 14, 391-398. 
Hofvind, S. S.-H. (2006). En pilotstudie av mammografiaktiviteten ved to private 
røntgeninstitutter i Norge (Rep. No. 1). Oslo: Kreftregisteret, Institutt for 
populasjonsbasert kreftforskning. 
Hofvind, S. S.-H. (2005). The Norwegian Breast Cancer Screening Program: 
Selected Process Indicators and their Utilization in Epidemiological 
Research. Faculty of Medicine, University of Oslo, Oslo. 
Holland, W. W., Stewart, S., & Masseria, C. (2006). Policy Brief. Screening in 
Europe World Health Organization, on behalf of the European Observatory on 
Health Systems and Policies. 
Hollnagel, H. (1999). Explaining risk factors to patients during a general practice 
consultation. Conveying group-based epidemiological knowledge to 
individual patients. Scandinavian Journal of Primary Health Care, 17, 3-5. 
Holst, D., Bakketeig, L. S., Brekken, A., Evensen, Å. R., Kristiansen, E., Olsen, B. et 
al. (1989). Konsensuskonferansen om mammografiscreening (Rep. No. 2). 
Trondheim: Norsk institutt for sykehusforskning/Kommuneforlaget. 
Howson, A. (1998). Embodied obligation: the female body and health surveillance. In 
S.Nettleton & J. Watson (Eds.), The Body in Everyday Life (pp. 218-240). 
London: Routledge. 
 96
Howson, A. (1999). Cervical screening, compliance and moral obligation. Sociology 
of Health & Illness, 21, 401-425. 
Hyde, A., Howlett, E., Brady, D., & Drennan, J. (2005). The focus group method: 
insights from focus group interviews on sexual health with adolescents. Social 
Science & Medicine, 61, 2588-2599. 
Hydle, I. (2003). Regjering av helse: Fra pasient til risikant. In I.B.Neumann & O. J. 
Sending (Eds.), Regjering i Norge (pp. 154-175). Oslo: Pax Forlag. 
Jasen, P. (2002).  Breast Cancer and the Language of Risk, 1750-1950. Social History 
of Medicine, Vol. 15, 17-43. 
Jepson, R. G., Hewison, J., Thompson, A., & Weller, D. (2007). Patient perspectives 
on information and choice in cancer screening: a qualitative study in the UK. 
Social Science & Medicine, 65, 890-899. 
Jepson, R. G., Hewison, J., Thompson, A. G. H., & Weller, D. (2005). How should 
we measure informed choice? The case of cancer screening. Journal of 
Medical Ethics, 31, 192-196. 
Johansson, E. E., Risberg, G., & Hamberg, K. (2003). Is qualitative research 
scientific, or merely relevant? Scandinavian Journal of Primary Health Care, 
21, 10-14. 
Johnson, K. M., Taylor, V. M., Lessler, D., Thompson, B., & Goldberg, H. I. (1998).  
Inner City Primary Care Providers' Breast Cancer Screening Knowledge: 
Implications for Intervention. Journal of Community Health, 23, 1-13. 
Jørgensen, K. J. & Gotzsche, P. C. (2006). Content of invitations for publicly funded 
screening mammography. British Medical Journal, 332, 538-541. 
Jørgensen, K. J. & Gøtzsche, P. G. (2004). Information in practice. Presentation on 
websites of possible benefits and harms from screening for breast cancer: 
cross sectional study. British Medical Journal, 148. 
Junghans, C., Feder, G., Hemingway, H., Timmis, A., & Jones, M. (2005). Recruiting 
patients to medical research: double blind randomised trial of "opt-in" versus 
"opt-out" strategies. British Medical Journal, 331, 940. 
Kaufert, P. A. (2000). Screening the body: the pap smear and the mammogram. In 
M.Lock, A. Young, & A. Cambrosio (Eds.), Living and Working with the New 
Medical Technologies. Intersections of Inquiry (pp. 165-183). Cambridge: 
Cambridge University Press. 
Keating, P. & Cambrosio, A. (2005). The Production of Biomedical Measures: Three 
Platforms for Quantifying Cancer Pathology. In G.Jorland, A. Opinel, & G. 
 97
Weisz (Eds.), Body Counts. Medical Quantification in Historical & 
Sociological Perspectives (1 ed., pp. 173-202). Montreal: McGill-Queen's 
University Press. 
Kitzinger, J. (1994). The methodology of Focus Groups: the importance of interation 
between research participants. Sociology of Health & Illness, 16, 103-121. 
Kitzinger, J. (1995). Qualitative Research - Introducing Focus Groups. British 
Medical Journal, 311, 299-302. 
Kitzinger, J. & Barbour, R. S. (1999). Developing focus group research. Politics, 
theory and practice. London: SAGE. 
Kvale, S. (1997). InterView. En introduktion til det kvalitative forskningsinterview. 
København: Hans Reitzels Forlag. 
Lagerlund, M., Hedin, A., Sparen, P., Thurfjell, E., & Lambe, M. (2000). Attitudes, 
beliefs, and knowledge as predictors of nonattendance in a Swedish 
population-based mammography screening program. Preventive Medicine, 31, 
417-428. 
Lairson, D. R., Chan, W., & Newmark, G. R. (2005). Determinants of the demand for 
breast cancer screening among women veterans in the United States. Social 
Science & Medicine, 61, 1608-1617. 
Lampic, C., Thurfjell, E., & Sjødén, P.-O. (2003). The influence of a false-positive 
mammogram on a woman's subsequent behaviour for detecting breast cancer. 
European Journal of Cancer, 39, 1730-1737. 
Latour, B. (1990). Drawing things together. In M.Lynch & S. Woolgar (Eds.), 
Representation in scientific practice. Cambridge, MA: The MIT press. 
Latour, B. (1991). Technology is society made durable. In J.Law (Ed.), A sociology of 
monsters. Essays on power, technology and domination (pp. 103-133). 
London: Routledge. 
Lebel, S., Jakubovits, G., Rosberger, Z., Loiselle, C., Seguin, C., Cornaz, C. et al. 
(2003). Waiting for a breast biopsy - Psychosocial consequences and coping 
strategies. Journal of Psychosomatic Research, 55, 437-443. 
Lerner, B. H. (2001). The Breast Cancer Wars. Fear, Hope, and the Pursuit of a Cure 
in Twentieth-Century America. Oxford: Oxford University Press. 
Lewis, J. D. & Weigert, A. (1985). Trust As A Social Reality. Social Forces, 63, 967-
985. 
 98
Lillquist, P. P. (2004). Can case management be used to facilitate diagnostic testing in 
publicly funded breast cancer screening programs? Social Work in Health 
Care, 40, 55-71. 
Lunde, I. M. (1997). "Jeg håber det bedste..." Om deltagernes syn på 
mammografiscreening. Ringkøbing, Denmark: Den Medicinske 
Forskningsenhed. 
Lupton, D. (1997). Foucault and the medicalisation critique. In A.Petersen & R. 
Bunton (Eds.), Foucault Health and Medicine (pp. 94-112). London: 
Routledge. 
Makela, M. (2004). Evidence-based medicine in general practice: helping the whole 
patient. Scandinavian Jounal of Primary Health Care, 22, 132-135. 
May, C. (2006). Mobilising modern facts: health technology assessment and the 
politics of evidence. Sociology of Health & Illness, 28, 513-532. 
McPherson, G. & Thorne, S. (2006). Exploiting Exceptions to Enhance Interpretive 
Qualitative Health Research: Insights from a Study of Cancer Communication. 
International Journal of Qualitative Methods, 5, 1-11. 
Meland, E. (2007). Autoritær medisin før og nå. Tidsskrift for den norske 
lægeforening, 127, 2704. 
Miller, A. B., To, T., Baines, C. J., & Wall, C. (2000). Canadian National Breast 
Screening Study-2: 13-year results of a randomized trial in women aged 50-59 
years. Journal of the National Cancer Institute, 92, 1490-1499. 
Miller, A. B., To, T., Baines, C. J., & Wall, C. (2002). The Canadian National Breast 
Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. A 
randomized screening trial of mammography in women age 40 to 49 years. 
Annals of Internal Medicine, 137, 305-312. 
Miller, P. & Rose, N. (1990). Governing economic life. Economy and Society, 19, 1-
31. 
Möllering, G. (2001). The nature of trust: From Georg Simmel to a theory of 
expectation, interpretation and suspension. Sociology, 35, 403-420. 
Möllering, G. (2006). Trust: Reason, Routine, Reflexivity. Oxford: Elsevier. 
Morabia, A. & Zhang, F. F. (2004). History of medical screening: from concepts to 
action. Postgraduate Medical Journal, 80, 463-469. 
Morgan, D. L. (1996). Focus Groups. Annual Review of Sociology, 22, 129-152. 
 99
Mørland, B., Lund Håheim, L., & Linnestad, K. (2002). Screening for brystkreft (Rep. 
No. 4). Oslo: Senter for medisinsk metodevurdering. 
Nettleton, S. (1997). Governing the risky self. How to become healthy, wealthy and 
wise. In A.Petersen & R. Bunton (Eds.), Foucault Health and Medicine (pp. 
207-222). London: Routledge. 
Neumann, I. B. (2003). Regjeringsbegrepet og regjeringens historiske fremvekst. In 
I.B.Neumann & O. J. Sending (Eds.), Regjering i Norge (pp. 9-43). Oslo: Pax 
Forlag. 
NOU. (1987). Mammografiscreening i Norge. Masseundersøkelse for brystkreft. 7. 
Sosialdepartementet. Hearing. 
Nystrom, L., Andersson, I., Bjurstam, N., Frisell, J., Nordenskjold, B., & Rutqvist, L. 
E. (2002). Long-term effects of mammography screening: updated overview 
of the Swedish randomised trials. Lancet, 359, 909-919. 
Nystrom, L., Rutqvist, L. E., Wall, S., Lindgren, A., Lindqvist, M., Ryden, S. et al. 
(1993). Breast cancer screening with mammography: overview of Swedish 
randomised trials. Lancet, 341, 973-978. 
O'Malley, P. (2004). Risk, Uncertainty and Government. London: Glasshouse Press. 
Olsson, P., Armelius, K., Nordahl, G., Lenner, P., & Westman, G. (1999). Women 
with false positive screening mammograms: how do they cope? Journal of 
Medical Screening, 6, 89-93. 
Padgett, D. K., Yedidia, M. J., Kerner, J., & Mandelblatt, J. (2001). The Emotional 
Consequences of False Positive Mammography: African-American Women's 
Reactions in Their Own Words. Women & Health, 33, 1-14. 
Patton, M. Q. (2002). Qualitative research & evaluation methods. (3rd ed.) Thousand 
Oaks, California: Sage. 
Peipins, L. A., Shapiro, J. A., Bobo, J. K., & Berkowitz, Z. (2006). Impact of 
women's experiences during mammography on adherence to rescreening 
(United States). Cancer Causes Control, 17, 439-447. 
Pelfrene, E. R., Bleyen, L. J. P. M., & De Backer, G. (1998). Uptake in Breast Cancer 
Screening: A Sociogeographical Analysis. European Journal of Public Health, 
8, 146-149. 
Petersen, A. (1997). Risk, governance and the new public health. In A.Petersen & R. 
Bunton (Eds.), Foucault Health and Medicine (pp. 189-206). London: 
Routledge. 
 100
Pfeffer, N. (2004a). "If you think you've got a lump, they'll screen you.'' Informed 
consent, health promotion, and breast cancer. Journal of Medical Ethics, 30, 
227-230. 
Pfeffer, N. (2004b). Screening for breast cancer: candidacy and compliance. Social 
Science & Medicine, 58, 151-160. 
Pfeffer, N. & Laws, S. (2006). 'It's only a blood test': What people know and think 
about venepuncture and blood. Social Science & Medicine, 62, 3011-3023. 
Pineault, P. (2007). Breast cancer screening: Women's experiences of waiting for 
further testing. Oncology Nursing Forum, 34, 847-853. 
Reventlow, S. D., Hvas, L., & Malterud, K. (2006). Making the invisible body visible. 
Bone scans, osteoporosis and women's bodily experiences. Social Science & 
Medicine, 62, 2720-2731. 
Riessman, C. K. (1983). Women and Medicalization: A New Perspective. Social 
Policy, Summer 1983, 3-18. 
Rose, N. (2001). The Politics of Life Itself. Theory, Culture & Society, 18, 1-30. 
Rose, N. S. (1999). Powers of freedom. Reframing political thought. Cambridge, 
United Kingdom: Cambridge University Press. 
Sætnan, A. R. (1992). To screen or not to screen? The impact of science on two 
medical technology controversies Trondheim, Norway.: University of 
Trondheim, Center of technology and society. 
Saetnan, A. R. (2007). Nothing to Hide, Nothing to Fear? Assessing Technologies for 
Diagnosis of Security Risks. International Criminal Justice Review, 17, 193-
206. 
Sandaunet, A. G. (2008). The challenge of fitting in: non-participation and withdrawal 
from an online self-help group for breast cancer patients. Sociology Of Health 
and Illness, 30, 131-144. 
Sandell, K. (2001). Att (åter)skapa "det normala". Bröstoperationer och brännskador 
i plastikkirurgisk praktik. Lund: Arkiv förlag. 
Saracevic, I. (2003). Mammografi: forskjeller i opplevd sykdomsrisiko mellom by og 
land? Department of Public Health and General Practice, NTNU. Unpublished 
Work 
Scambler, G. & Britten, N. (2001). System, lifeworld and doctor-patient interaction. 
Issues of trust in a changing world. In G.Scambler (Ed.), Habermas, critical 
theory and health (1 ed., pp. 45-67). London: Routledge. 
 101
Schei, B. (1989). Ballografiscreening - "it should save lives". Tidsskrift for den norske 
lægeforening, 109, 1088-1089. 
Schwartz, L. M. & Woloshin, S. (2007). Participation in mammography screening. 
British Medical Journal, 335, 731-732. 
Schwartz, L. M., Woloshin, S., Sox, H. C., Fischhoff, B., & Welch, H. G. (2000). US 
women's attitudes to false positive mammography results and detection of 
ductal carcinoma in situ: cross sectional survey. British Medical Journal, 320, 
1635-1640. 
Shapiro, S. (1977). Evidence on screening for breast cancer from a randomized trial. 
Cancer, 39, 2772-2782. 
Silverman, E., Woloshin, S., Schwartz, L. M., Byram, S. J., Welch, H. G., & 
Fischhoff, B. (2001). Women's views on breast cancer risk and screening 
mammography: a qualitative interview study. Medical Decision Making, 21, 
231-240. 
Sim, J. (1998). Collecting and analysing qualitative data: issues raised by the focus 
group. Journal of Advanced Nursing, 28, 345-352. 
Skolbekken, J.-A. (2007). Unlimited medicalization? Risk and the pathologization of 
normality. In A. Petersen & I. Wilkinson (Eds.), Health, Risk and 
Vulnerability London: Routledge. 
Skolbekken, J.-A., Østerlie, W., & Forsmo, S. Lay constructions of osteoporosis 
among Norwegian women attending the Nord-Trøndelag Health Study 
(HUNT). Social Science & Medicine, (in press). 
Søndergaard, D. M. (1996). Tegnet på kroppen. Køn: koder og konstruktioner blandt 
unge voksne i akademia. Museum Tusculanums Forlag, København 
Starks, H. & Trinidad, S. B. (2007). Choose your method: A comparison of 
phenomenology, discourse analysis, and grounded theory. Qualitative Health 
Research, 17, 1372-1380. 
Stenvoll, D., Elvbakken, K. T., & Malterud, K. (2005). Blir norsk 
forebyggingspolitikk mer individorientert? Tidsskrift for den norske 
lægeforening, 125, 603-605. 
Stevenson, F. & Scambler, G. (2005). The relationship between medicine and the 
public: the challenge of concordance. Health, 9, 5-21. 
Straughan, P. T. & Seow, A. (2000). Attitudes as barriers in breast screening: a 
prospective study among Singapore women. Social Science & Medicine, 51, 
1695-1703. 
 102
Tabar, L., Fagerberg, G., Chen, H. H., Duffy, S. W., Smart, C. R., Gad, A. et al. 
(1995). Efficacy of breast cancer screening by age. New results from the 
Swedish Two-County Trial. Cancer, 75, 2507-2517. 
Taylor-Gooby, P. (2006). Trust, risk and health care reform. Health Risk & Society, 8, 
97-103. 
Tyler, T. R. (2001). Why do people rely on others? Social identity and social aspects 
of trust. In K. S. Cook (Ed.), Trust in society (pp. 285-306). New York: 
Russell Sage Foundation. 
Unic, I., Stalmeier, P. F. M., Peer, P. G. M., & van Daal, W. A. J. (1997). A Review 
on Family History of Breast Cancer: Screening and Counseling Proposals for 
Women with Familial (Non-Hereditary) Breast Cancer. Patient Education and 
Counseling, 32, 117-127. 
Vallgårda, S. (2007). Public health policies: A Scandinavian model? Scandinavian 
Journal of Public Health, 35, 205-211. 
von Euler-Chelpin, M., Olsen, A. H., Njor, S., Vejborg, I., Schwartz, W., & Lynge, E. 
(2006). Women's patterns of participation in mammography screening in 
Denmark. European Journal of Epidemiology, 21, 203-209. 
Wang, H., Hofvind, S. S.-H., & Thoresen, S. Ø. (2000). Prøveprosjekt med 
mammografi - resultater fra første undersøkelsesrunde. Tidsskrift for den 
norske lægeforening, 120, 3237-3240. 
Wang, H., Kåresen, R., Hervik, A., & Thoresen, S. Ø. (2001). Mammography 
screening in Norway: results from the first screening round in four counties 
and cost-effectiveness of a modeled nationwide screening. Cancer Causes 
Control, 12, 39-45. 
Weisz, G. (2005). From Clinical Counting to Evidence-Based Medicine. In G.Jorland, 
A. Opinel, & G. Weisz (Eds.), Body Counts. Medical Quantification in 
Historical & Sociological Perspectives. (pp. 377-393). Montreal: McGill-
Queen's University Press. 
Welch, H. G. (2004). Should I be tested for cancer? Maybe not and here's why. 
Berkeley: University of California Press. 
Westin, S. (1989). Mammografiscreening på venteliste. Tidsskrift for den norske 
lægeforening, 109, 1038-1039. 
Wilkinson, S. (1999). How useful are focus groups in feminist research. In R. S. 
Barbour & J. Kitzinger (Eds.), Developing Focus Group Research. Politics, 
Theory and Practice (pp. 64-78). London: Sage. 
 103
Wilkinson, S. (2001). Breast cancer: feminism, representations and resistance - a 
commentary on Dorothy Broom's 'Reading breast cancer'. Health, 5, 269-277. 
Wilkinson, S. & Kitzinger, C. (1993). WHOSE BREAST IS IT ANYWAY? A 
Feminist Consideration of Advice and "Treatment" for Breast Cancer. 
Women's Studies International Forum, 16, 229-238. 
Williams, S. J. & Calnan, M. (1996). The "limits" of medicalization?: Modern 
medicine and the lay populace in "late" modernity. Social Science & 
Medicine, 42, 1609-1620. 
Willis, K. (2004). Personal Choice/Social Responsibility: Women Aged 40-49 Years 
and Mammography Screening. Journal of Sociology, 40, 121-136. 
Willis, K. & Baxter, J. (2003). Trusting technology: Women aged 40-49 years 
participating in screening for breast cancer - an exploratory study. Australian 
and New Zealand Journal of Public Health, 27, 282-286. 
Wilson, J. M. G. & Jungner, G. (1968). Prinsiples and practice of screening for 
disease. Geneva: World Health Organization. 
Witz, A. (1992). Professions and patriarchy. London: Routledge. 
Woloshin, S., Schwartz, L. M., & Welch, H. G. (2007). The effectiveness of a primer 
to help people understand risk: two randomized trials in distinct populations. 
Annals of Internal Medicine, 146, 256-265. 
Yalom, M. (1999). Kvinnebryst. En kulturhistorie. Oslo: Pax Forlag. 
Yi, J. K. & Reyes-Gibby, C. C. (2002). Breast Cancer Screening Practices among 
Low-Income Vietnamese Women. International Quarterly of Community 
Health Education, 21, 41-49. 
Zackrisson, S., Andersson, I., Janzon, L., Manjer, J., & Garne, J. P. (2006). Rate of 
over-diagnosis of breast cancer 15 years after end of Malmo mammographic 
screening trial: follow-up study. British Medical Journal, 332, 689-692. 
Zahl, P. H. & Maehlen, J. (2005). Model of outcomes of screening mammography: 
spontaneous regression of breast cancer may not be uncommon. British 
Medical Journal, 331, 350. 
Zahl, P. H., Strand, B. H., & Maehlen, J. (2004). Incidence of breast cancer in 
Norway and Sweden during introduction of nationwide screening: prospective 
cohort study. British Medical Journal, 328, 921-924. 
Østerlie, W. et al. (2008). Mammography screening: the participants' attitudes and 
perception of breast cancer risk in a prospective study. Unpublished Work 
 104
  
 
 
 
Appendix 1: Invitation letter - focus groups 
 105
 106
  107
  
 
 
 
Appendix 2: Interview guides - focus groups 
 108
Intervjuguide fokusgrupper 1.samling 
Introduksjon 
Velkommen 
Presentasjon av staben  
- Marit og meg: Sosiologer ved NTNU, to forskningsprosjekter (ende ut 
doktorgrader). Hittil har mye av forskningen vært konsentrert rundt hvor 
mange som får brystkreft, hvilke aldersgrupper etc. Det er for lite forskning 
knyttet til hvordan kvinner opplever det å delta i slike helseundersøkelser.  
- Transkribør 
- Solveig: Fra Oslo, holder også på med forskning rundt mammografi. Er 
bisitter her i dag. 
Hva skal dere gjøre her i dag: 
Innkalt til mammografiundersøkelse. Skal kanskje på undersøkelse om kort tid. 
Dere har kanskje gjort dere noen tanker rundt dette nå i forkant.  
 - Som gruppeintervju der dere kan utveksle tanker og erfaringer med hverandre. 
Temaer -  leveres ut etterhvert: ark 
Svar: Ingen riktige og ingen gale  
Snakke fritt, men ikke i munnen på hverandre med hverandre. 
Snakk med hverandre -  ikke til oss. 
Spørsmål:  
Dere har kanskje sp.mål, eller det kan dukke opp sp.mål underveis: Spør hverandre, 
ikke oss.  
Samle opp: Vi kommer ikke til å svare på disse sp.mål nå. Vi noterer dem og dere kan 
notere ned selv også. Ved siste samling (3. gang) vil en representant for 
Kreftregisteret komme, og da kan dere stille sp.mål og få svar. 
 
Taushetsplikten 
 - ikke formelt, men tillitsforhold. 
 
Varighet: Inntil to timer 
To båndspillere: Fordi transkripsjon. 2 stk pga kvaliteten.  
Fornavn på navneskilt 
 
Mat og drikke. Pappkrus pga unngå støy 
 
Toalett-besøk/pause - når vi snur båndet. 
 
Ny avtale før dere går. 
 
Før start:  
Stemmeprøve for båndet, Kjenne igjen når skrives ut.  
Presentasjon med fornavn og om vært til mammografiundersøkelse tidligere (snakk 
tydelig) 
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Spørsmål på første samling 
 
1. Hvilke tanker har dere gjort dere i forkant av 
mammografiundersøkelsen? 
 
Tenkt mye/lite?  Opptatt dere mye – eller ikke tenkt i det hele tatt? 
Forventninger?   Pos./neg. 
Spenning?   Engstelig? Snakket med andre? 
Usikkerhet? 
Hatt mer fokus på brystene i det siste (pga innkallelsen)? 
Snakket med noen? 
Utført mammografi før? 
Hva tenkte du da du fikk screening-invitasjonen? 
Motivasjon for å delta? 
 
2. Hvilke tanker har dere gjort dere om egen risiko for brystkreft? 
 
Høy/lav? 
Disponerende faktorer – tanker om hvorfor noen får brystkreft (årsaker) 
Atferd/ arv/ alder 
 
3. Hvilken betydning har masseundersøkelser som denne 
mammografiundersøkelsen for deres helse? 
 
Ingen/stor betydning 
Betryggende/skremmende 
Viktigere enn blodtrykksmåling? 
Viktigere enn bentetthetsmåling? 
 
4. Hva kan man gjøre for å forebygge brystkreft? 
 
Mat/mosjon/røyking 
Medisiner    (Vaksine? Østrogen?) 
Mammografi 
Selvundersøkelser 
Besøk hos fastlegen 
Når bør man få barn? 
Amming 
 
5. Vil dere anbefale andre kvinner å foreta mammografi? 
 
Hvilken anbefaling? 
Til hvem? –alder? 
Hvordan? 
Privat eller offentlig? 
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Spørsmål på andre samling 
1. Hvordan gikk mammografiundersøkelsen? 
Prosessen – undersøkelsen   
Smerte? 
Kommunikasjonen  
Informasjonen underveis 
Hvordan følte du deg tatt vare på? 
Resultatet (For de som er på 2. Samling etter mottatt svar) 
 
 
2. Hvordan opplever du ventetiden før resultat?  (Hvordan opplevde 
du ventetiden før resultatet?) 
Tanker? 
Tanker om kroppen din/opplevelser av kroppen  
Følt på om det er noe?  
Mer oppmerksom? 
 
Usikkerhet? Ubehag? 
Snakket med noen andre? 
 
 
3. Hvilket utbytte har du hatt av mammografien? 
Stort / lite? 
Begrunnelse 
Betydning for egen helse 
 Trygghet nå?  
Trygghet for framtiden?  
 
 
4. Hvilke tanker har du om å gå til mammografi igjen? 
Behov? 
Planer? 
Hvor ofte tenker du å gå? 
Begrunnelse for å gå? 
Kostnader? 
 
 
5. Bør helsemyndighetene gi alle kvinner tilbud om mammografi? 
Tanker om prioriteringer? 
 Hvem: Alle/ noen? Alder? 
 Ift. Ressursbruk 
 
Hvem har ansvaret for kvinners helse? 
Vil du anbefale andre kvinner å ta imot tilbud om mammografi? 
Privat eller offentlig?  
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NTNU Institutt for samfunnsmedisin 
Norges teknisk-naturvitenskapelige Psykologisk institutt 
universitet Institutt for sosiologi og statsvitenskap 
  
  
Til deg som skal til undersøkelse         
på mammapoliklinikken. 
 Stipendiat 
 Marit Solbjør  
 Telefon 73 59 89 05 
 E-post marit.solbjor@medisin.ntnu.no  
Forespørsel om å delta i en vitenskapelig undersøkelse 
Du som får dette brevet har nylig vært til mammografi, og har i dag fått innkalling til videre 
undersøkelser på mammapoliklinikken. Vi ønsker å snakke med noen av kvinnene som blir 
innkalt til nye bilder/nye prøver en av dagene før timen på mammapoliklinikken. 
Formålet med samtalen er å høre om deres egne tanker rundt denne opplevelsen. Kunnskapen 
om dette håper vi kan bli til nytte i arbeidet rundt forebygging av brystkreft. Dette er et 
forskningsprosjekt, og deltagelse er helt frivillig.  
Deltagelse i prosjektet består i å bli intervjuet 2 eller 3 ganger. Første intervju gjøres en av 
dagene før undersøkelsen på mammapoliklinikken. Andre intervju blir gjennomført noen 
dager etter at du har fått svaret på undersøkelsen. Intervjuene behandles konfidensielt, og 
ingen andre vil vite hvem intervjupersonene er. Den som intervjues kan når som helst, og 
uten begrunnelse trekke seg fra intervjuet og prosjektet uten at det får konsekvenser for 
videre medisinsk oppfølging. Alle opplysninger vil da bli slettet fra prosjektet. 
Forskningsgruppen arbeider ved Institutt for samfunnsmedisin ved NTNU, og ikke på 
sykehuset. Derfor vet vi foreløpig ikke hvem du er. Vi får kun vite navn på dem som 
kontakter oss.  
Prosjektet er et samarbeid mellom NTNU, St. Olavs hospital og Kreftregisteret, og er 
finansiert av Norges forskningsråd. Prosjektet er vurdert og godkjent av Regional komite for 
medisinsk forskningsetikk, Region Midt-Norge.  
Dersom du kan tenke deg å delta i dette prosjektet må du ringe oss så snart som mulig 
på telefon 73 59 89 05 (arbeid) eller mobil 98 84 52 62 (når som helst), slik at vi kan 
avtale et tidspunkt og sted for den første samtalen før undersøkelsen. Vi beklager den 
korte tiden.  
 
Vennlig hilsen 
 
Marit Solbjør,       Siri Forsmo,  
Stipendiat i medisinsk sosiologi    Lege, dr.med. 
Prosjektleder  
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INFORMASJON OM INTERVJUET 
 
Dette intervjuet vil inngå som del av et forskningsarbeid i medisinsk sosiologi og er 
en del av prosjektet “Screening og helseundersøkelser – veien til god helse?”. 
Prosjektet tar for seg kvinners møte med mammografiscreening, og det vil bli 
gjennomført intervjuer med kvinner som har møtt til mammografi. Spørsmålene vil 
være åpne, slik at de kan besvares med den intervjuedes egne ord, og det finnes ingen 
riktige eller gale svar 
Deltagelsen i intervjuet er frivillig. Den som intervjues bestemmer selv når intervjuet 
kan skje, hun kan når som helst trekke seg fra intervjuet uten å gi noen begrunnelse 
for det og kan unnlate å svare på spørsmål hun ikke vil si noe om. Den som intervjues 
kan underveis spørre om ting hun lurer på.  
Forskeren kan notere underveis i samtalen, og samtalene tas opp på lydbånd for å 
sikre en mest mulig nøyaktig gjengivelse av det som blir sagt. Senere blir lydopptaket 
skrevet ut, før opptaket slettes. Intervjuene oppbevares  kun som anonymiserte 
utskrifter, dvs. de vil ikke inneholde navn på personene som deltar. Utskriftene blir 
kun tilgjengelig for forskerne, som alle er underlagt taushetsplikt. Resultatene fra 
forskningsarbeidet vil bli publisert i vitenskapelige tidsskrift og i avhandlinger. 
 
SAMTYKKEERKLÆRING  
Jeg har lest informasjonsskrivet og har hatt anledning til å stille spørsmål. 
Jeg samtykker i å delta i prosjektet. 
 
 ……………. den   .…/…. 2004 
 
 
……………….................................... 
prosjektdeltaker 
 
Dette eksemplaret beholdes av prosjektdeltager 
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Intervjuguide etterundersøkte: 1. intervju 
Kvinner som skal til etterundersøkelse på mammapoliklinikken. 
Introduksjon:  
Du har vært til mammografi og har nå fått brev om at bildene ikke var entydige, slik 
at du skal på mammapoliklinikken i morgen/senere i dag. 
 
1. Kan du fortelle om dette? 
- bekymret? 
- Trygg? 
 
2. Hvordan har ventetiden vært? 
- etter mammografien 
- etter å ha mottatt brevet fra mammapoliklinikken 
 
3. Hvilke forventninger har du til etterundersøkelsen? 
- Hva tanker har du gjort deg om utfallet av denne undersøkelsen? 
 
4. Hvordan opplever du din egen helse? 
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Intervjuguide etterundersøkte: 2. Intervju 
Kvinner som har vært til etterundersøkelse på mammapoliklinikken 
Introduksjon:  
Nå er det 3 dager/en uke siden vi snakket sammen, og du har fått svar på prøvene fra 
mammapoliklinikken. 
 
1. Kan du fortelle om det? 
- hvordan gikk undersøkelsene? 
- Positive og negative opplevelser av resultatet? 
- bekymret ? 
- trygg? 
 
2. Vil du gå til mammografi igjen? 
- hvor ofte? 
 
 
3. Vil du anbefale andre å gå til mammografiundersøkelse? 
- Hvem? 
- Hvor ofte? 
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Abstract 
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screened in a national breast cancer screening program. Their prospective design, both strategic and 
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In this article we present reflections on our experiences regarding the role, design, and effectiveness of a 
qualitative research project on mammography screening. In Norway, as in the world at large, 
mammography and screening have traditionally been seen as located within the medical field. Although 
qualitative research in medicine is far from a new invention, the medical discourse is dominated by a 
quantitative, evidence-based logic (Grypdonck, 2006). Clinical and epidemiological studies have 
dominated research on mammography screening. These have focused mainly on the core issues for policy, 
namely the safety and effectiveness of mammography screening (Gotzsche & Olsen, 2000; Nystrom, 
Andersson, et al., 2002; Nystrom, Rutqvist et al., 1993). Throughout these discussions arguments are 
focused primarily on numbers and survival estimates. Other issues addressed have been treatment options 
in connection with screening; psychological research, which has also to some extent been included 
through research on anxiety levels for participants (Brodersen, Thorsen, & Cockburn, 2004; Brunton, 
Jordan, & Campbell, 2005); and how information about medical screening should be given to secure 
participation in the screening programs (Ahmad, Cameron, & Stewart, 2005). These kinds of research can 
be seen as playing a supporting role in a field where medical expertise has had the leading role in decision 
making, execution, and research, even though recent decades have seen a rising consciousness of patient 
or lay rights in what traditionally have been seen as medical questions (Lerner, 2001). 
 
A question is how medical dominance of the discourse affects how and why research on subjects is carried 
out. One might also ask what the pursuit of other research questions and methods might give to the 
dominant medical discourse. Even though quantitative, evidence-based research gives important 
information on biomedical issues (Hetlevik, 2004), it has clear limitations when it comes to producing 
knowledge about, for instance, patient experiences or lay perspectives on health issues. 
A screening program for breast cancer had been initiated in Norway in 1996 and was becoming 
nationwide during 2003, when we conducted our study. We knew of only one study of women’s 
experiences as participators in the program (Hofvind, Wang, & Thoresen, 2003). Hofvind’s study was 
survey based and quantitative, and our multidisciplinary research group chose to carry out focus group 
interviews to explore women’s experiences and lay perspectives on mammography screening. Because of 
the strong dominance of numerical arguments on the field of screening, we opted to provide “new” 
knowledge to both medical professionals and policy makers. Despite several studies using focus groups on 
health issues (Bender & Ewbank, 1994; Waldorff, Bulow, Malterud, & Waldemar, 2001), including 
studies of mammography (Pfeffer, 2004b; Willis, 2004), throughout the project we were frequently faced 
with critical questions concerning the qualitative nature of the research. This led us to ask how our 
qualitative research might be secured and what impact it might have in a field where quantitative studies 
are the norm. 
Communication problems between paradigms 
Different research methods have somewhat different theoretical bases and different views on what it 
makes sense to study. There is not one standard approach to qualitative research, but one might claim that 
a constructivist approach dominates, just as there is not one standard approach in medical research, 
although a natural science ontology dominates (Silverman, 1993). The main features of qualitative 
research might be said to be that it involves examining social phenomena in their natural environment, 
attending to commonsense assumptions about what constitutes a field, and doing theoretically driven 
research rather than research driven by technical considerations (Silverman, 1993). 
 
One assumption that qualitative methods share is an acknowledgement of the role of the researcher in both 
creating and analyzing the data. Although there are different approaches to researcher presence in 
qualitative research, there is a certain acknowledgement of the researcher as the analytic interpreter of the 
material (Gubrium & Holstein, 1997). This has led critics of qualitative research to point to what they see 
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as the lack of objectivity in data materials and analyses. For instance, Weinberger et al. (1998) have 
discussed the reliability and generalizability of interpretations of focus group material. One response to 
this is that qualitative data can be said to take better care of objectivity when studying “objects” existing in 
a context of language and social relations than methods developed to study nonhuman spheres, such as the 
methods of the natural sciences (Kvale, 1996). 
 
One aspect of medical discourses is the use of numbers such as statistics in medical arguments, with 
emphasis on evidence-based medicine and randomized controlled trials (Hetlevik, 2004; Makela, 2004). In 
a Swedish study physicians were shown to evaluate quantitative and qualitative research differently 
(Johansson, Risberg, & Hamberg, 2003). Quantitative abstracts were acknowledged for their scientific 
accuracy, whereas qualitative abstracts were seen as less scientific and accurate but nonetheless clinically 
relevant. This can give us a notion of how medical professionals think about science and its status. 
Nevertheless, qualitative research is not unknown in medical journals. Both The Lancet and BMJ–British 
Medical Journal have published papers on qualitative research methods during the last decennials 
(Malterud, 2001; Mays & Pope, 1996). Still, without pushing too far, we will claim that medical science 
discourse is primarily quantitative and oriented toward naturalism and realism. 
 
Even within this general orientation, however, different medical specialties have different approaches to 
quantification of data. Different orientations can be exemplified by looking at how tools to deal with 
breast cancer risk have been met with uneven acknowledgement by different medical groups. Breast self-
examinations, “breast awareness,” and public mammography screening all have their supporters in 
different strata of the medical profession, where epidemiology and radiology are most in favor of 
mammography (Pfeffer, 2004a). One reason for support from epidemiologists is that mammography can 
be seen as innovative among screening programs for having been evaluated by means of randomized trials 
to estimate the potential for reducing breast cancer mortality (Morabia & Zhang, 2004). 
 
Epidemiology is based on the use of large amounts of quantitative data materials (Rothman & Greenland, 
1998). Epidemiological evaluations of randomized controlled trials have been one of the main sources of 
arguments in medical science discourses both in favor of and against organized screening. Randomized 
controlled trials have been seen to generate facts, as opposed to nonscientific or “emotional” arguments 
(Lerner, 2001). Nevertheless, when clinical and epidemiological arguments are in confrontation, clinical 
research tends to “trump” epidemiology, but in material on mammography screening it was difficult to test 
splits between epidemiologists and clinically oriented authors, perhaps because both directions have 
reached the same conclusions in this case (Sætnan, 1992). 
 
Our choice to use qualitative methods to study lay perspectives on mammography screening was based on 
the fact that it had not been much studied, so there were no clear hypotheses to be “tested.” Rather, we 
wished to gather whatever meanings were out there, with only loose reins on the discussions. Quantitative 
methods presume that one knows in advance the relevant categories and that these can be measured 
accurately. We wanted to open up space for unknown categories of lay participant experiences and 
consequently chose to do qualitative research by using focus groups. 
 
Nevertheless, even when exploring a new field, it is the researcher who formulates the questions for the 
interview. He or she is thereby setting an agenda and at least in part deciding the kind of knowledge that is 
relevant for the research question. One strength of the qualitative interview is still that the researcher may 
alter the design or add questions to the interview guide when knowledge of new issues is developed. The 
interview participants can also challenge the assumptions underlying a question, thus changing the 
direction of an interview. The possibility of altering questions according to responses among interviewees 
has been questioned by quantitative researchers asking how one can generalize from such data. Trying to 
communicate with research participants and other scientists in a way that made sense, we experienced 
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ourselves as in “a squeeze” between different discourses. In the following we discuss some paradoxes that 
emerged during our study. 
Our study 
During 2003 we conducted a set of focus groups to study how women invited to a mammography 
screening program interpret screening and breast cancer. Focus groups were chosen primarily because we 
wanted to get in touch with how women experience being part of a screening program for a potentially 
fatal disease and hear how they talked about their experiences while among their peers. The study focused 
on women’s conceptions of mammography screening, breast cancer, and risk; on trust and technology; 
and on being cared for or being frightened. Our findings will be reported elsewhere (Solbjør, in press). 
 
The design of the study was prospective. We followed eight groups of women through their experiences of 
a screening, from invitation, through examination, to results and reflection. We did this by interviewing 
the groups at three points: before, shortly after, and 6 months after their mammography screening 
examination. Referring to previous experiences, we assumed that eight groups would be enough to reach 
data saturation. Selections from each of the four municipalities were split in two age groups: 50 to 59 and 
60 to 69 years. Municipalities were selected to represent an urban-rural dimension, although we chose 
only communities that had population densities that made it likely that we could gather enough women for 
group interviews without them having to drive for hours to meet. Each group had 6 to 10 participants, with 
a total of 69 women participating in the study. 
 
The group sessions were structured by an interview guide. The interview guide consisted of five questions, 
some repeated and some specific to the three respective sessions with each group. The questions were 
copied and presented, one at a time, to the participants. A moderator read the questions and kept control of 
the discussion so that it stayed within the research themes. Aside from this, the women were encouraged 
to speak freely and ask each other questions rather than asking the researchers. This will be discussed 
more thoroughly later in this article. 
The prospective design 
 
Our prospective design acknowledges the possibility of changing constructions over time. New 
experiences can change the way we feel and talk about our opinions and attitudes. It was therefore our 
goal to catch the women’s experiences of and opinions on mammography screening both before and after 
they had participated in the screening program. This choice was based on two influences. In the literature 
on psychological distress related to mammography screening, it is common to apply psychometric 
measures at various times in relation to the screening to measure the psychological effects of the screening 
(Brett, Bankhead, Henderson, Watson, & Austoker, 2005; Brodersen et al., 2004). The other influence was 
prior experiences with studying screening experiences with retrospective interviews. Such a design would 
also give interesting and valuable data, but they represented the participants’ reconstruction of their 
screening experiences rather than their constructions at the time of the screening. 
 
For instance, during the first focus group interviews we found that women expressed uncertainty about 
how they would experience the mammography examination and what consequences it could have for them: 
 
First group session 
 
Interviewer: What are your expectations to the examination? 
G: I hope they don’t find a lump . . . because yesterday I had a lot of lumps . . . 
E: Did you check [your breasts]? 
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G: Yes, it [the invitation letter] said I should. “Tick this box if . . .” Found some lumps yesterday, 
but today it was gone. Thank God. 
// 
E: But about something else . . . I haven’t been there, so I don’t even know how it is done. So it is a 
question I would like to ask those who have been there before. Well, is it as . . . bad . . . like . . . It 
isn’t that it is dangerous, I can take pain, right? But, is it good to be squeezed like that? So hard as 
they tell you it is? 
G: It has been discussed. I saw a program about it on the television about this research that’s been 
done in Denmark. And it wasn’t good. 
 
The experience of uncertainty was more or less marginalized during the second round of interviews. At 
that time women were more concerned about their experience of the particular examination and the work 
of those in charge of the program as well as about having the answer. The woman concerned about her 
potential lumps and participating in the discussion of negative consequences from mammography during 
the first focus group session seems to be little concerned when interviewed after the mammography 
examination: 
 
Second group session 
 
G: I thought it was all right . . . I hadn’t expected any information either, so… not much more than 
about having the result in about four weeks. We don’t need any other information, I can’t see that. 
And about being called again [in 2 years’ time]. . . . So I can’t see what other information we should 
have had either. If we should have had any more. 
 
Having women talk about their experiences with mammography screening at two different times during 
the experience gave somewhat different results. It is impossible to claim that one of these interviews gives 
the correct picture of women’s experiences over the other. Our choice, therefore, addresses the validity of 
the data. Both constructions and reconstructions of one’s life experiences should be seen as representing 
valid data, but they should also be seen as representing different phenomena. We wanted to study 
women’s experiences as they developed in the context of medical screening and thus opted for a 
prospective design. 
 
In medical research prospective designs are preferred over retrospective ones, as they are seen as superior 
with respect to both to validity and reliability. Our design might, hence, have a greater appeal to medical 
researchers than some other qualitative designs would, as it can be seen as created on a common ground, 
although from quite different epistemic perspectives. Nevertheless, one can ask whether the prospective 
design actually obtains greater validity or reliability than a retrospective study would have done. Is the 
assumption that women’s notions of mammography can be grasped before they are influenced by an 
intervention like a screening program also acknowledging data as naturally given, as something that can 
be found in its natural state? We, rather, chose to see data as a changeable construction. This can be solved 
as a practical problem while collecting data, but it is important to discuss and be clear about one’s 
perspective when doing analyses, not least when communicating results to different parties. We will look 
into this in more detail in the discussion. 
Sampling and recruitment 
 
As mentioned above, we chose to recruit focus group participants using both strategic and random 
sampling. Choosing a sampling process that gave credibility in both qualitative and medical discourses 
seemed like a good choice and has given us data material that can be communicated to several parties. 
When we were inviting women to participate in the project, our purpose was to inform them about our 
intentions and the nature of the project so that they could make an informed choice as to whether to 
 48
International Journal of Qualitative Methods 2007, 6(3) 
 
participate. An invitation letter was sent to women due to be screened for breast cancer. In it we gave a 
brief introduction to the project and a short description of how the focus groups would be carried out. We 
also made it clear that this was a cooperative project between our university and the Norwegian Cancer 
Registry. 
 
Women wanting to participate returned a signed statement of consent to us and were later called to be 
reminded of the time and place of the focus group interview. During the phone conversation they were 
invited to ask questions. Despite our efforts to give sufficient information, we experienced that some of 
the women were unsure about the purpose of the project at the beginning of the focus groups. Some 
women understood it as being part of the breast examination, and some expressed that they participated 
because they wanted to contribute to medical research on breast cancer or as an act of solidarity with 
women who had breast cancer. This made us ask how our research project could be interpreted as having a 
strictly medical benefit and how these preconceptions might have influenced the data. 
 
One answer to the first question is that we informed potential participants that our project was accepted by 
the Regional Committee for Medical Research Ethics, which initially locates the project in a medical 
context. Another potential answer is that lay perspectives on mammography screening are influenced by 
medical discourses, leading women to assume that all research in the field of breast cancer is rooted in 
medical science. This might have influenced how women talked and what they saw as important to report 
to researchers. A further question is whether it is possible to inform participants properly about how data 
will be used and interpreted (Bosk, 2001). Even though we informed the participating women of the 
purpose of the project, we cannot expect them to see the potential interpretations that will occur. After all, 
as researchers we discover new interpretations as we write up our results. This merely reflects that 
information will always be interpreted within a context. 
Researcher participation and participator communication 
 
The focus groups were conducted as discussions but still following an interview guide with preset 
questions. Questions were put forward in a standardized manner and in a set order. Each question led to a 
group discussion where the participants spoke freely about the issue in question. In this manner a focus 
group can be said to be both an interview and a discussion group. 
 
As mentioned earlier, groups were directed by a moderator, who kept the discussion on topic by asking 
questions, inviting silent participants to join the discussion, and asking women to elaborate on their 
statements. Still, the main strategy at each group was to let the women discuss in their own ways so that 
we could hear their stories and perspectives. We chose to inform them that we (as researchers) would 
participate as little as possible during the discussion and that they were welcome to speak freely. 
Many women addressed the researchers with questions, especially during the first group session, as we 
can see in the example below: 
 
S: I thought it was very good to have the invitation [to the examination], that is, it is like a 
push . . . I am trying to examine myself sometimes but . . . it’s never on a regular basis, it’s like now 
and then. Ought to do it more regularly . . . Don’t know how often? Once a month or what? Can 
someone answer that? (S is turning towards the interviewer) 
Interviewer (looking at the group): Anybody know? Anybody have thoughts about this? 
A: I got this advice at the GP’s once. 
 
The group moderator turned the question toward the other participants in the group, and the discussion 
developed further through the other women’s advice and knowledge. One choice that we made was to 
refuse to answer questions from the participants until the set of three focus group sessions was completed. 
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After the last session the women were given information about mammography screening and breast cancer 
based on the questions they had brought forward during the focus groups. 
 
It is interesting to ask about the influence that a decision such as not answering questions might have on 
the group discussion and, furthermore, on the data we obtained. It is a paradox that although we were 
trying to obtain a normalized conversation between the focus group participants, as researchers we did not 
act in a manner normal to conversation in a group. In an ordinary group of people it would probably be 
considered impolite to refuse to answer a direct question. By choosing to observe more than participate in 
the conversation, we probably put ourselves at a distance from the participants, influencing how the 
women talked to us and to each other. 
 
Participants were a bit reserved at the beginning of the focus groups. Eventually they spoke more freely as 
the first session progressed and even more freely during the second and third group sessions. Sometimes 
discussions wandered away from the issues put forward by the moderator, and she had to turn the 
conversation back on track. At other times they brought up themes that the researchers did not cover in 
their interview guide, such as issues related to family structures and “descending from healthy people” as 
well as the use of alternative medicine and their relations to general practitioners while living in a small 
community. All of these subjects were brought forward in connection to women’s experiences of 
participating in mammography screening and could hardly have been anticipated by a researcher. 
 
This shows how focus groups are discussions to which the participants bring their knowledge, experiences, 
and attitudes but where these presumptions are stirred together with those of the other participants’ stories 
and opinions, thereby creating data from discourses and negotiations. Information lost in this process 
includes thoughts that are considered unsuitable in a group setting but that might have been revealed in a 
personal interview. The idea of focus groups as a construction site for data is therefore an argument for the 
researchers’ staying out of the discussion. 
 
On the other hand, one can see the choice to interfere as little as possible as a question of data biases. The 
idea of the researcher’s role as involving as little interference as possible to avoid bias is relevant in the 
more quantitative medical discourse. Another choice that was made early on was to omit the two most 
experienced focus group moderators in the research team from these groups. We saw the mere presence of 
a male moderator to be an unfortunate intervention considering the subject in question, no matter how the 
role was played. Having a doctor as moderator might also influence how focus group participants act 
during the discussion (Reventlow & Tulinius, 2005). Again, this choice can be defended from two points 
of view. From a natural science standpoint, using moderators less likely to evoke specific notions as to the 
topic of discussion can be seen as restraint from intervention. However, we did see that having two young 
women as moderators had some effects on conversations: The participants often took a motherly, 
instructive, or protective tone toward the moderators, a form of bias but a data-productive one. From a 
constructivist standpoint, our choice of moderators could be viewed as avoiding putting constraints on 
participants’ data-building conversations. From that standpoint, too, the choice can also be critiqued: What 
interesting exchanges, shifts of focus, and elisions might we have seen by inserting a man or a physician 
into the setting? 
Discussion 
Our research group aimed to perform multidisciplinary research acceptable and valid in both medical and 
qualitative fields of science. Using focus groups to find out how women experience participating in a 
screening program for breast cancer means accepting certain scientific perspectives. The choices we made 
were influenced by both medical discourses and our qualitative approach, and have presumably influenced 
the data material. Wilkinson (1999) has pointed to the loss of epistemological clarity when interpreting 
focus group data. For us it has been a challenge to stay true to the philosophical ideas of qualitative 
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research while opting for communication of our results to several parties participating in the field of 
mammography screening. In the end, our project design became something of a compromise, with 
elements that can be interpreted in both realist and constructivist terms. One can ask why it is necessary to 
approach two methods with different, perhaps even contrasting, theoretical bases. We wished to 
communicate results so that they could be seen as scientifically valid and relevant to all parties in the 
multifaceted field of mammography screening. 
 
It is relevant to ask whether it is possible to satisfy different epistemologies at the same time. The answer 
to this question is not a simple one and can be discussed on many levels. Others have seen data from focus 
groups as open to both essentialist and constructionist interpretations (Wilkinson 1999). We chose to 
approach the question in a practical manner; finding our way and testing possibilities in both directions 
while doing our research project. Our main choices have been presented in the previous sections of this 
article, and we will now discuss further the applicability of our approach to a multidisciplinary research 
field. 
 
In an attempt to make our research communicable to others, sampling and recruitment of focus group 
participants had to be done according to the claims for validity in different scientific traditions. Our 
strategic grouping by age and an urban/rural community dimension could be seen as a tool for producing 
variation, in keeping with a qualitative tradition, or as a tool for testing specific hypotheses, for example 
about the effects of age and closeness to “nature” as influences on health attitudes. 
 
Where the most widely accepted medical perspective might be to avoid bias and variation in the data 
material, qualitative theories acknowledge the idea of methods as practice, craftsmanship that is shaped 
and recreated during the situation. How, then, can we manage to maintain validity and reliability for both 
qualitative and medical researchers? Perhaps the answer is that it is impossible to satisfy strict 
methodologies—the one way or the other—and that validity and reliability can be treated as more open 
concepts. For instance, validity is not destroyed by this variation in approach to the object under study. 
Rather, the multiple experiences and attitudes that women present during a focus group session are 
valuable to the research field of mammography screening. Nevertheless, researcher presence will probably 
always be a bias, and data’s reliability can never be guaranteed when the researcher behaves differently in 
each unique situation. Rather, one could ask about the concept of reliability’s relevance for a qualitative 
study. This challenge seems inescapable when one is presenting qualitative research to an audience 
favoring natural science epistemologies. 
 
Our prospective design can also give room for more than one scientific perspective. It can be seen as 
showing how the experience of mammography screening becomes an element in the construction of the 
meanings of cancer and health. It can also be seen as isolating the invitation, the examination, and the 
results letter as separate factors influencing opinions. 
 
An obvious question, then, is how this might have influenced our data and analysis. Is it possible to 
analyze data at the same time both as constructions of meaning among those studied and as determined by 
interventions from the outside? Our choice when interpreting the data has been to see the data as a process 
whereby women’s interpretations and constructions of meaning are influenced by the intervention; that is, 
the screening invitation, examination, and results letter. However, instead of looking at the data as isolated 
before and after the screening intervention, we chose to focus on how women use the invitation and the 
screening program as part of their ongoing, dynamic constructions of meaning about, for instance, cancer 
and health. 
 
Whether our analyses will be accepted by either constructivist social scientists or realist natural scientists 
remains to be seen. It might be that in trying to obtain data on common grounds for both constructivists 
and naturalists, we have rendered it impossible for either to accept our study’s reliability or, even more, its 
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validity. Maintaining validity from two perspectives, namely the medical and the qualitative, seems 
possible with minor adjustments in both directions. Although this looks like a good hybrid between 
qualitative and medical research, one can ask whether it, rather, turned out as a bastard. 
Conclusion 
Mammography screening is entangled in medical discourses. Focus group research is based on theories of 
science that are partly opposed to the quantitative, or positivistic, medical discourse. Our research stands 
in the middle of a cross-disciplinary field, and our methodological and analytical choices reflect how 
qualitative research on mammography screening is in a squeeze between theories of qualitative research 
and medical discourses. The design of a study, sampling procedures, and researcher presence during data 
collection have different implications depending on the epistemological perspective of the researcher. It is 
therefore necessary to find a way to communicate to several discourses at once without rejecting one’s 
own perspective. Focus groups can be seen as a solution to a desire to do qualitative research in a field 
dominated by medical discourse. As we have shown, the process of focus groups and analyses of the data 
can be interpreted from a qualitative, constructivist point of view as well as from a more naturalist, or 
objectivist, perspective. Nevertheless, when we are analyzing data, the question of data perspective always 
remains. This makes focus group data valuable in a field of complex knowledge such as mammography 
screening. 
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